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Populations around the world are aging at a rapid pace, presenting new challenges for 
health services. This is because older adults encounter a different set of challenges than younger 
age groups, such as an increase in the proportion of the population at risk for age-related 
cognitive decline. As cognitive function is one of the most commonly referenced indicators of 
health because it is necessary for everyday functioning and adaptation to change, and studying 
factors that influence cognitive function is important. To date, most of the factors associated with 
cognitive decline are determined in early life, or develop across the lifespan. However, there may 
be some factors that can be altered at any point of the lifespan, including later life.  
Depressive symptoms have been previously examined as a potential area of intervention 
because they have been shown to be positively associated with many health outcomes in later 
life, including cognitive function. While the relationship between major depression and cognitive 
function has been investigated, much of the research focuses on older adults and global cognitive 
impairment. As such, the relationship between depressive symptoms and specific domains of 
cognitive function, such as executive function, is not well understood. 
This study used baseline cross-sectional data from the Comprehensive cohort of the 
Canadian Longitudinal Study on Aging (CLSA). The CLSA is an ongoing prospective cohort 
study of community-dwelling adults who were between 45 to 85 years of age at recruitment. The 
30,097 participants in the Comprehensive cohort lived within 25–50 km of 1 of 11 Data 
Collection Sites across seven provinces. Depressive symptoms were measured using the Center 
for Epidemiological Studies Short Depression Scale. A neuropsychological battery was used to 
assess executive function, a key domain of cognitive function required for purposeful decision 
making, planning, and behaviour. Bivariate and multivariable logistic regression were used to 
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examine the association between depressive symptoms and executive function. This study builds 
on previous research that has largely focused on the association between major depression and 
global cognitive impairment.  
Specific aims of the current study were to examine whether the presence of depressive 
symptoms was associated with low executive function after stratifying by age group and sex, and 
adjusting for confounders (i.e., province, education, household income, urban/rural residence, 
self-rated general health, chronic conditions, medication for depression, marital status, social 
support availability, smoking status, and alcohol use). In descriptive analyses, the prevalence of 
depressive symptoms was found to be highest among those 45–54 years compared to other age 
groups, and higher in females compared to males. The prevalence of low executive function was 
highest among those 75 years and over compared to other age groups and was approximately 
equal among males and females. 
In multivariable analyses, depressive symptoms were associated with low executive 
function overall. As social support availability (SSA) was identified as an effect modifier, those 
with higher SSA who reported depressive symptoms had significantly greater odds of low 
executive function compared to those who did not report depressive symptoms. In contrast, those 
with low SSA who reported depressive symptoms had lower odds of low executive function, 
although this finding was not significant. When stratified by age group, those 45–54 years, 55–
64 years, and 75 years and over with higher SSA had significantly greater odds of low executive 
function when reporting depressive symptoms compared to not. A positive association between 
depressive symptoms and low executive function was found in those 65–74 years, although this 
finding was not significant. The direction of the association in those 75 years and over with low 
SSA was reversed, where reporting depressive symptoms was associated with lower odds of low 
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executive function compared to not reporting depressive symptoms. In males, both current and 
former/never drinkers had significantly greater odds of low executive function when reporting 
depressive symptoms compared to not. In females, those with higher SSA and depressive 
symptoms had significantly greater odds of low executive function, whereas those with low SSA 
and depressive symptoms had lower odds of low executive function, although this was not 
significant.  
Findings from this study add to existing evidence that psychosocial factors are important 
to the health of middle-aged and older adults, and that depressive symptoms are associated with 
specific domains of cognitive function. Overall, the presence of depressive symptoms appears to 
negatively affects cognitive function, and that the association differs by age group and sex. As 
well, SSA may be another important psychosocial factor closely linked with depressive 
symptoms and cognitive function. Future work should examine the longitudinal association 
between depressive symptoms and executive function, and investigate whether this longitudinal 
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Populations around the world are aging at a rapid pace. Today, 13% of the global 
population is 60 years and older. By 2020, for the first time in history, the proportion of older 
adults will outnumber children younger than five (He, Goodkind, Kowal, & U.S. Census Bureau, 
2016; World Health Organization, 2017). By 2050, the proportion of older adults will contribute 
to 22% (two billion) of the global population (World Health Organization, 2015). The population 
aging observed at the global level is also reflected at the national level. In Canada, 17% of the 
population is currently 65 years or older, and this proportion is expected to increase to 25% by 
2036 (Canadian Institute for Health Information, 2011; Statistics Canada, 2019). These 
demographic transitions, driven by a decrease in fertility rates and an increase in life expectancy, 
present new challenges to social and health services, as an older population has different needs 
than a younger one. Now more than ever, it is crucial that research be conducted to examine 
ways to promote healthy aging.  
  In general, living longer provides opportunities that are beneficial to the individual and 
society. For example, older adults contribute to society as mentors, caregivers, consumers, and 
members of the workforce (World Health Organization, 2017). In turn, this engagement may 
reinforce the health and well-being of the individual. However, the extent to which these 
opportunities are beneficial is dependent on the health of the older population. If the increase in 
life expectancy is marked by substantial declines in physical and mental abilities, then the 
consequences of aging are more negative than positive, at both the individual and population 
level (World Health Organization, 2017). Declines in physical function may result in reduced 
functional independence for the individual, as well as an increased demand for health services. In 
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contrast, high cognitive and physical function, low probability of disability and disease, and 
active engagement and participation in life may promote better health (Rowe & Kahn, 1997).  
 Cognitive function is one of the most commonly referenced indicators of health because 
it is necessary for everyday functioning and adaptation to change (Meyers, 2012; Murman, 2015; 
Rowe & Kahn, 1997). While some changes in cognitive function are expected in later life, some 
individuals experience declines in cognitive function that are not part of the normal aging 
process. For example, mild cognitive impairment is a condition characterized by problems in 
memory or thinking that are greater than the changes normally expected with aging. Although 
these changes are not severe enough to interfere with activities of daily living and functional 
independence, having MCI may increase the risk of developing dementia (Alzheimer’s Society 
of Canada, 2018). Dementia, a chronic and progressive condition, can affect an individual’s 
memory, thinking, orientation, comprehension, learning capacity, and judgement (World Health 
Organization, 2012). Worldwide, it is estimated that 5–8% of people 60 years and older are 
living with dementia (World Health Organization, 2015). In Canada, the prevalence of dementia 
in people 65 years and older doubles every five years, from 1% for those ages 65–69, to 25% for 
those 85 years and older (Canadian Institute for Health Information, 2018). There are also 
differential effects between sexes, both nationally and globally. Overall, dementia is more 
prevalent in females than males, and this difference increases with age (Canadian Institute for 
Health Information, 2018).  
Declines in overall cognitive function, as well as declines in specific domains of 
cognitive function, are also important indicators of health for middle-aged and older adults. For 
example, declines in executive function, a key domain of cognitive function responsible for 
controlling behaviour, planning, and purposeful decision making, can negatively affect 
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functional independence and reduce the ability of an individual to perform activities of daily 
living (Diamond, 2014).  
 While overall trends suggest that population aging is associated with increases in the 
proportion of individuals at risk for age-related cognitive decline, there are still variations in how 
certain populations, or individuals, experience aging (World Health Organization, 2015). In 
general, the variation may be attributed to differences in genetics, demographic factors, health 
factors, social factors, and health behaviours. It is likely that these factors are not mutually 
exclusive. Therefore, a better understanding of which factors allow some individuals to reach 
older age without functional declines, while others experience declines by midlife, is key to 
alleviating the demand on social and health services, and to promoting more sustainable 
population aging. 
 While there are a number of modifiable factors that are associated with MCI, dementias, 
and cognitive function in specific domains, many of these factors require early intervention, long 
before symptoms of cognitive decline develop. This means that for a proportion of the 
population, it may be too late to intervene. Although primary prevention is important, secondary 
and tertiary prevention methods should be available for those with greater risk for cognitive 
decline, or who have already begun to show symptoms of cognitive decline.  
One possible factor that is modifiable across the lifespan is mental health, and in 
particular, depressive symptoms. Depression is a common mood disorder that affects more than 
300 million people worldwide. It is the leading cause of disability and contributes to a large 
portion of the global disease burden (World Health Organization, 2018). In Canada, 11.3% of 
adults reported experiencing depressive symptoms that met criteria for clinical depression at 
some point in their lifetime. Adults 65 years and older contributed to the highest proportion of 
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the population who reported subclinical symptoms of depression (Public Health Agency of 
Canada, 2016). As both depression and dementia are common disorders in the older population, 
past research has heavily focused on the association between depression and global cognitive 
impairment. However, the association between depressive symptoms and specific cognitive 
domains, such as executive function, is not well understood. In addition, depressive symptoms 
are often underreported in the older adult population and cannot be as readily captured without a 
substantial investment of time and resources. Due to these limitations, the possible modifying 
effects of age and sex on the association between depressive symptoms and domain-specific 
cognitive function have not been explored either, although depressive symptoms have been 
described to affect age groups, as well as males and females, differently.  
The purpose of this study was to examine the association between depressive symptoms 
and executive function, a key domain of cognitive function, and to explore how this association 
is impacted by factors, such as age and sex. The first objective was to examine if the presence of 
depressive symptoms was associated with low executive function, adjusting for potential 
confounders (i.e., age, sex, education, annual household income, province, urban/rural residence, 
self-rated general health, chronic conditions, medication for depression, marital status, social 
support availability, smoking status, and alcohol use). Other research objectives included 
stratifying the association across age groups (45–54, 55–64, 65–74, and 75 years and over) and 
by sex (males and females) to explore possible effect modification by these factors.  
This research project used secondary data from the Canadian Longitudinal Study on 
Aging (CLSA). The CLSA is an ongoing prospective cohort study designed to better understand 
the aging process in Canadians. The CLSA is comprised of approximately 50,000 Canadian 
residents, who were between the ages of 45 to 85 years at recruitment (2010-2015) (Raina, 
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Wolfson, & Kirkland, 2009). Separated into the Tracking cohort and the Comprehensive cohort, 
participants will be followed for at least 20 years, with repeated waves of assessment every three 
years (first follow-up occurred between 2015 and 2018). This study focused on data from the 
Comprehensive cohort at baseline, which consists of 30,097 participants who were recruited and 
lived within 25–50 km of the 11 Data Collection Sites (DCS) across seven provinces. 
Participants in the Comprehensive cohort provided physical and cognitive data by completing at-
home and DCS interviews with trained CLSA personnel. Depressive symptoms were determined 
using the Center for Epidemiological Studies Short Depression Scale. Executive function, a key 
cognitive domain, was assessed using a neuropsychological battery consisting of five tests. A 
variety of confounding variables were also assessed.  
 Overall, an aging population will ultimately experience age-related declines in cognitive 
function. Since cognitive function is an important determinant of health and depressive 
symptoms are more common in later life, a better understanding of the relationship between 
depressive symptoms and cognitive function may inform public health initiatives that can be 
applied at any point throughout the lifespan, but especially in later life. Understanding how 
depressive symptoms affect specific domains of cognitive function will help to reduce poorer 
cognitive outcomes for middle-aged and older adults.  
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2.0 Literature Review 
 
2.1 Cognitive Function 
 
Cognitive function refers to the range of mental processes that permit information 
processing and knowledge application (Meyers, 2012). Cognitive function underpins many of the 
actions an individual performs on a daily basis throughout the life course. It is integral to overall 
well-being and functional independence (Meyers, 2012; Murman, 2015; St. John, Montgomery, 
Kristjansson, & McDowell, 2002). Declines in cognitive function are associated with decreased 
autonomy, increased frailty, and inability to adapt to functional and social changes (Clegg, 
Young, Lliffe, Rikkert, & Rockwood, 2013; Depp & Jeste, 2006; World Health Organization, 
2015).  
Cognitive function can be measured as an overall entity (i.e., globally) or by domain 
(Sachdev et al., 2014). Global cognitive function and performance on measures that assess 
specific domains of cognitive function, are important determinants of successful aging (Depp & 
Jeste, 2006; Sachdev et al., 2014; Wlodarczyk, Brodaty, & Hawthorne, 2004). While the number 
of domains of cognitive function that exist has been debated, the Diagnostic Statistical Manual of 
Mental Disorders (DSM-5) defines six domains that best describe neurocognitive conditions, 
based on the type of action being performed and the brain circuits being activated. The six 
domains of cognitive function are executive function, perceptual-motor function, language, 
learning and memory, complex attention, and social cognition (American Psychiatric 
Association, 2013; Sachdev et al., 2014). Across the six domains, executive function is 
particularly important to successful aging as it involves many brain regions and allows for 
persons to engage in independent, appropriate, purposeful, and self-serving behaviours (Harada, 
Love, & Triebel, 2013). 
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2.1.1 Executive Function 
 
Executive function refers to a set of top-down mental processes that occur when 
behaviour is guided by intention and requires effort (Diamond, 2014; Miller & Cohen, 2001). 
For example, executive function is activated when individuals plan future actions or goal-
oriented behaviours. These actions can span from simple to complex. Diamond (2014) identifies 
three subcategories of executive function: 1) inhibition, 2) working memory, and 3) cognitive 
flexibility. These subcategories of executive function align with the six subdomains of executive 
function described in the DSM-5: inhibition, working memory, cognitive flexibility, planning, 
decision-making, and responding to feedback (Sachdev et al., 2014).  
Inhibition, the first subcategory of executive function, requires individuals to selectively 
attend to given stimuli while inhibiting a predominant response and controlling one’s attention, 
behaviour, and emotions. Inhibition allows individuals to practice self-control and voluntarily 
ignore background stimuli that may hinder goals or intentions. Examples of measures of 
inhibition include the Stroop Neurological Screening Test or delay-of-gratification tasks 
(Diamond, 2014; Tuokko, Griffith, Simard, & Taler, 2017). Declines in inhibition result in errors 
of impulsivity (e.g., impatience), poor self-control, and poor self-discipline (Diamond, 2014). 
Working memory requires individuals to hold information in their mind and selectively 
remain focused on the information although it may not be perceptually present. Working 
memory is often used when following instructions, communicating with others, problem solving, 
and connecting ideas logically (Diamond, 2014). This subcategory of executive function is 
distinct from the domain of cognitive function called memory. Working memory requires 
information to be remembered and then manipulated (e.g., reordering remembered objects based 
on size for sorting), whereas memory requires information to just be held (e.g., remembering 
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objects) (Diamond, 2014). They are also distinct from one another from a developmental 
standpoint. Memory is present in very young children and may require no effort. In contrast, 
working memory develops during adolescence through adulthood, and grows as individuals start 
to connect ideas and apply past knowledge to new surroundings (Diamond, 2014). Measures of 
working memory include repeating a list of tasks demonstrated by an administrator or re-
ordering remembered objects (Diamond, 2014). 
Cognitive flexibility, the final subcategory of executive function, requires individuals to 
adjust to new and changing situations or demands, and to take on new perspectives while 
considering rewards and punishments (Diamond, 2014). It develops after inhibition and working 
memory as it requires individuals to be able to deactivate previous perspectives (inhibition) and 
activate newer perspectives based on spatial and interpersonal awareness (working memory). 
Tests that measure cognitive flexibility include those that examine task-shifting, semantic or 
categorical fluency, and word or letter fluency. These include the Mental Alternation Test, the 
Animal Fluency Test, and the Controlled Oral Word Association Tests, respectively (Diamond, 
2014; Tuokko et al., 2017). 
Although three subcategories of executive function have been defined, they generally co-
occur (Diamond, 2014). The connectivity between the subcategories of executive function are 
also reflected anatomically. That is, the prefrontal cortex (PFC), a brain structure with 
widespread connectivity to other cortical (cortico-cortical) and subcortical (cortico-subcortical) 
brain areas, is believed to be responsible for executive function (Chung, Weyandt, & Swentosky, 
2014). A meta-analysis by Alvarez & Emory (2006) suggests that the PFC is divided into three 
circuits, the dorsolateral, ventromedial, and orbitofrontal circuits, that send and receive 
information from nearly all major sensory and motor systems (Gilbert & Burgess, 2013). Across 
 9 
these brain circuits, the left PFC is responsible for cognitive flexibility and the right PFC is 
linked to inhibition (Alvarez & Emory, 2006). Other important brain structures associated with 
executive function include the basal ganglia, thalamus, cerebellum, and the parietal lobe 
(Alvarez & Emory, 2006). 
Declines in executive function result in symptoms of impulsivity; inability to inhibit 
reflective actions (Gilbert & Burgess, 2013; Takeuchi et al., 2013); inappropriate social 
behaviours; hyper- or hypo-sexual arousal; motor dysfunction; and increased reckless behaviour, 
drug use, and aggression (Suchy, 2009; Takeuchi et al., 2013). Given that executive function is 
critical for independent daily living, and is associated with a number of brain regions that span 
all sensory and motor systems in the body, it is important that research focusing on age-related 
cognitive decline investigate factors that may influence executive function.   
2.1.2 Declines in Cognitive Function 
 
Global and domain-specific levels of cognitive function can range from normal function 
to severe declines that may represent the onset of progressive neurodegenerative disorders, such 
as dementia. Levels of cognitive function can also change across the lifespan. For example, some 
individuals may transition from normal cognitive function to mild cognitive impairment, and 
then back at different points throughout their life course (Iraniparast et al., 2016; Koepsell & 
Monsell, 2012). However, the general trend is to observe worsening global and domain-specific 
cognitive function in later life. While most research has focused on global cognitive impairment, 
overall executive function and its subcategories have been also shown to decline in older age 
(Diamond, 2014; Harada et al., 2013). Although some age-related cognitive decline is expected, 
normal cognitive aging can still result in subtle declines that negatively impact functional 
independence (Harada et al., 2013). In addition, cognitive scores, even within the normal range, 
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can predict morbidity, mortality, and institutionalization (St. John et al., 2002). Therefore, testing 
the subcategories and overall executive function in healthy middle-aged and older adults may 
identify those at risk for further cognitive decline before the onset of severe symptoms that 
significantly reduce functional independence (St. John et al., 2002; Suchy, 2009). 
More severe forms of cognitive decline include mild cognitive impairment (MCI) and 
dementia. MCI, also known as mild neurocognitive disorder, is considered an intermediate stage, 
positioned between normal cognition and dementia (Petersen, 2004; Petersen et al., 1999). It is 
characterized by an initial decline in executive function and memory although the ability to 
perform activities of daily living is not affected (Hugo & Ganguli, 2015). MCI is believed to 
occur in 16–20% of individuals over 60 years (R. Roberts & Knopman, 2013). Some individuals 
with MCI may convert back to normal cognitive function, but the majority of studies report that 
20–40% of those with MCI will progress to dementia (R. Roberts & Knopman, 2013). 
Diagnosing MCI requires the use of global and domain-specific cognitive tests. A cut-off of 1–2 
SD below the average score on a test is generally used as part of the diagnostic criteria (R. 
Roberts & Knopman, 2013; Sachdev et al., 2014). 
Dementia is a descriptive term that refers to a set of clinical symptoms associated with 
severe declines in both cognitive function and the ability to perform activities of daily living 
(Alzheimer’s Association, 2019). There are several forms of dementia and each is classified by 
symptom etiology (Sachdev et al., 2014). While most forms are progressive, with permanent and 
fatal pathophysiological changes, there are some exceptions. When treated or addressed, 
symptoms of dementia caused by depression, thyroid problems, vitamin deficiencies, medication 
side effects, or excessive use of alcohol (i.e., thiamine deficiency) may be reversed (Alzheimer’s 
Association, 2019). Otherwise, the majority of the types of dementia are a result of abnormal and 
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irreversible damage to brain cells in different brain regions (Alzheimer’s Society of Canada, 
2019). Alzheimer’s disease (AD) is the most common cause of dementia and accounts for more 
than two-thirds of the cases (Tyas & Gutmanis, 2015; World Health Organization, 2012). AD is 
associated with severe declines in executive function, memory, and perceptual-motor function 
(Alzheimer’s Society of Canada, 2019). Symptoms of AD will increase in severity over time, 
with marked declines in functional independence (Alzheimer’s Association, 2019; Alzheimer’s 
Society of Canada, 2019). As dementia is progressive and develops over time, it is necessary to 
be able to identify pre-clinical symptoms as early as possible. This may provide a sufficient 
window to intervene and lower the risk of dementia. 
2.1.3 Factors Influencing Cognitive Function 
 
 To date, research has shown a variety of factors that are associated with cognitive 
function. Common examples of non-modifiable factors include age, sex, and genetics. Common 
examples of modifiable factors include various demographic, health, and lifestyle factors. The 
mechanism(s) that connect these factors to cognitive function have long been debated because 
the relationship between neuropathology and its clinical manifestation is not direct (Stern, 2002). 
That being said, a commonly referenced theory that describes how certain factors may influence 
cognitive function is the reserve theory. It consists of two interacting components: brain reserve 
theory and cognitive reserve theory (Stern, 2002). 
 Brain reserve theory describes the passive loss of brain structure until a threshold, that is 
predetermined, is reached and symptoms of brain loss become clinically apparent (Stern, 2002). 
It relies on the physical structure of the brain, such as brain weight and the number of synapses 
(Stern, 2002, 2012). In contrast, the cognitive reserve theory describes both the passive loss of 
brain structure and also the ability of the brain to actively recruit other brain structures and 
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synaptic pathways to compensate for these losses in an efficient manner (Stern, 2002). Cognitive 
reserve differs across individuals and depends on factors that enhance cognitive stimulation and 
promote efficient use of brain networks, such as higher educational attainment (Stern, 2002, 
2012). A better understanding of factors that influence cognitive function may identify ways to 
improve cognitive reserve by 1) protecting the brain’s physical health despite passive structural 
loss, and 2) increasing the brain’s efficiency and ability to recruit alternative mental processes, 
when needed. 
2.1.3.1 Non-modifiable Factors for Cognitive Function 
 
 Cognitive function is associated with several non-modifiable risk factors. Age is the most 
established non-modifiable risk factor, displaying a negative association with cognition in later 
life. Older age is associated with declines in executive function (Buckner, 2004; van Hooren et 
al., 2007) and overall cognitive function (Tilvis et al., 2004). Also, advanced age is associated 
with increased risk for MCI and dementias (Wang & Blazer, 2015). Among population-based 
studies, the prevalence of MCI is approximately 19% in adults over the age of 65 years, with 
more than half of these cases progressing to dementia within five years (Gauthier et al., 2006). 
The prevalence of dementia increases exponentially with age, and incidence increases steadily 
until 85 years of age, after which it continues to rise, but less rapidly (Hugo & Ganguli, 2015). 
Even cognitively healthy adults, who have no typical risk factors for AD (e.g., genetic 
predisposition, vascular risk factors, or previous traumatic brain injury), can still develop AD in 
later life because of increasing age (Honjo, Black, & Verhoeff, 2012).  
There is some debate about sex as a risk factor for cognitive decline and dementia. While 
some studies have not observed sex differences (Barnes et al., 2003), others have found females 
to be at higher risk for cognitive impairment (Alvarado, Zunzunegui, Del Ser, & Béland, 2013; 
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Z. Zhang, 2006). Based on population statistics, approximately two-thirds of individuals living 
with dementia in Canada and the United States are female (Alzheimer’s Association, 2019; 
Public Health Agency of Canada, 2017). While the prevailing argument was that females, on 
average, lived longer than males, there is evidence that sex differences may also be attributed to 
the combination of biological and genetic variations alongside life experiences (Snyder et al., 
2016; Z. Zhang, 2006). Biological differences between males and females include the tendency 
for females to have a smaller head circumference; experience hormonal changes, particularly 
after menopause; and respond differently to stress (Snyder et al., 2016). Males and females also 
experience differences in access to education and highly skilled occupations, cultural 
expectations, diet, and social networks, all of which are believed to impact the association 
between sex and cognitive outcomes (Alvarado et al., 2013; Z. Zhang, 2006).  
Genetics also influences risk for cognitive decline. The apolipoprotein E (APOE) gene on 
chromosome 19 codes a plasma protein whose major functions include transportation of lipids 
(e.g., cholesterol) and participation in processes implicated in neuronal repair (Small, Rosnick, 
Fratiglioni, & Bäckman, 2004). One of its allelic variations, APOE-!4, is the best-established 
genetic risk factor for the development of AD (Hugo & Ganguli, 2015). APOE-!4 is also 
associated with poorer performance on tests of global cognitive function and executive function 
in healthy adults (Small et al., 2004). Other genetic risk factors for early-onset (or familial) AD 
include inherited autosomal dominant mutations in presenilin 1, presenilin 2, and the amyloid 





2.1.3.2 Modifiable Factors for Cognitive Function 
 
 There are a number of modifiable risk factors associated with declines in cognitive 
function and its domains, such as executive function. These include demographic, health, social, 
and lifestyle factors. 
 The association between educational attainment, often measured as years of formal 
education completed, and risk of cognitive decline is well known (Anstey & Christensen, 2000; 
Barnes & Yaffe, 2011; Caamaño-Isorna, Corral, Montes-Martínez, & Takkouche, 2006). Higher 
educational attainment is shown to be associated with slower declines in scores on tests 
measuring specific cognitive domains, including executive function (Anstey & Christensen, 
2000). Higher educational attainment and higher intelligence scores are also associated with a 
reduced risk for dementia. In contrast, low educational attainment is associated with an increased 
risk for AD and other dementias (Barnes & Yaffe, 2011).  
 Socioeconomic status (SES), often measured using educational attainment, income, and 
occupational complexity, is also associated with cognitive function. Adults with lower SES were 
shown to have poorer performance on tests for overall cognitive function and domain-specific 
cognitive function (Gallacher et al., 1999). Compared to higher income or higher occupational 
complexity, low income and low occupational attainment are also associated with greater risk for 
AD and dementia (Alzheimer’s Association, 2019; Fratiglioni & Wang, 2007). Geographical 
location of residence may also be an important factor, although findings are mixed. While some 
studies have shown that the prevalence of AD and dementia is significantly higher in those living 
in rural regions versus urban (Jia et al., 2014), more recent findings found no difference in the 
risk of dementia (St. John, Seary, Menec, & Tyas, 2016).  
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Chronic health conditions, and lower reported physical health, are associated with poorer 
performance on measures of executive function and overall cognitive function, as well as an 
increased risk for AD and other dementias. In fact, cardiovascular disease, a common health 
condition, is recognized as an independent risk factor for executive dysfunction, global cognitive 
impairment, and dementias (e.g., Benisty et al., 2009; Brands, Biessels, de Haan, Jaap Kappelle, 
& Kessels, 2005; Brickman et al., 2011).  
Other chronic conditions associated with cognitive function include diabetes, high blood 
pressure, and stroke. Diabetes is associated with reduced performance in executive function, 
memory, and perceptual-motor function (Kodl & Seaquist, 2008; Weinger et al., 2008). A meta-
analysis demonstrated even mild to moderate deficits in executive function in those with diabetes 
significantly impacted everyday functioning (Brands et al., 2005). 
High blood pressure disrupts the structure and function of blood vessels, leading to an 
increase in brain atrophy from ischemic damage, an increase in the number of senile plaques, and 
a decrease in brain weight (Barnes & Yaffe, 2011; Iadecola et al., 2016). In adults over the age of 
60 years, high blood pressure is believed to initiate cognitive impairment (Knopman et al., 2001). 
Other studies have shown it is associated with a two-fold increase in odds of cognitive decline 
(Honjo et al., 2012; Tzourio, Dufouil, Ducimetière, & Alpérovitch, 1999). However, the risk of 
cognitive decline has been shown to decrease in those taking antihypertensive medication on at 
least one occasion versus those who did not (Tzourio et al., 1999).  
Strokes are also associated with cognitive function by affecting neurological health. 
Large and small vessel damage following a stroke has shown to be associated with severe 
cognitive decline and increased risk for dementia (Honjo et al., 2012; Marchant et al., 2012). In 
addition, both white matter lesions and lacunar infarcts can be observed in cognitively normal 
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adults and are associated with worsening executive function (Benisty et al., 2009; Brickman et 
al., 2011), poorer global cognition (van der Flier et al., 2005), and increased risk for dementia 
(Honjo et al., 2012; Marchant et al., 2012).  
Besides health conditions, social factors (such as social support and marital status) are 
associated with cognitive function. Compared to those who were married, those who were single 
and living alone were shown to have an increased risk for developing dementia (Fratiglioni, 
Wang, Ericsson, Maytan, & Winblad, 2000). In contrast, being married, living with a partner, or 
being in a satisfying relationship by midlife was associated with reduced risk for cognitive 
impairment by 65 years of age compared to those who were widowed, divorced, or separated 
(Håkansson et al., 2009). Perceived social support, regardless of marital status, is also important. 
Regardless of frequency of contact with social network(s), older adults who reported a poor or 
limited social network showed a 60% increased risk for dementia compared to older adults who 
reported having a moderate or extensive social network (Fratiglioni et al., 2000). Among adults 
who reported being socially isolated and having greater perceived loneliness, lower overall 
cognitive function and lower domain-specific cognitive function in late life were observed in 
comparison to adults who reported no loneliness (Boss, Kang, & Branson, 2015; Wilson et al., 
2007).  
 Other notable modifiable factors include various lifestyle behaviours. Physical activity is 
associated with cognitive impairment and dementia (Barnes & Yaffe, 2011; Langa, 2015). 
Compared to individuals who do not partake in physical activity, participating in regular or 
highly frequent physical activity protects against cognitive impairment, all-cause dementia, and 
AD (Barnes & Yaffe, 2011; Hugo & Ganguli, 2015; Laurin, Verreault, Lindsay, MacPherson, & 
Rockwood, 2001).  
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Smoking is another lifestyle factor that can affect cognitive function. Nicotine, the 
primary psychoactive constituent in tobacco and cigarette smoke, has plausible mechanisms for 
improving cognitive function by improving executive function, attention, reaction time, and 
short-term memory in a dose-response manner (Murray & Abeles, 2002; Peters, Peters, Warner, 
Beckett, & Bulpitt, 2008b). Despite nicotine presenting a potential neuroprotective role, cigarette 
smoke contains approximately 4,700 compounds (Borgerding & Klus, 2005). As such, the other 
compounds in cigarette smoke, alongside the pharmacological factors and behaviours associated 
with smoking, may increase the risk of cognitive decline (Swan & Lessov-Schlaggar, 2007) and 
AD (Tyas et al., 2003). Compared to never smokers, current and former smokers had greater 
yearly declines in global cognitive function (Anstey, Von Sanden, Salim, & O’Kearney, 2007; 
Duron & Hanon, 2008; Peters et al., 2008b). There is also a strong dose-response effect between 
amount smoked and risk of cognitive impairment, AD, and all-cause dementia, with heavy 
smokers being more at risk than light smokers (Duron & Hanon, 2008; Tyas et al., 2003). While 
the most likely mechanism between smoking and subsequent cognitive decline is underlying 
vascular disease (Barnes & Yaffe, 2011), the neurotoxins in smoke could contribute to the risk 
for AD through oxidative stress and free radical formation, inflammatory processes, or other 
mechanisms (Barnes & Yaffe, 2011; Tyas et al., 2003).   
Alcohol consumption is another modifiable lifestyle behaviour that has been widely 
studied. Two separate meta-analyses found that light to moderate drinkers had a 25–32% reduced 
risk for AD and other dementias compared to non-drinkers (Anstey, Mack, & Cherbuin, 2009; 
Peters, Peters, Warner, Beckett, & Bulpitt, 2008). Moderate drinkers also had a reduced risk for 
cognitive decline and MCI (Anttila et al., 2004; Zuccala et al., 2006). The J-shaped relationship 
between alcohol consumption and risk for declines in cognitive function has been consistently 
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reported in these studies. The J-shape curve suggests that moderate consumption is associated 
with the lowest risk for adverse cognitive and overall health outcomes, whereas no consumption 
or excessive alcohol consumption is associated with higher risk for adverse and deleterious 
effects on cognitive function (Alzheimer’s Association, 2019; Andreasson, 1998; Anstey et al., 
2009; Ballard & Lang, 2018; Schwarzinger et al., 2018; Tyas, 2001). The potential mechanisms 
underlying the relationship between alcohol use and cognitive function include the direct 
neurotoxic effect of ethanol and metabolites; thiamine deficiency; and hepatic encephalopathy, 
epilepsy or head injuries from intoxication (Schwarzinger et al., 2018). However, many cohort 
studies vary in their considerations of the types of alcohol consumed and the thresholds of 
consumption assessed (Anstey et al., 2009; Ballard & Lang, 2018). Many studies also face the 
challenge of distinguishing alcoholic dementia from other dementias as alcoholic dementia is 
generally not an outcome considered in epidemiological studies (Ballard & Lang, 2018; Tyas, 
2001). In addition, alcohol consumption is associated with depression and various lifestyle 
behaviours, including poorer diet, smoking, lower adherence to medical treatments, and social 
isolation (Ballard & Lang, 2018; Schwarzinger et al., 2018; Tyas et al., 2000). Therefore, there 
may be a spurious association and the full effect of alcohol consumption on cognitive function is 
not fully understood.   
 Overall, the majority of the modifiable factors for cognitive function discussed above 
affect processes that occur in early life or have additive effects over the lifespan. However, it 
may be possible that some factors can be modified at any point throughout the lifespan, including 
later life, to either prevent cognitive decline by preventing the pre-clinical systems, or to prevent 
further decline, such as transition to MCI or dementia, in those already demonstrating symptoms. 
A potential area of focus is mental health and, in particular, depressive symptoms. In addition to 
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the fact that mental health has become a public health priority in recent years, given that 
depressive symptoms can occur at any point throughout the lifespan and levels of cognitive 
function may also change across the lifespan, intervention on depressive symptoms may reduce 
the risk of cognitive decline.  
2.2 Depressive Symptoms 
 
Older age is associated with important life changes, such as retirement, bereavement, and 
declines in health. These changes may cause feelings of sadness, stress, and uneasiness. While 
the prevalence of clinically diagnosed depression decreases in older age, the prevalence of 
depressive symptoms increases, where depressive symptoms are most frequently reported among 
the oldest old (Chui, Hoppmann, Gerstof, & Luszcz, 2015). Given the relatively higher 
prevalence of depressive symptoms, compared to depression, among older adults, depressive 
symptoms are an important factor to study when considering later-life health outcomes.  
2.2.1 Depressive Symptoms, Depression, and Diagnostic Criteria 
 
Depression, also known as major depressive disorder or clinical depression, is a common 
mental disorder that can occur any time throughout the life course. Depression accounts for 4.3% 
of the global burden of disease and is the largest single cause of worldwide disability (World 
Health Organization, 2016). Compared to the general population, individuals with depression are 
at increased risk for declines in cognitive function and have a 40% greater chance of premature 
death, primarily due to unattended physical health problems (World Health Organization, 2016). 
In the DSM-5, depression is defined as experiencing depressive symptoms nearly every 
day, for most of the day, for a minimum of two weeks. Depressive symptoms that can result in a 
diagnosis of depression include, but are not limited to: persistent sadness; irritability; decreased 
energy or fatigue; feeling hopeless, helpless, restless, or worthless; difficulty concentrating, 
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remembering, or making decisions; appetite and weight changes; inability to perform activities 
of daily living; and aches or pains, headaches, or digestive issues without clear physical causes 
that alleviate after treatment (American Psychiatric Association, 2013). It is important to note 
that individuals with depression may not experience every symptom listed. Some individuals 
may experience many of the symptoms listed, while others do not. Also, not all individuals who 
experience depressive symptoms will receive a clinical diagnosis of depression (National 
Institute of Mental Health, 2018). Therefore, it is important to differentiate whether an individual 
has depression, or more broadly, is experiencing depressive symptoms. This is because it may 
have implications on the type of intervention needed to mitigate the effects of depressive 
symptoms versus depression.  
2.2.2 Factors Influencing Depressive Symptoms 
 
A variety of genetic, biological, environmental, and psychosocial factors for depression 
and depressive symptoms have been discussed (National Institute of Mental Health, 2018). Of 
these factors, there are two important variables that have been known to consistently modify both 
depression and depressive symptoms. These variables are age and sex. It is believed that age and 
sex work independently, and in combination, to influence depression and depressive symptoms.  
2.2.2.1 Age and Depressive Symptoms 
 
Contrary to common perception, while depression is associated with increased risk for 
morbidity, mortality, and decreased cognitive, social, and physical functioning, depression is less 
frequent among older adults than younger adults (Blazer, 2003). The prevalence of depression in 
community-dwelling adults is between 1–5%, with higher prevalence (10–12%) among those 
hospitalized for medical or surgical reasons (Fiske, Loeback Wetherell, & Gatz, 2009; Koenig, 
Bhalla, & Butters, 2014). While the prevalence of depression decreases in older age, longitudinal 
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studies show an increase in depressive symptoms in older age (Chui et al., 2015; Zhang, Kahana, 
Kahana, Hu, & Pozuelo, 2009). The prevalence of depressive symptoms has been reported to be 
8–16% among community-dwelling older adults and greater than 30% among those hospitalized 
(Blazer, 2003). Other studies have reported the prevalence of depressive symptoms as high as 
34–58% in community-dwelling adults over 65 years of age (Minicuci, Maggi, Pavan, Enzi, & 
Crepaldi, 2002). Despite this, few studies have been able to show the association between age 
and depressive symptoms in both middle-aged and older adults. For example, one 20-year study 
was able to show that depressive symptoms were persistently high and that the prevalence of 
depressive symptoms increased with age. However, the study population contained only women 
65 years and over (Byers et al., 2012). Therefore, findings cannot be generalized to men, and do 
not explain how depressive symptoms differ between middle-aged and older adults as the study 
population focused on those 65 years and over. 
Age also impacts the types of depressive symptoms experienced. For example, younger 
adults generally report symptoms related to irritability or behavioural problems, whereas older 
adults are more likely report symptoms related to anxiety, agitation, physical and memory 
problems, or somatic issues, like gastrointestinal issues, insomnia, and fatigue (Koenig et al., 
2014).  
In addition, etiology and prognosis of depressive symptoms and depression differs with 
age. Depression or depressive symptoms that occur in younger adults are associated with a 
higher likelihood of family history of depression, possibly implying the condition is genetically 
influenced. In contrast, depression or depressive symptoms that occur in late life (i.e., after the 
age of 60 years) appear to be related to structural brain changes or vascular risk factors (Fiske et 
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al., 2009). As such, it is possible that depressive symptoms that arise in older age are relatively 
modifiable compared to depressive symptoms experienced in younger age.  
Although the majority of evidence supports an association, there are some studies that 
have not observed an association between age and depression (Cole & Dendukuri, 2003; 
Livingston, Watkin, Milne, Manela, & Katona, 2000). One possible explanation for this 
discrepancy is that disability confounds the relationship. Disability is independently and 
positively associated with both older age and depression (Berkman et al., 1986). Since 
depression in older age is frequently comorbid with other physical conditions, and the diagnostic 
criteria for depression omits symptoms attributable to other medical conditions or disability, the 
influence that age has on depression may not be evident (Blazer et al., 1991; Blazer, 2003). 
Overall, the likelihood of feeling depressive symptoms differs across the lifespan, where older 
adults are more likely to report depressive symptoms. Age should be considered as having an 
influence on risk for depressive symptoms and experiences unique to older age (e.g., retirement)  
may trigger more depressive symptoms than previously present (Alexopoulos, 2005). 
2.2.2.2 Sex and Depressive Symptoms 
 
Sex has also been shown to be associated with depression and depressive symptoms. 
Globally, the prevalence, incidence, and morbidity risk for depression are higher in females than 
males (Fiske et al., 2009; Piccinelli & Wilkinson, 2000). This is a similar pattern to that seen in 
Canada, where females reported a higher rate of depression (5.8%) than males (3.6%) in the last 
12 months (Pearson, Janz, & Ali, 2017). Compared to males, females are twice as likely to 
develop depression, with some studies reporting a three- to four-fold increase in risk for 
depression (Culbertson, 1997; Nolen-Hoeksema, 2001). In addition, the number and severity of 
depressive symptoms affect males and females differently across the life course (Albert, 2015; 
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Koenig et al., 2015; Lugtenburg et al., 2017), where females generally exhibit higher cumulative 
depressive symptoms and are more likely to report depressive symptoms than males (Albert, 
2015; Zeki Al Hazzouri et al., 2014). Males are also more likely to report depressive symptoms 
related to irritability or anger, whereas females are more likely to report depressive symptoms 
related to sadness (Public Health Agency of Canada, 2016). One possible explanation for this 
difference is that compared to males, females experience more feelings of powerlessness and 
lack of societal status; traumas and sexual abuse; and chronic strains, such as poverty, 
harassment, lack of respect, and constrained choices. Even if males and females experience the 
same stressors, females may have an increased risk for depressive symptoms because of 
biological responses to stress, self-concepts, and copying styles unique to females (Nolen-
Hoeksema, 2001). It is also possible that since males are generally less likely to report depressive 
symptoms than females, males less frequently meet the clinical criteria for depression, and 
therefore their depressive symptoms go underreported (Angst et al., 2002).  
Overall rates of depression are also higher in older females than older males compared to 
younger females and males, respectively (Fiske et al., 2009). One possible explanation is that 
women experience more chronic conditions and are more likely to be widowed in older age 
(Chui et al., 2015). Although females are at higher risk of developing depressive symptoms and 
comprise a larger proportion of those 85 years and over with depressive symptoms, gender 
differences in the trajectories of depressive symptoms are important, particularly as targets for 
intervention (Byers et al., 2012). That is, among older adults, the development and trajectory of 
depressive symptoms in males may primarily be attributable to perceived health and disability, 
whereas in females, it may be attributable to perceived social support and disability (Byers et al., 
2012) 
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2.2.2.3 Other Factors Affecting Depressive Symptoms 
 
Genetics is a factor thought to influence depressive symptoms, and family history of 
depression increases the risk for depression, as previously mentioned (Gatz, Pedersen, Plomin, 
Nesselroade, & McClearn, 1992). Although there is an apparent link between genetics and 
depression, definitive genetic markers for depression have yet to be identified (Alexopoulos, 
2005). Previous studies have shown an association between the serotonin 2A receptor gene 
promoter and depression in males, but this finding did not extend to females (Jansson et al., 
2003). Other studies have explored the effects of the APOE-!4 allele on depression although an 
association was not observed (Blazer, Burchett, & Fillenbaum, 2002; Köhler et al., 2010). 
 Other factors that may influence the occurrence of depressive symptoms include various 
demographic factors, health factors, and social factors, including social support. Regarding 
socioeconomic status, an increased number of depressive symptoms was observed among 
individuals, especially older adults, experiencing impoverishment and economic strain. Higher 
educational attainment was associated with a reduced risk of loneliness, a depressive symptom, 
whereas low income was associated with increased risk for loneliness (Shankar, Hamer, 
McMunn, & Steptoe, 2013). For urban or rural living status, a significantly higher prevalence for 
psychiatric disorders (38%) and mood disorders (39%) has been found among those living in 
urban areas (Peen, Schoevers, Beekman, & Dekker, 2010). Similarly, a significantly lower 
prevalence of depression was observed among those living in rural areas (Wang, 2004). 
However, the temporality of this relationship is unknown and it is possible that individuals with 
depression move to urban areas for better access to treatment.  
Physical health is also a significant predictor of depressive symptoms. The prevalence of 
depression and depressive symptoms is higher among individuals who are hospitalized for 
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medical conditions or surgery (Blazer, 2003; Fiske et al., 2009; Koenig et al., 2015). Greater 
deficits in instrumental activities of daily living, disability, and functional impairment are 
significantly associated with depressive symptoms (Alexopoulos, 2005; Steffens, Hays, & 
Krishnan, 1999).  
Depressive symptoms are also associated with social isolation, and the strength of the 
association increases when considering the oldest-old, as they generally report less frequent 
contact with their social networks (Blazer et al., 1991). Other forms of social isolation include 
widowhood, bereavement, and associated loneliness (Alexopoulos, 2005; Cole & Dendukuri, 
2003). Approximately 10–20% of older adults develop depressive symptoms following the first 
year of bereavement and more than half will go on to develop major depression (Alexopoulos, 
2005). Perceived social support is also associated with depressive symptoms, where higher 
perceived support is negatively associated with depressive symptoms in older age (Adams et al., 
2016; Stafford, McMunn, Zaninotto, & Nazroo, 2011; X. Wang, Cai, Qian, & Peng, 2014). 
2.3 Depressive Symptoms, Depression, and Cognitive Function 
 
2.3.1 Potential Theoretical Models Linking Depression and Depressive Symptoms with 
Cognitive Function 
 
While the exact pathophysiological mechanism linking depressive symptoms to cognitive 
function has yet to be identified, possible explanations propose that depressive symptoms are: i) 
a psychological reaction to worsening cognitive function, ii) an early preclinical symptom of an 
adverse cognitive outcome, iii) the consequence of vascular risk factors or diseases that are 
predictive of subsequent cognitive impairment, or iv) a true causal risk factor linked to the 
pathophysiology of adverse cognitive outcomes (Alexopoulos et al., 1997; Bennett & Thomas, 
2014; Butters et al., 2008; Jorm, 2001; Krishnan, Hays, & Blazer, 1997). These theories can be 
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categorized into two overarching hypotheses: i) the risk factor hypothesis, and ii) the prodromal 
hypothesis.  
The risk factor hypothesis suggests that individuals who develop depressive symptoms 
are at an increased risk for declines in cognitive function (Figure 1a). In contrast, the prodromal 
hypothesis suggests that depressive symptoms are one of the earliest symptoms of cognitive 

















Figure 1b. Conceptual diagram of the prodromal hypothesis 
Figure 1a. Conceptual diagram of the risk factor hypothesis 
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Although these two hypotheses have been proposed, the temporal relationship between 
depressive symptoms and cognitive function is not well established. Most studies have 
considered depressive symptoms as an exposure and changes in cognitive function as an 
outcome. However, it is possible that depressive symptoms are a result of worsening cognitive 
function or an early preclinical symptom of cognitive decline (i.e., the prodromal hypothesis) 
(Bennett & Thomas, 2014; Geda et al., 2006). In general, evidence suggests that the risk factor 
hypothesis and the prodromal hypothesis are not mutually exclusive. Findings from longitudinal 
studies are promising, but limited. While there is evidence building to suggest that depressive 
symptoms are risk factors, it is believed that the relationship between depressive symptoms and 
cognitive function is bidirectional (Wang & Blazer, 2015).  
2.3.2 Potential Biological Mechanisms Linking Depression and Depressive Symptoms 
with Cognitive Function 
 
Both the risk factor hypothesis and the prodromal hypothesis have been linked to 
potential underlying biological mechanisms that explain how depressive symptoms are related to 
biological changes in the brain that result in declines in cognitive function. The potential 
biological mechanisms that may contribute to the structural and functional alterations are: 1) 
vascular disease, 2) cortisol-hippocampal pathway, 3) amyloid plaque formation, 4) 
inflammatory changes, and 5) nerve growth factors.  
Vascular disease 
The relationship of depressive symptoms with cognitive outcomes is best explained by 
vascular disease. This explanation is grounded in the vascular depression hypothesis, which 
suggests that vascular disease, vascular lesions, and structural brain changes cause depressive 
symptoms in older age (Alexopoulos et al., 1997; Krishnan et al., 1997). However, it is likely 
that depressive symptoms and vascular disease exist in a bidirectional relationship, in which each 
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condition is associated with an increased risk of developing the other. Vascular disease can also 
contribute to the development of cognitive impairment and dementia. In particular, the ischemic 
damage caused by vascular disease can lead to damage in the frontotemporal regions of the brain 
and the PFC. This can result in significant cognitive deficits and explains declines in executive 
function in older adults with depression (Taylor, Aizenstein, & Alexopoulos, 2013).  
Cortisol-Hippocampal Pathway 
 Cortisol is a glucocorticoid steroid hormone that is produced by the adrenal glands in 
response to stress (Butters et al., 2008). Depressive symptoms can activate the hypothalamic-
pituitary-adrenal axis and increase glucocorticoid production. In turn, this can damage the 
hippocampus, a key brain structure necessary for executive function and formation of 
glucocorticoid receptors. As a result of hippocampal damage, glucocorticoid receptors are down-
regulated and the abundance of cortisol causes hippocampal atrophy and subsequent cognitive 
deficits (Jorm, 2001; Ownby, Crocco, Acevedo, John, & Loewenstein, 2006). It is possible that 
cortisol is not the only factor mediating the pathway, and other mechanisms may work alongside 
elevated cortisol levels.  
Amyloid Plaque Formation 
 Some studies have observed that individuals with AD and depression have a greater 
accumulation of amyloid plaques and neurofibrillary tangles in their hippocampus compared to 
individuals with AD and no depression (Rapp et al., 2006, 2008). Amyloid plaque formation can 
result from stress and experiencing depressive symptoms. In parallel, amyloid plaques are known 
to promote neuronal death and are associated with an increased risk for AD (Butters et al., 2008; 
Rapp et al., 2006). In addition, a specific type of amyloid, called "-amyloid peptide 40, has also 
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been observed in individuals with depression and has been linked to impairments in executive 
function (Byers & Yaffe, 2012) 
Inflammatory Changes 
 Chronic inflammation of the central nervous system influences the neurological changes 
associated with depression and dementia (Bennett & Thomas, 2014; Leonard, 2007). There are 
two possible pathways by which inflammation causes central nervous system changes. First, 
depression may signal an increase in cytokines. This signals for a decrease in anti-inflammatory 
and immunosuppressant responses and increase pro-inflammatory responses in the central 
nervous system. Ultimately, this inflammation leads to cognitive deficits and dementia (Leonard, 
2007). The second mechanism suggests that depression reduces synaptic plasticity and promotes 
hippocampal atrophy via pro-inflammatory cytokines. The pro-inflammatory cytokines interfere 
with serotonin metabolism, which is a neurotransmitter thought to regulate emotions, and motor, 
cognitive, and behavioural functions (Lucki, 1998). As such, low serotonin levels lead to poorer 
cognitive outcomes.  
Nerve Growth Factors 
 Nerve growth factors, such as brain-derived neurotrophic factor (BDNF), are responsible 
for neuronal health and modulation of synaptic plasticity (Byers & Yaffe, 2012). Both 
individuals with depression and individuals with AD have shown impaired BNGF signalling. 
Past research has also observed reduced levels of BDNF in the hippocampus of individuals with 
both depression and AD (Byers & Yaffe, 2012).  
 In summary, it is unlikely that a single biological mechanism explains the relationship 
between depressive symptoms and cognitive function. It is more likely that multiple biological 
mechanisms work in combination (Butters et al., 2008).  
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2.3.3 Literature Supporting an Association of Depression and Depressive Symptoms with 
Cognitive Function 
 
There is a large body of evidence on the association between depression and cognitive 
function, and it can be divided into two subsections based on onset of depression. The first, most 
well-established evidence, exists for the association between late-life depression and cognitive 
function. The second subsection is for the association between midlife depression and cognitive 
function. However, since not all individuals who experience depressive symptoms receive a 
clinical diagnosis of depression, and depressive symptoms are highly prevalent among older 
adults, studying the relationship between depressive symptoms and cognitive function also 
appears to be important. A review of existing literature is discussed in further detail below. 
2.3.3.1 Late-life Depression and Cognitive Function 
 
Late-life depression (LLD) is defined as the onset of depression after 65 years of age. The 
association of LLD and cognitive function is well studied. Past prospective studies show that 
LLD is associated with a two- to five-fold increased risk for MCI, AD, and other dementias 
(Barnes et al., 2012; Diniz, Butters, Albert, Dew, & Reynolds, 2013; Geda et al., 2006; Jorm 
Anthony, 2001; Ownby, Crocco, Acevedo, John, & Loewenstein, 2006). Other studies have only 
observed an association in specific subgroups (Geerlings et al., 2000), such as those with APOE-
!4 (Byers & Yaffe, 2012; Geda et al., 2006) or low educational attainment (Byers & Yaffe, 
2012; Jungwirth et al., 2011). Two separate meta-analyses showed an association between LLD 
and dementia in overall pooled findings (Jorm, 2001; Ownby et al., 2006). While some studies 
did not observe an association, discrepancies may be attributed to differences in methodology 
(e.g., sampling procedures, operationalization of depression, operationalization of cognitive 
function), cultural considerations (e.g., study samples from differing countries such as the United 
 31 
States, Canada, and China), or variations among subpopulations (e.g., veterans, Japanese 
American men) (Byers & Yaffe, 2012; Diniz et al., 2013). 
 LLD is also associated with global and domain-specific cognitive deficits. Approximately 
20–50% of individuals with LLD have poorer cognitive function than their age- and education-
matched comparisons without LLD (Koenig et al., 2015; Osorio, De García Lózar, Ramos, & 
Agüera, 2009). When compared to those without LLD, individuals with LLD showed a pattern 
of impairments across cognitive domains similar to older adults with MCI who are not depressed 
(Tam & Lam, 2012). This included declines in executive function (Cui, Lyness, Tu, King, & 
Caine, 2007; Klojčnik, Kavcic, & Bakracevic Vukman, 2017; Koenig et al., 2015; Osorio et al., 
2009), working memory (Butters et al., 2008), attention (Rapp et al., 2005), and processing speed 
(Butters et al., 2004). In fact, LLD was commonly associated with significant impairments in 
executive function in cross-sectional studies (Klojčnik et al., 2017; Osorio et al., 2009), cohort 
studies (Boyle, Porsteinsson, Cui, King, & Lyness, 2010; Cui et al., 2007; Jungwirth et al., 2011; 
Koenig et al., 2015), and case-control studies (Ros, Aguilar, Serrano, Ricarte, & Latorre, 2013) 
studies.  
When compared to those with early-onset depression (i.e., depression observed in 
childhood, adolescence, or young adulthood), those with LLD display larger deficits in executive 
function. When compared to those without depression, both LLD and early-onset depression 
were associated with reduced functioning across all cognitive domains. Findings support age as 
an effect modifier, where LLD is associated with more severe cognitive impairment than 
depression in younger age (Herrmann, Goodwin, & Ebmeier, 2007). Furthermore, declines in 
executive function may mediate deficits in other cognitive domains (Alexopoulos, 2005; Butters 
et al., 2004; Rapp et al., 2005), and this is why cognitive deficits may improve, but do not 
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completely dissipate after remission of LLD following treatment (Koenig et al., 2015). Overall, 
these studies provide substantial evidence supporting an association between LLD and cognitive 
function. 
2.3.3.2 Midlife Depression and Cognitive Function 
 
 The association between midlife depression and cognitive function is less well 
established than the association between LLD and cognitive function. Most research has been 
conducted on populations aged 65 years and older. Therefore, information on middle-aged adults 
(e.g., 45–64 years) is limited (Bennett & Thomas, 2014; Diniz et al., 2013). As it is widely 
accepted that dementia develops over decades, it is possible that depression in middle age may 
be a remote risk factor (i.e., the risk factor hypothesis) or a subclinical feature (i.e., the 
prodromal hypothesis) of dementia (Bennett & Thomas, 2014; Byers & Yaffe, 2012; Ownby et 
al., 2006).  
 Only a few studies have explored the association between midlife depression and 
cognitive function. In a small case-control study of young and middle-aged adults, depression 
was associated with deficits in mental flexibility and episodic memory (Airaksinen, Larsson, 
Lundberg, & Forsell, 2004). In another study, the risk of developing dementia was found to 
increase with the number of affective episodes in patients with midlife depression. Yet, there 
were some methodological limitations. Many of these studies relied on hospital data from 
admitted patients. Therefore, diagnoses were made by different clinicians and were not 
standardized for research purposes (Kessing & Andersen, 2004). In more recent studies, 
individuals with midlife depression, compared to those with LLD or no depression, performed 
worse on measures of executive function and memory (Riddle et al., 2017; Singh-Manoux et al., 
2010). Another study showed both midlife depression and LLD were associated with worse 
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executive function, although the strength of the association was reduced in those with midlife 
depression compared to LLD (Lugtenburg et al., 2017).  
Although additional research is required, emerging findings suggest that cognitive 
outcomes associated with depression may vary according to age (Lugtenburg et al., 2017; Riddle 
et al., 2017; Singh-Manoux et al., 2010). In particular, although the general trend of the 
association is similar across individuals with midlife depression and LLD, the strength of the 
association with cognitive function may differ according to whether the individual is a middle-
aged or older adult. 
2.3.3.3 Depressive Symptoms and Cognitive Function 
 
As previously described, there is evidence to support an association between midlife 
depression and LLD with declines in cognitive function. However, not all middle-aged and older 
adults who experience depressive symptoms receive a clinical diagnosis of depression. One 
possible explanation is that their depressive symptoms do not meet criteria for a clinical 
diagnosis. It is also possible that older adults mistake their depressive symptoms as part of the 
normal aging process and attribute their symptoms to other conditions or life changes. As a 
result, studies that rely on participants receiving or reporting a diagnosis of clinical depression 
may be underestimating prevalence rates of depression (Girling & Huppert, 1995). Nonetheless,  
depressive symptoms are reported to occur in approximately 8–16% of community-dwelling 
older adults (Barnes et al., 2012; Blazer et al., 1991; Fiske et al., 2009), and are most frequent 
among the oldest old (Blazer, 2003).  
Depressive symptoms been identified as an independent risk factor for many adverse 
health outcomes (World Health Organization, 2016). Empirical data have found an association 
between depressive symptoms and cognitive outcomes, such as cognitive decline, MCI, and 
 34 
dementia (Bennett & Thomas, 2014; Boyle et al., 2010; Dlugaj et al., 2015; Geda et al., 2006; 
Goveas, Espeland, Woods, Wassertheil-Smoller, & Kotchen, 2011; Heser et al., 2016; Richard et 
al., 2013; Spira, Rebok, Stone, Kramer, & Yaffe, 2012; S. Wang & Blazer, 2015). In a cohort 
study, the hazard of dementia increased by 20% for those with midlife depressive symptoms, 
70% for those with late-life depressive symptoms, and 80% for those with both midlife and late-
life depressive symptoms (Barnes et al., 2012). As well, a dose-response relationship may exist, 
where every additional depressive symptom increases the risk for dementia and cognitive 
disorders not otherwise specified (Boyle et al., 2010; Dotson, Beydoun, & Zonderman, 2010; 
Geda et al., 2006). This dose-response relationship may also be exacerbated by the synergistic 
interaction between depressive symptoms and APOE genotype (Geda et al., 2006).  
When specific types of dementia were examined, having both midlife and late-life 
depressive symptoms was associated with a greater than three-fold increase in risk for vascular 
dementia. In contrast, late-life depressive symptoms were associated with a two-fold increase in 
risk for AD only (Barnes et al., 2012). Findings suggest that late-life depressive symptoms could 
be an early symptom of AD, whereas a combination of midlife and late-life depressive symptoms 
are risk factors associated with vascular dementia (Barnes et al., 2012). This is consistent with 
some studies that suggest the relationship between depressive symptoms with dementia and MCI 
differs depending on the age of the individual (Dlugaj et al., 2015; Spira et al., 2012; 
Sundermann, Katz, & Lipton, 2017). However, not all studies agree with this (Geda et al., 2006). 
In addition, some studies did not observe an association between depressive symptoms and 
neurocognitive disorders (Dotson et al., 2010; Richard et al., 2013).  
In addition to studies examining dementia and MCI as outcomes, there is some evidence 
supporting an association between depressive symptoms and cognitive function, but it has not 
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been well explored. Depressive symptoms in older adults have been shown to be associated with 
poorer cognitive function and longitudinal cognitive decline across multiple cognitive domains 
(e.g., Dotson, Resnick, & Zonderman, 2008; Freiheit et al., 2012; Royall, Palmer, Chiodo, & 
Polk, 2012; Sachs-Ericsson, Joiner, Plant, & Blazer, 2005; Zeki Al Hazzouri et al., 2014). Of 
these studies, some suggest that depressive symptoms temporally preceded cognitive deficits, 
such that individuals with depressive symptoms that arise and persist before the age of 60 years 
are at a greater risk for cognitive deficits in later life (Barnes et al., 2012; Bunce et al., 2014; 
Singh-Manoux et al., 2010). In fact, clinically meaningful and persistently high depressive 
symptoms are shown to be associated with faster declines in cognitive function and are 
predictive of future cognitive impairment, even among individuals with the highest levels of 
cognitive function (Almeida, Hankey, Yeap, Golledge, & Flicker, 2016; Chodosh et al., 2007; 
Gatz, Tyas, St. John, & Montgomery, 2005; Köhler et al., 2010). There are studies that did not 
observe an association between depressive symptoms and cognitive function (Almeida et al., 
2016), or only observed a cross-sectional, but not longitudinal association (Ganguli, Du, Dodge, 
Ratcliff, & Chang, 2006). These studies argued that longitudinal cognitive decline cannot be 
explained by depressive symptoms, but rather, depressive symptoms most likely reflect incipient 
dementia (Almeida et al., 2016; Ganguli et al., 2006).  
In studies that were able to examine specific cognitive domains, depressive symptoms 
were most commonly associated with executive function (Dotson et al., 2008; Klojčnik et al., 
2017; Pantzar et al., 2017; Reppermund et al., 2011; Royall et al., 2012). Multiple studies found 
that elevated depressive symptoms were associated with lower baseline cognitive scores and 
greater longitudinal declines in global cognition and/or executive function (Dotson et al., 2008; 
Freiheit et al., 2012; Goveas et al., 2014). In a study by Brodaty et al. (2012), depressive 
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symptoms were associated with a two-fold increase in risk for impairments in executive function. 
Although not consistently observed, co-occurring vascular risk factors and co-morbid 
cerebrovascular disease with depressive symptoms were also related to worse treatment 
outcomes and greater declines in global cognition and executive function (Goveas et al., 2014). 
Older adults with both depressive symptoms and low executive function may also be at greater 
risk for functional disability (Reppermund et al., 2011; Wilcox et al., 2016), poorer treatment 
response (Pantzar et al., 2017), and recurrence of depression (Dotson et al., 2010). In addition to 
executive function, a higher average number of depressive symptoms and longitudinal declines 
in memory were observed in some (Dotson et al., 2008; Köhler et al., 2010; Panza et al., 2009), 
but not all studies (Reppermund et al., 2011; Royall et al., 2012). The effects of depressive 
symptoms on domain-specific cognitive changes may also vary according to age. 
Overall, while there is some evidence supporting an association between depressive 
symptoms and domain-specific cognitive function, a larger and stronger body of evidence 
supports an association between depressive symptoms and global cognitive impairment (Goveas 
et al., 2014; Pantzar et al., 2017; Potter et al., 2013). Nonetheless, the studies that focus on 
depressive symptoms and cognitive function set the foundation for longer cohort studies that can 
provide clarity regarding the true relationship between depressive symptoms and cognitive 
function, and whether age is an effect modifier (Byers & Yaffe, 2012; Saczynski et al., 2010). 
2.4 Conclusion 
 
 The relationship between depressive symptoms and cognitive function is complex. 
Currently, most of the evidence supports an association between LLD with neurocognitive 
disorders and global cognitive impairment, although the exact mechanisms underlying the 
association have yet to be identified. While associations between depressive symptoms and 
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domains of cognitive function have been identified, the strength and direction of the association 
appears to differ depending on the age of the individual with depressive symptoms, as well as the 
domain of cognitive function examined. Furthermore, sex may also be an additional risk factor 
that modifies the association between depressive symptoms and cognitive function, although past 






































3.0 Study Rationale and Research Questions 
 
3.1 Study Rationale 
 
The association between depressive symptoms and cognitive function in adulthood is 
multifaceted. While many studies have observed an association between depressive symptoms 
and global cognitive impairment, the association with specific cognitive domains is less 
established. Previous research examining depressive symptoms is generally limited to 
populations 65 years or older (Bennett & Thomas, 2014). Therefore, these studies are not able to 
determine whether the association between depressive symptoms and specific cognitive domains 
differs between middle-aged and older adults. In addition, most study participants are recruited 
from clinical settings since it is easier to identify individuals with depressive symptoms in the 
healthcare system rather than among community-dwelling adults (Boyle et al., 2010; Cui et al., 
2007; Heser et al., 2016). As such, findings may not be representative of the population at large. 
Other studies have only been able to recruit participants from one geographical location (e.g., 
province, city), limiting generalizability. Although age and sex have been mentioned as possible 
effect modifiers of the association between depressive symptoms and global cognitive 
impairment, the modifying effects of age and sex are less clear when considering their 
relationship with the cognitive domain of executive function. 
Many studies also depend on a clinical diagnosis of dementia, failing to demonstrate the 
impact that depressive symptoms may have on early subclinical differences, as well as 
vulnerabilities in specific cognitive domains (Goveas et al., 2014; Panza et al., 2009). In studies 
that examined cognitive function, either global cognitive function was assessed or a limited 
number of tests was used to examine domain-specific cognitive function. For example, executive 
function is a key domain of cognitive function that is responsible for controlling behaviour, 
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purposeful decision making, and functional independence. Despite its importance, the 
relationship between depressive symptoms and executive function has not been well established. 
As well, past studies have not simultaneously considered a wide variety of covariates. This has 
prevented the inclusion of certain confounders, such as subjective and objective measures of 
health, functional and structural measures of social support, and health behaviours. 
 In summary, there is limited evidence on the association between depressive symptoms 
and executive function in middle-aged and older adults. There is also limited evidence among 
population-based samples, studies that measure executive function using more than one cognitive 
test, and studies that are able to incorporate a variety of confounders. Both age and sex 
differences have also not been simultaneously studied.  
The aim of this study was to examine the association between depressive symptoms and 
executive function, after controlling for a variety of confounding variables and assessing whether 
age and sex were effect modifiers. The potential confounders included sociodemographic factors 
(i.e., age, sex, education, annual household income, province, and urban/rural residence), health 
factors (i.e., self-rated general health, chronic conditions, and medication for depression), social 
factors (i.e., marital status and social support availability), and health behaviours (i.e., smoking 
status and alcohol use). In general, it was hypothesized that the presence of depressive symptoms 
would be associated with lower executive function, and the strength of the association would 






3.2 Research Questions 
 
1. Is the presence of depressive symptoms associated with low executive function, after 
adjusting for confounders? 
2. Does the association between depressive symptoms and low executive function differ 
across age groups? 
3. Does the association between depressive symptoms and low executive function differ in 






4.1 Literature Search  
 
A systematic search, using two different databases, was conducted in September 2018 to 
identify relevant literature on the relationship between depressive symptoms and executive 
function in older adults. The first database that was searched was PubMed. Initially, search terms 
related to “depressive symptoms” (e.g., depression, depressive symptoms) and “cognitive 
function” (e.g., executive function, neuropsychological tests) were used. To narrow the scope of 
relevant articles, “age” (e.g., middle age, older adult, elderly) and “time” (e.g., aging, prospective 
cohort study) were added as additional search concepts. The search was further limited to 
human-based and peer-reviewed articles that were written in English. No date limits were 
applied to the search strategy (Appendix A, Table A1). The initial search resulted in 399 articles.  
The second database that was search was PsycINFO. The same search concepts from the 
PubMed search strategy were used in PsycINFO. The search was limited to peer-reviewed 
articles and no date limits were set (Appendix A, Table A2). The initial search resulted in 608 to 
be further screened. In total, 1,007 articles were retrieved from both PubMed and PsycINFO for 
screening.  
After duplicate articles were removed, the remaining articles were screened in three steps, 
with assessment for eligibility based on their title, abstract, and then full text. Articles were 
excluded if the exposure was not related to depression, depressive symptoms, cognitive function, 
or executive function, if the outcome was not related to depression, depressive symptoms, 
cognitive function, or executive function, or if the sample only included participants under the 
age of 45 years. After applying exclusion criteria, 36 articles remained.  
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In July 2019, the original literature search was updated using the same search concepts 
(depressive symptoms, cognitive function, age, and time) and databases (i.e., PubMed and 
PsycINFO) to identify more recently published articles. In total, 1,076 articles were retrieved. 
After articles that were already screened from the September 2018 search were removed, there 
were an additional 69 articles to screen for eligibility. In the end, 40 articles were included in the 
final review (Appendix A, Figure A1). A summary of each of these articles can be found in 
Appendix B, Table A3.  




The CLSA is a large, population-based, ongoing prospective cohort study with the goal of 
examining the dynamic aging process. The original proposal, submitted by lead investigator Dr. 
Parminder Raina (McMaster University, Hamilton) and co-principal investigators, Dr. Christina 
Wolfson (McGill University, Montréal) and Dr. Susan Kirkland (Dalhousie University, Halifax), 
was part of the Canadian Institutes of Health Research (CIHR) Institute of Aging Request for 
Applications. The proposal was awarded CIHR funding in 2002 and underwent development and 
national and international review until 2006. The developed protocol was awarded infrastructure 
funding from the Canadian Foundation for Innovation and later received full ethics approval in 
2010. The CLSA was formally launched in 2011 (Raina et al., 2009). 
4.2.2 Overall Study Design 
 
In total, the CLSA sampled 51,338 participants between 45 to 85 years of age at the time 
of recruitment (Raina et al., 2009). The inclusion of men and women as young as 45 years 
captures midlife experiences and allows investigators to observe how these experiences are 
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associated with later-life outcomes. Additionally, the wide age range captures the experiences of 
those entering older adulthood, retirement, and their final years of life.  
All study participants were categorized into one of two study components: the Tracking 
cohort or the Comprehensive cohort. Participants from both cohorts provided information about 
the key elements of aging, including biological, physical, social, and psychological functioning, 
as well as various lifestyle and demographic factors. Both cohorts follow an identical follow-up 
timeline, with repeated waves of data collection every three years for at least 20 years, or until 
death. However, each cohort uses a different sampling design and data collection process. This is 
discussed in further detail below (Raina et al., 2009).  
Data for the Tracking cohort were collected using computer-assisted telephone 
interviews. This method permits the estimation of health and social factors of participants from a 
geographically representative population across Canada. Recruitment for the Tracking cohort 
used three different sampling frames: the Canadian Community Health Survey (CCHS) 4.2 on 
Healthy Aging, provincial healthcare registries, and Random Digit Dialing (RDD). Recruitment 
occurred in all 10 provinces, yielding a final total of 21,241 participants in the Tracking cohort 
(Canadian Longitudinal Study on Aging, 2017a; Raina et al., 2009).   
 Participants in the Comprehensive cohort provided information through physical 
examinations, biological samples, and in-home and DCS interviews (Main-wave In-home 
Questionnaire and the Main-wave Data Collection Site Questionnaire). Participants were 
recruited using provincial healthcare registration databases, RDD sampling frames, and the 
Quebec Longitudinal Study on Nutrition and Aging (NuAge) study. Participants had to live 
within 25 to 50 km of a DCS. There were 11 DCS across seven provinces: British Columbia 
(Victoria, Vancouver, and Surrey), Alberta (Calgary), Manitoba (Winnipeg), Ontario (Hamilton 
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and Ottawa), Quebec (Montreal and Sherbrooke), Nova Scotia (Halifax), and Newfoundland and 
Labrador (St. John’s). Each DCS was responsible for recruitment of approximately 3,000–6,000 
participants. As a result of population size and geographical location, three provinces were not 
included in the CLSA (New Brunswick, Prince Edward Island, and Saskatchewan). After 
recruitment, there was a final total of 30,097 participants in the Comprehensive cohort (Canadian 
Longitudinal Study on Aging, 2017a; Raina et al., 2009). 
4.2.3 Sampling Frames 
 
Based on the CLSA protocol, recruitment was initially done exclusively for the Tracking 
cohort. The initial enrollment platform was the CCHS 4.2 on Healthy Aging. Since the original 
target population of the CCHS on Healthy Aging included participants 55 years and older, an 
additional sample of individuals aged 45–54 years was included to capture the age range 
specified by the CLSA. Provincial healthcare registration databases were used in eight provinces 
as the second sampling frame. To achieve target sample size numbers and age and sex quotas, 
RDD was employed (Canadian Longitudinal Study on Aging, 2017a; Raina et al., 2009). RDD 
was performed only using landline numbers and omitted households that were exclusively 
mobile-phone users. The Residential Telephone Service Survey by Statistics Canada indicated 
that the impact of omitting households that only use mobile phones was modest as most 
households with individuals 45 years and older have landlines (Raina et al., 2009). 
 The Comprehensive cohort consisted of participants recruited from three sampling 
frames. Provincial healthcare registration databases were used as the main sampling frame across 
five provinces (British Columbia, Manitoba, Newfoundland, Nova Scotia, and Ontario). Due to 
the unique set of administrative and infrastructure regulations set out by each province for the 
liberation of data, this enrolment platform could not be used in all provinces. RDD was used to 
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achieve the target sample size and quotas for age and sex. The NuAge study was also used to 
recruit additional participants between 75 and 85 years of age in Quebec (Canadian Longitudinal 
Study on Aging, 2017a; Raina et al., 2009). 
 To ensure accurate estimates for the national and provincial population, 136 sampling 
strata, based on age group (45–54, 55–64, 65–74, and 75–85), sex (male or female), province, 
and distance from a DCS catchment area were created for the Tracking cohort. For the 
Comprehensive cohort, 56 sampling strata, based on age group, sex, and province, were created. 
Sample weights for each age group, sex, and province stratum were also calculated. Response 
rates for the Tracking and Comprehensive cohort were 9% and 10%, respectively (Canadian 
Longitudinal Study on Aging, 2017a). Refer to Appendix D for a breakdown of response rates by 
province. 
 In addition to using sampling weights and strata, there were early indications that the 
proportion of recruited participants with low education levels was less than the proportion in the 
Canadian population. As such, low education areas were targeted using data from the 2006 
Census. The goal was to oversample people with lower educational levels to increase the number 
of participants with lower education (Canadian Longitudinal Study on Aging, 2017a). 
4.2.4 Eligibility Criteria 
 
Since the CCHS on Healthy Aging was used as the initial enrolment platform, eligibility 
criteria for all participants of the CLSA mirrored the criteria implemented by the CCHS on 
Healthy Aging. Therefore, individuals living in any one of the three territories; some remote 
areas or First Nation reserves; residents of long-term care facilities who required 24-hour 
medical care; full-time workers in the Canadian Armed Forces; and individuals with non-
permanent residency, including visa holders or individuals with transitional health care coverage, 
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were excluded from the study. Individuals in transitional living facilities or senior apartments 
were included in the study. Other inclusion criteria required participants to be between the ages 
of 45 to 85 years, speak either English or French, be cognitively able to provide consent and 
understand the purpose of the study, and be free of cognitive impairment at baseline, as 
determined by the CLSA interviewer during telephone or in-person interviews (Raina et al., 
2009). 
4.3 Current Project 
 
4.3.1 Study Sample 
 
Data from the Comprehensive cohort of the CLSA were used for this thesis. The 
Comprehensive cohort is comprised of participants who completed a Comprehensive Main-wave 
Disease Symptoms Questionnaire and neuropsychological battery at a DCS. In addition to the 
DCS visit, the Comprehensive Main-wave In-home Questionnaire was administered during in-
home interviews. These methods of data collection allowed for a greater number of measures to 
be gathered, including measures for depressive symptoms and executive function.  
 To assess the association between depressive symptoms and executive function, the 
analytic sample was restricted to participants with completed data available on the exposure and 
outcome variables, as well as all covariates. This included individuals who completed all tests at 
the DCS and in-home interviews. Participants without complete data for exposure or outcome 
variables were excluded first. Next, participants without complete data on all covariates were 
excluded. The final analytic sample consisted of 23,069 participants. A visual diagram of the 








Depressive symptoms were assessed using the Center for Epidemiological Studies Short 
Depression Scale (CES-D10), a self-reported questionnaire that screens and measures the 
affective component of depressive symptoms (i.e., depressed mood). The CES-D10 has good 
predictive accuracy compared to the original 20-item CES-D, which was first established for the 
National Institute of Mental Health Studies (Andresen, Malmgren, Carter, & Patrick, 1994). 
Since its development, the CES-D10 has shown high validity and reliability to detect clinically 
relevant and significant depressive symptoms among individuals in the general and older 
population (Björgvinsson, Kertz, Bigda-Peyton, McCoy, & Aderka, 2013; Mohebbi et al., 2018; 
Radolff, 1977). Additionally, the CES-D10 is a validated measure applicable to heterogeneous 
groups, such as participants in the CLSA (O’Connell et al., 2018). For a complete list of items on 
the CES-D and CES-D10, refer to Appendix F.   
 The CES-D10 measured depressive symptoms based on participants’ feelings from the 
past week. There were four possible responses for each item, scaled from 0–3, for a possible 
score out of 30. The coding for 8 out of 10 items on the scale was as follows: 0 (rarely or never; 
less than 1 day), 1 (some of the time; 1–2 days), 2 (occasionally; 3–4 days), or 3 (all of the time; 
5–7 days). For two items (i.e., “how often did you feel hopeful about the future?” and “how often 
did you feel happy?”), the scores were reversed. For example, a score of 0 meant feeling happy 
all of the time, and a score of 3 indicated rarely or never feeling happy (Radolff, 1977). The 
overall score was obtained by summing the individual response values from each item on the 
CES-D10. An overall higher score reflected a greater number of depressive symptoms.  
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 As scores were not normally distributed, the overall CES-D10 score was categorized 
dichotomously into a variable named presence of depressive symptoms based on an established 
cut-off (Andresen et al., 1994; Canadian Longitudinal Study on Aging, 2017b). A CES-D10 
score greater than or equal to 10 indicated the presence of depressive symptoms. In contrast, a 
score less than 10 indicated the absence of depressive symptoms.  
4.3.2.2 Outcome 
 
This thesis used a neuropsychological test battery consisting of all five measures of 
executive function available in the Comprehensive cohort of the CLSA (Tuokko et al., 2017). 
These measures assessed the three most common subtypes of executive function: cognitive 
flexibility, working memory, and inhibition. The Animal Fluency Test, Mental Alternation Test, 
and Controlled Oral Word Association Test measured cognitive flexibility. The Time-based 
Prospective Memory Test assessed working memory, and the Victoria Stroop Neurological 
Screening Test measured inhibition. Details regarding the procedure and scoring of these tests 
are explained in detail below.  
 The Animal Fluency Test (AFT) measured verbal fluency by asking participants to recite 
as many animals as possible in 60 seconds. Responses received a seven-digit code based on the 
scientific taxonomic classification of the animal. Two coding algorithms were applied to 
calculate participants’ scores. In the first algorithm, repetition of a breed or taxonomic sub-
species of an animal (i.e., variation of the same animal) was not counted towards the final score. 
For example, if a participant recited “bird, parrot, seagull,” only bird received a point because it 
is the broader category that the subsequent responses belong in. In the second algorithm, scores 
reflected the total number of valid animals listed. This thesis used the scores from the second, 
less strict, algorithm (Strauss, Sherman, & Spreen, 2006). 
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 The Mental Alternation Test (MAT) is a measure of cognitive flexibility. Participants 
completed three progressive subtasks: i) counting from one to 20; ii) reciting the letters of the 
alphabet; and iii) alternating between numbers 1–26 and letters of the alphabet (e.g., 1A, 2B, 
3C). Each subtask was allotted a 30-second time limit. Only scores for the third trial were 
recorded, and points were awarded for each correct alternation. Total scores ranged from 0–51. 
The Controlled Oral Word Association Test (COWAT) asked participants to complete 
three independent subtasks. Each subtask was limited to 60 seconds and participants were asked 
to name as many words as they could that began with a certain letter. The administered letters 
were F, A, and S. One point was awarded for each unique word per trial. All homophone words 
(i.e., words with the same root but different suffixes) were entered into a software to correct 
scoring. All sister words (i.e., words with the same root but different suffixes) only received one 
point. Scores from all three one-minute trials were summed to determine an overall COWAT 
score (Strauss et al., 2006).  
 The Time-Based Prospective Memory Test (TMT) is a measure of working memory and 
inhibition (Mioni & Stablum, 2014). At the beginning of the testing period, participants were 
shown an envelope containing a series of cards and were instructed to provide the interviewer 
with the card labeled with the number 17. A clock was set to 8:00 and participants were 
instructed to interrupt whatever was happening at 8:15 to complete the task. Performance was 
based on three categories: intention to perform, accuracy of response, and need of reminders 
when the alarm sounds. Possible scores for each category ranged from 0–3. All three scores from 
each category were summed to get a final score out of 9 (Hernandez Cardenache, Burguera, 
Acevedo, Curiel, & Loewenstein, 2014). 
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 The Victoria Version of the Stroop Neurological Screening Test (Stroop) is divided into 
three tasks where participants were asked to state the colour of the ink on the stimulus cards. The 
three types of stimulus cards corresponding to each task were coloured dots, common words 
printed in coloured ink, and colour words (e.g., red, blue) printed in non-corresponding colours 
of ink. Scores were based on the number of errors and the average length of time (in seconds) 
required to complete the three tasks. An interference score was calculated by dividing the score 
of the third task (colour words with non-corresponding colours of ink) by the score on the first 
task (coloured dots) (Graf, Uttl, & Tuokko, 1995). On the first task, scores below seven seconds 
or above 30 seconds, and on the third task, scores below seven seconds or above 137 seconds, 
were removed based on pre-established standards (Strauss et al., 2006). These standards were 
applied to reflect scores that were feasible response times as opposed to measurement errors.  
 Scores were standardized within each test of executive function using z-scores. Z-scores 
were also calculated separately for English and French speakers, and bilingual responses were 
not included. An overall executive function score was calculated by combining the standardized 
scores on the AFT, MAT, COWAT, TMT, and Stroop. Since performance on the Stroop is 
calculated based on time to response, a higher score reflected worse cognitive function. 
Therefore, the standardized score for the Stroop was reversed and then included in the 
calculation for overall executive function (Demnitz et al., 2018). 
As normed data and cut-offs have not been well established, low executive function was 
defined by applying a cut-off to the distribution of the overall executive function scores after 
combining the z-scores of each executive function measure. A cut-off of ≥ 1.5 SD below the 
mean was defined as low executive function. This was based on previous work assessing early 
cognitive decline and MCI (Petersen et al., 1997; Sachdev et al., 2014). The 1.5 SD cut-off was 
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calculated using the weighted executive function scores of a cognitively healthy sample 
(n=24,297). The cognitively healthy sample excluded participants who reported a diagnosis of 
Alzheimer’s disease (n=68), multiple sclerosis (n=202), epilepsy (n=322), memory problems 
(n=519), parkinsonism or Parkinson’s disease (n=125), stroke or cerebrovascular accidents 
(n=522), or ministroke or transient ischemic attack (n=965). In addition, those who screened 
positive for a traumatic brain injury and reported two or more concussions or any symptoms of a 
concussion (n=3949) were excluded. These groups were not mutually exclusive. Once the cut-off 
was determined, it was applied to the overall executive function scores of the analytic sample.  
4.3.2.3 Covariates 
 
To examine the association between depressive symptoms and executive function, the 
following potential confounders were included in final models: sociodemographic factors (i.e., 
age, sex, province, education, annual household income, and urban/rural residence), health 
factors (i.e., self-rated general health, chronic conditions, and medication for depression), social 
factors (i.e., social support availability and marital status), and health behaviours (i.e., smoking 
status and alcohol use). Each variable is described in further detail below. Refer to Appendix C 
for a conceptual diagram displaying the relationships between these variables.   
Sociodemographic Factors 
 Age, in years, was determined at the time of the in-home interview and DCS visit. 
Participants of the CLSA ranged from 45 to 87 years. Age was based on the age groups 
described in the sampling strategy (divided into four groups: 45–54 years, 55–64 years, 65–74 
years, and ≥75 years). Age was included a priori as an effect modifier. 
 Sex was determined by asking participants whether they identified as male or female. Sex 
was a dichotomous variable and included a priori as another effect modifier.  
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 Education was determined based on the highest degree obtained. Responses were 
categorized as a four-level measure: less than high school, high school graduate, some post-
secondary education, and post-secondary degree or diploma.  
Annual household income was assessed using a five-level income measure. Possible 
responses were less than $20,000; $20,000 or more, but less than $50,000; $50,000 or more, but 
less than $100,000; $100,000 or more, but less than $150,000; and $150,000 or more. 
Province of residence was determined at the time of recruitment. Possible responses 
included Alberta, British Columbia, Manitoba, Newfoundland and Labrador, Nova Scotia, 
Ontario, and Quebec. Urban/rural residence was based on the participant’s forward sortation 
area and was categorized as a dichotomous variable. Participants living in any territory outside of 
a population centre were classified as rural. Participants living in a core, secondary core, fringe, 
or population centre located outside of a census metropolitan area (CMA) or census 
agglomeration (CA) were classified as urban. CMAs had a population over 100,000, with at least 
50,000 people living in the core, or population centre. CAs had at least 10,000 people living in 
the core. Secondary cores had a population of 10,000 people and required the core of a CA to 
merge with an adjacent CMA. An urban fringe was the core of a CMA or a CA with less than 
10,000 persons (Canadian Longitudinal Study on Aging, 2018). Both province and urban/rural 
residence were included in this study to account for potential geographical differences in the 
sample. 
Health Factors 
 Self-rated general health was measured by asking participants to rate their general health. 
Possible responses included excellent, very good, good, fair, and poor.  
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 Medication for depression was measured by asking participants “Are you currently 
taking medication for depression?” This variable was assessed as a dichotomous measure (i.e., 
yes versus no).  
 Chronic conditions were assessed following the methodology used in past CLSA 
research. A combined measure consisting of 11 self-reported medical conditions, selected based 
on existing literature describing their impact on cognitive function, was used to determine the 
presence of chronic conditions (O’Connell, personal communication). Conditions included high 
blood pressure/hypertension; diabetes/borderline diabetes/high blood sugar; cancer; under-active 
thyroid gland/hypothyroidism/myxedema; over-active thyroid gland/hyperthyroidism/Grave’s 
disease; chronic obstructive pulmonary disease/emphysema/chronic bronchitis; kidney 
disease/failure; cardiac chronic conditions (i.e., heart disease/congestive heart failure; myocardial 
infarction/heart attack/acute myocardial infarction; angina/chest pain due to heart disease); 
stroke-related conditions; peripheral vascular disease; and asthma. For each item, participants 
reported whether they had ever been diagnosed with the condition. For example, a positive 
screen for high blood pressure was determined by asking participants “Has a doctor ever told you 
that you have high blood pressure or hypertension?” Chronic conditions were assessed as a 
dichotomous variable (i.e., at least one chronic condition versus no chronic conditions).  
Social Factors 
 Social support availability (SSA) was measured using the 19-item self-administered 
Medical Outcomes Study-Social Support Survey (MOS-SSS) (Sherboune & Stewart, 1991). The 
MOS-SSS can measure four subtypes of SSA (i.e., emotional/informational, tangible, 
affectionate, and positive social interactions) and overall perceived SSA. One item in the MOS-
SSS (someone to do things with to help you get your mind off things) was included for the 
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calculation of the overall SSA score (RAND Health, 2018). For each item, participants were 
asked to rate how often the type of support was available to them when needed. Possible 
responses were 1 (none of the time), 2 (a little of the time), 3 (some of the time), 4 (most of the 
time), and 5 (all of the time), where a higher score indicated greater perceived support levels. For 
this study, the overall SSA score was used, with low SSA defined as an average score of three or 
less after responding to all 19 items on the MOS-SSS.  
 Marital status was treated as a categorical variable with four levels: single, never married 
or never lived with a partner; married or living with a partner in a common-law relationship; 
widowed; and divorced or separated.  
Health Behaviours 
 Smoking status was determined by creating a derived variable classifying participants as 
current, former, or never smokers. Those who were classified as current smokers responded 
“yes” to smoking at least 100 cigarettes in their lifetime and “yes” to smoking daily or 
occasionally within the past 30 days. Those who were classified as former smokers responded 
“yes” to smoking at least 100 cigarettes in their lifetime, but reported not having smoked in the 
last 30 days. Never smokers were those who had smoked less than 100 cigarettes in their lifetime 
and were not smoking at the time of the interview (Government of Canada, 2008).   
Alcohol use was assessed by creating a derived variable classifying participants into 
current, former, or never drinkers. Current drinkers were defined as those who responded “yes” 
to consuming alcohol almost every day, 4–5 times a week, 2–3 times a week, once a week, 2–3 
times a month, about once a month, or less than once a month over the past 12 months. Former 
drinkers were defined as those who responded “yes” to drinking alcohol in the past, but not 
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within the past 12 months. Never drinkers were those who reported to have never drank (Centers 
for Disease Control and Prevention, 2018).  
4.3.3 Data Analysis 
 
All analyses were completed using SAS Studio Enterprise Edition 3.6 (SAS Institute Inc., 
Cary, North Carolina).  
4.3.3.1 Descriptive Analyses 
 
Bivariate analyses for the exposure, outcome, and covariates were conducted to provide 
an overall description of the analytic sample. Frequency tables were computed to gain a better 
understanding of the characteristics in the analytic sample. Pearson’s chi-square tests to test for 
significant associations between categorical variables were applied. Age group and sex were 
included as a priori effect modifiers. Therefore, analyses were done separately for each age 
group, and for males and females.   
Descriptive analyses were conducted on unweighted and weighted data. Trimmed 
weights were used for descriptive analyses. The trimmed weights were calculated by the CLSA 
and were based on inclusion probabilities in the Canadian population (provided by Statistics 
Canada) and the DCS of the participant (Canadian Longitudinal Study on Aging, 2017a). 
4.3.3.2 Multivariable Analyses 
 
Weighted logistic regression analyses were used to address each research question. Odds 
ratios (OR) and 95% confidence intervals were used to determine the strength and direction of 
the associations for the low executive function outcome. Covariates were entered into the models 
in four themed chunks: sociodemographic factors, health factors, social factors, and health 
behaviors. The variables that comprise each themed chunk are presented in Table 1.  
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First-order interactions with the exposure variable were assessed. A significance ($) level 
of 0.20 for main effects and 0.05 for first-order interaction terms was used with backwards 
elimination variable selection (Tyas et al., 2000). Model fit was assessed using the Mann-
Whitney U statistic for the area under the curve of receiver operating characteristic curves. 
Results for the final models are presented in Appendix G, Table A7. Multicollinearity between 
depressive symptoms (exposure) and covariates was examined by assessing the variance 
inflation factor (VIF), where highly correlated variables would identified based on having VIF 
scores greater than 10 (Kleinbaum, Kupper, Nizam, & Rosenberg, 2013). There were no issues 
of multicollinearity found among the variables.      
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Table 1. Analytic plan for assessing the association between depressive symptoms and low 
executive function 
Model Statistical Approach Measures and Variables 
Model A1,2,3  
(Unadjusted) 
Logistic regression Exposure: Depressive symptoms 
 







Logistic regression Exposure: Depressive symptoms 
 
Outcome: Low executive function 
 
Covariates:  
Sociodemographic: Age, sex, education, annual 
household income, province, urban/rural residence 
Health: Self-rated general health, medication for 
depression, chronic conditions 
Social: Marital status, social support availability 
Health behaviours: Smoking status, alcohol use 
 
Interaction terms:  
Depressive symptoms* 
(Sociodemographic: Age, sex, education, annual 
household income, province, urban/rural residence 
Health: Self-rated general health, medication for 
depression, chronic conditions 
Social: Marital status, social support availability 





Logistic regression  Exposure: Depressive symptoms 
 
Outcome: Low executive function 
 
Covariates:  
Sociodemographic: Age, sex, education, annual 
household income, province, urban/rural residence 
1Reflects the set of models that were used to assess the association between depressive symptoms 
and low executive function.  
1Models were run separately for the four different age groups (Research Question 2). 
2Models were run separately for males and females (Research Question 3). 








Table 1. Analytic plan for assessing the association between depressive symptoms and low 
executive function, continued 





Logistic regression  Exposure: Depressive symptoms 
 
Outcome: Low executive function 
 
Covariates:  
Sociodemographic: Age, sex, education, annual 
household income, province, urban/rural residence 
Health: Self-rated general health, medication for 
depression, chronic conditions 
Model D1,2,3 Logistic regression Exposure: Depressive symptoms 
 
Outcome: Low executive function 
 
Covariates:  
Sociodemographic: Age, sex, education, annual 
household income, province, urban/rural residence 
Health: Self-rated general health, medication for 
depression, chronic conditions 
Social: Marital status, social support availability 
Model E1,2,3 
(Final Model) 
Logistic regression Exposure: Depressive symptoms 
 
Outcome: Low executive function 
 
Covariates:  
Sociodemographic: Age, sex, education, annual 
household income, province, urban/rural residence 
Health: Self-rated general health, medication for 
depression, chronic conditions 
Social: Marital status, social support availability 
Health behaviours: Smoking status, alcohol use 
 
1Reflects the set of models that were used to assess the association between depressive symptoms 
and low executive function.  
1Models were run separately for the four different age groups (Research Question 2). 
2Models were run separately for males and females (Research Question 3). 






4.3.4 Ethics and Data Access 
 
The CLSA adheres to the policies and procedures of the CIHR Best Practices for 
Protecting Privacy in Health Research, Tri-Council Policy Statement: Ethical Conduct for 
Research Involving Humans. Written, informed consent was obtained by all study participants 
upon recruitment and all study participants were only identified by a number code, not name. 
Within the CLSA, the CIHR’s Advisory Committee on Ethical, Legal, and Social Issues ensures 
that ethical practices and confidentiality are maintained for the duration of the study.  
 This present study is part of the approved Office of Research Ethics (ORE) application at 
the University of Waterloo, titled “Profiles of Socially and Cognitively Vulnerable Canadians: A 
Cross-sectional Analysis of the Canadian Longitudinal Study on Aging (CLSA); ORE #21398.” 
In November 2015, the University of Waterloo research team submitted a CLSA data access 
request, which was granted in December 2015. In April 2016, baseline data for the Tracking 
cohort was received. A data request update including baseline Comprehensive data (Tracking 
v3.1, Comprehensive v2.0) was received in February 2017. In April 2017, a modification or 
amendment form was submitted to the ORE at the University of Waterloo for Emily Ha to be 
added to the project as a student investigator. In April 2017, Emily Ha was also approved for 
access by the CLSA. Following approval, three data request updates for Comprehensive data 
were received. In June 2017, all variables related to cognitive function were updated 
(Comprehensive v3.1). In January 2018, baseline Comprehensive data for SSA were updated 
(Comprehensive v3.2). In September 2018, data for the CES-D10 were updated (Comprehensive 
v4.0) and used in the analyses for this study. All data files stored at the University of Waterloo 
are password protected and only made available to researchers who have been approved by the 
CLSA and the University of Waterloo. 
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5.0 Results  
 
The results of the descriptive and multivariable regression analyses for the three research 
questions are presented below. An overview of the prevalence of depressive symptoms (Figure 
2a) and low executive function (Figure 2b) by age group and sex is presented below. Both age 
group and sex were significantly associated with depressive symptoms (p<0.001). Age group 

































































































Figure 2b. Prevalence of low executive function by age group and sex 
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 In summary, the prevalence of depressive symptoms was highest among those 45–54 
years (16.25%) compared to the other age groups, and in females (18.35%) compared to males 
(12.08%). The prevalence of low executive function was highest among those 75 years and over 
(28.06%) compared to other age groups and was approximately equal among males (9.98%) and 
females (9.97%).  
An overview of the multivariable results is presented in Figure 3. Some results were 
stratified based on significant first-order interactions (e.g., research question 1 was stratified by 
SSA because SSA was a significant first-order interaction term). In Figure 3, a bolded label 
indicates a significant association was observed, a positive symbol indicates that a positive 
association between depressive symptoms and low executive function was found, and a negative 
symbol indicates that a negative association between depressive symptoms and low executive 












Figure 3. Summary of the results from multivariable regression analyses  
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5.1 Research question 1: Is the presence of depressive symptoms associated with low 
executive function, after adjusting for confounders? 
 
5.1.1 Descriptive analyses for the association between depressive symptoms and low 
executive function 
 
Overall, depressive symptoms were significantly (p<0.001) associated with low executive 
function in both unweighted and weighted descriptive analyses (Table 2). Depressive symptoms 
were significantly more common in those with versus without low executive function (23.95% 
versus 14.28%, p<0.001).  
5.1.2 Descriptive analyses for the association between covariates and low executive 
function  
 
Age was negatively associated with low executive function (p<0.001). Among 
participants with low executive function, depressive symptoms were most prevalent among those 
75 years and over (44.59%), yet this age group only accounted for 15.88% of the overall 
unweighted analytic sample. Both education and income were positively associated with 
executive function (p<0.001). For education, 5.14% of participants obtained less than a high 
school diploma, yet these individuals accounted for nearly one-fifth of those with low executive 
function. Considering finances, of those with low executive function, 13.04% had annual 
household incomes less than $20,000, whereas 5.08% had incomes of $150,000 or more. 
Province was also significantly associated with low executive function, whereas sex and 
urban/rural residence were not.  
Self-rated general health and reporting a chronic condition were significantly associated 
with executive function (p<0.001), whereas reporting to take medication for depression was only 
significant in weighted analyses (p<0.05). Of those who reported poor or fair self-rated general 
health, a higher proportion had low executive function (17.21%) than not (7.60%). Participants 
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who reported at least one chronic health condition were more likely to have low executive 
function (81.96%) than not (65.31%). 
Marital status was significantly associated with executive function (p<0.001). The most 
notable differences were observed among those who reported to be married/common-law or 
widowed. In those who reported being married/common-law, a lower proportion had low 
executive function (56.50%) than not (71.61%). For widows, a higher proportion (20.73%) had 
low executive function compared to the 7.15% who did not. SSA was also significantly 
associated with low executive function. Among those with low SSA, 11.73% had low executive 
function, compared to 5.87% who did not. Among the covariates classified as health behaviours, 
both smoking status and alcohol use were significantly associated with low executive function. 
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Table 2. Distribution of depressive symptoms and covariates by low executive function status, 
Canadian Longitudinal Study on Aging 
1Presence of depressive symptoms: CES-D10 score ≥10;  
Absence of depressive symptoms: CES-D10 score <10 
Abbreviations: NFLD = Newfoundland and Labrador 















Not Low  
(n=2,686,643) Total 
Depressive symptoms1 (%)       
Presence 23.95 14.28*** 15.25 24.09 14.07*** 14.77 
Absence 76.05 85.72 84.75 75.91 85.93 85.23 
Sociodemographic Factors    
   
Age, groups (%)       
45–54 years 8.60  28.91*** 26.88 18.23 45.62*** 43.69 
55–64 years 17.47 35.37 33.58 18.86 30.97 30.12 
65–74 years 29.34 23.06 23.69 26.06 15.56 16.30 
75 years and over 44.59 12.66 15.88 36.85 7.85 9.89 
Sex (%)       
Female 50.50 50.51 50.51 51.75 49.89 50.02 
Male 49.50 49.49 49.49 48.25 50.11 49.98 
Education (%)       
Less than high school 16.99 3.83*** 5.14 19.54 3.53*** 4.65 
High school graduate 14.43 8.47 14.43 14.73 8.08 8.54 
Some post-secondary 8.91 7.33 8.91 8.41 6.73 6.85 
Post-secondary 
degree/diploma 
59.57 80.37 59.67 57.32 81.67 79.95 
Annual household income (%)       
< $20,000 13.04 4.32*** 5.19 13.08 3.68*** 4.34 
≥	$20,000 and < $50,000 42.11 19.68 21.92 42.03 16.30 18.11 
≥	$50,000 and < $100,000 31.38 35.74 35.31 29.90 33.50 33.25 
≥	$100,000 and < $150,000 8.39 21.33 20.04 8.75 23.65 22.60 
≥	$150,000 5.08 18.92 17.54 6.24 22.87 21.70 
Province (%)       
Ontario 20.99 21.75*** 21.68 13.92 13.45*** 13.48 
Alberta  7.69 8.69 8.59 8.80 11.25 11.08 
British Columbia 16.99 22.38 21.84 24.57 31.99 31.47 
Manitoba 11.47 10.59 10.68 10.12 8.50 8.61 
NFLD 11.21 7.50 7.87 3.48 2.26 2.34 
Nova Scotia 12.30 10.51 10.69 4.68 3.60 3.68 
Quebec 19.34 18.58 18.66 34.42 28.96 29.34 
Urban/rural residence (%)       
Urban 90.70 90.51 90.53 89.31 90.50 90.41 
Rural 9.30 9.49 9.47 10.69 9.50 9.59 
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Table 2. Distribution of depressive symptoms and covariates by low executive function status, 
Canadian Longitudinal Study on Aging, continued 
2Chronic conditions: presence of at least 1 of 11 self-reported medical conditions 
Abbreviations: SSA = social support availability  
















Not Low  
(n=2,686,643) Total 
Health Factors       
Self-rated general health (%)       
Poor 3.00 1.20*** 1.38 3.21 1.05*** 1.20 
Fair 14.21 6.40 7.18 14.31 6.37 6.93 
Good 36.98 28.45 29.30 39.46 28.95 29.69 
Very good 33.12 42.71 41.75 31.29 41.97 41.22 
Excellent 12.69 21.24 20.39 11.74 21.65 20.96 
Medication for depression (%)       
Yes 8.95 8.08 8.17 78.97 60.25* 61.57 
No 91.05 91.92 91.83 21.03 39.75 38.43 
Chronic conditions2 (%)       
Yes 81.96 65.31*** 66.97 78.97 60.25*** 61.57 
No 18.04 34.69 33.03 21.03 39.75 38.43 
Social Factors       
Marital status (%)       
Single, never married  8.17 8.51*** 8.48 8.17 7.89*** 7.91 
Married/common-law 56.50 71.61 70.10 62.84 78.23 77.15 
Widowed 20.73 7.15 8.50 15.68 4.15 4.96 
Divorced/separated 14.60 12.73 12.92 13.30 9.73 9.98 
Low SSA (%)       
Yes 11.73 5.87*** 6.45 10.51 4.93*** 5.32 
No 88.27 94.13 93.55 89.49 95.07 94.68 
Health Behaviours       
Smoking status (%)       
Current 10.08 8.20** 8.39 10.55 8.61* 8.74 
Former 59.41 60.05 59.99 57.77 57.55 57.57 
Never 30.51 31.75 31.62 31.68 33.84 33.69 
Alcohol use (%)       
Current 77.49 88.12*** 87.06 77.51 88.28*** 87.53 
Former 18.86 10.02 10.90 19.18 9.95 10.60 
Never 3.65 1.86 2.04 3.31 1.76 1.87 
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5.1.3 Multivariable regression analyses for the association between depressive symptoms 
and low executive function  
 
As a consequence of significant first-order interactions between depressive symptoms 
and some covariates, the association between depressive symptoms and low executive function 
was stratified by SSA (Tables 3a and 3b). In addition, to reduce the number of significant 
interactions, some levels of multilevel variables (i.e., province, income, self-rated general health) 
were combined. For province, Alberta and Manitoba, and Newfoundland and Labrador and Nova 
Scotia were combined. For income, the top two levels (i.e., $100,000 or more, but less than 
$150,000; and $150,000 or more) were combined. For self-rated general health, fair or poor 
health were collapsed into one level. 
5.1.3.1 Depressive symptoms and low executive function in participants by social support 
availability  
 
 In the higher SSA stratum (Table 3a), depressive symptoms were associated with low 
executive function. The association was significant in the crude model (Model A) and remained 
significant with the addition of each chunk of themed covariates (Models B–E), although the 
strength of the association decreased. In the final model (Model E), which included all 
covariates, depressive symptoms were significantly associated with 47% greater odds of low 
executive function (OR=1.47, 95% CI=1.26–1.72). 
 In those with low SSA, depressive symptoms were positively associated with low 
executive function in the crude model. Following the addition of sociodemographic covariates, 
the strength of the association increased, but became protective (Table 3b). In the low SSA 
stratum, the association between depressive symptoms and low executive function was not 
significant.  
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5.1.3.2 Sociodemographic covariates and low executive function in participants by social 
support availability 
 
Overall, age was significantly associated with low executive function (Tables 3a and 3b). 
For those with higher SSA, there was a significant and positive dose-response relationship: 
compared to the youngest age group (45–54 years), there were significantly greater odds of 
having low executive function for the 55–64 years, 65–74 years, and 75 years and over age 
groups. This was also observed for those with low SSA, although the relationship was only 
significant for those 65–74 years and 75 years and over, compared to those 45–54 years. 
Sex was also significantly associated with low executive function in both SSA strata. 
Compared to males, females had lower odds of low executive function (Tables 3a and 3b, Model 
E). Overall, the association was stronger in the low SSA stratum (OR=0.60, 95% CI=0.43–0.85) 
than the higher SSA stratum (OR=0.81, 95% CI=0.72–0.92) for females compared to males. 
Education and income displayed significant, negative dose-response associations with 
low executive function in those with higher and low SSA. Although urban/rural residence was 
not significant in any of the models, geographical distribution across Canada was significant in 
some models (e.g., those with higher SSA living in British Columbia versus Ontario had 
significantly lower odds of low executive function).  
5.1.3.3 Health covariates and low executive function in participants by social support 
availability 
 
There was a significant, negative dose-response association between self-rated general 
health and low executive function in those with higher SSA and low SSA (Tables 3a and 3b). 
Compared to those who reported their health as ‘poor or fair’, those who had ‘good’, ‘very 
good’, or ‘excellent’ self-rated health had lower odds of low executive function. Reporting a 
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chronic condition or current use of medication for depression were not significantly associated 
with low executive function.  
5.1.3.4 Social covariates and low executive function in participants by social support 
availability 
 
In those with higher SSA, marital status was not significantly associated with low 
executive function in any final models (Table 3a). However, in the low SSA stratum, compared 
to those who reported being single or never married, those who reported being married or living 
with a common-law partner (OR=1.78, 95% CI=1.01–3.12) or who were widowed (OR=2.00, 
95% CI=1.14–3.50) had greater odds of low executive function (Table 3b). 
5.1.3.5 Health behaviours and low executive function in participants by social support 
availability 
 
Compared to never smokers, former smokers with higher SSA had significantly lower 
odds of low executive function (OR=0.84, 95% CI=0.74–0.96). When compared to never 
drinkers, current drinkers had lower odds of low executive function in both SSA strata, although 








Table 3a. Multivariable analysis of the association between depressive symptoms and low 
executive function in participants with higher social support availability, Canadian Longitudinal 
Study on Aging, n=21,580 
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Table 3a. Multivariable analysis of the association between depressive symptoms and low 
executive function in participants with higher social support availability, Canadian Longitudinal 
Study on Aging, n=21,580, continued 

























Self-rated general health  
(vs. poor/fair)     
 





















Medication for depression  









Marital status (vs. single)     
 
Married/common-law    1.01 (0.79-1.29) 
1.01 
(0.79-1.29) 
Widowed     1.11 (0.86-1.44) 
1.12 
(0.86-1.45) 
Divorced/separated    0.76 (0.58-0.98) 
0.77 
(0.59-1.00) 
Smoking status (vs. never)      
Current     1.04 (0.83-1.30) 
Former     0.84 (0.74-0.96) 
Alcohol use (vs. never)      
Current     0.72 (0.52-1.00) 
Former     1.02 (0.71-1.44) 
1Low executive function was defined as a score ≥	1.5 SD below the mean of the cognitively healthy 
sample. 
2Presence of depressive symptoms was defined as a score ≥ 10 on the CES-D10. 
3Chronic conditions were defined as the presence of at least 1 of 11 self-reported medical conditions. 
Abbreviations: CI = confidence interval; OR = odds ratio 




Table 3b. Multivariable analysis of the association between depressive symptoms and low 
executive function in participants with low social support availability, Canadian Longitudinal 
Study on Aging, n=1,489 
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Table 3b. Multivariable analysis of the association between depressive symptoms and low 
executive function in participants with low social support availability, Canadian Longitudinal 
Study on Aging, n=1,489, continued 
























Self-rated general health  
(vs. poor/fair) 
    
 























Medication for depression  







Marital status (vs. single)     
 
Married/common-law    1.83 (1.03-3.25) 
1.78 
(1.01-3.12) 
Widowed     1.96 (1.13-3.38) 
2.00 
(1.14-3.50) 
Divorced/separated    1.35 (0.84-2.14) 
1.39 
(0.87-2.23) 
Smoking status (vs. never)      
Current     1.09 (0.66-1.79) 
Former     0.78 (0.53-1.13) 
Alcohol use (vs. never)      
Current     0.44 (0.18-1.08) 
Former     0.96 (0.38-2.42) 
1Low executive function was defined as a score ≥	1.5 SD below the mean of the cognitively healthy 
sample. 
2Presence of depressive symptoms was defined as a score ≥ 10 on the CES-D10.  
3Chronic conditions were defined as the presence of 1 of 11 self-reported medical conditions. 
Abbreviations: CI = confidence interval; OR = odds ratio 




5.2 Research question 2: Does the association between the presence of depressive 
symptoms and low executive function differ across age groups? 
 
Descriptive results for age-stratified analyses are presented in Tables 4a–4b. Results for 
the age-stratified multivariable analyses are presented in Tables 5a–5e.  
5.2.1 Descriptive analyses for the association between depressive symptoms and low 
executive function across age groups 
 
Across age-stratified descriptive results, depressive symptoms were significantly 
associated with low executive function in both unweighted and weighted data (Tables 4a–4d; 
p<0.001). Overall, there was a significant difference in the frequency of those who reported 
depressive symptoms versus not. Those with depressive symptoms were more likely to have low 
executive function in all models.  
5.2.2 Descriptive analyses for the association between covariates and low executive 
function across age groups 
 
 Across all age-stratified descriptive analyses, sex was significantly associated with low 
executive function only in those 65–74 years of age (unweighted: p<0.05; weighted: p<0.001). 
Results from other sociodemographic covariates, and health covariates and health behaviours 
were consistent with unstratified descriptive results presented in Table 2. Across age groups, the 
influence of social factors was notable. Marital status was significantly associated with low 
executive function and participants were most likely to report being married or in a common-law 
relationship for all age groups. The highest proportion of those reporting to be widowed were 75 
years and over. In those 75 years and over, 33.53% of widowers had low executive function, but 
they accounted for 26.94% of the analytic sample. In addition, low SSA was significant in all 
models. Most notably, those 75 years and over were more likely to report low SSA (9.60%) than 
any other age group. Of those 75 years and over with low SSA, 11.60% had low executive 
function.  
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Table 4a. Distribution of depressive symptoms and covariates by low executive function status 
in adults 45–54 years of age, Canadian Longitudinal Study on Aging 
1Presence of depressive symptoms: CES-D10 score ≥10;  
Absence of depressive symptoms: CES-D10 score <10 
Abbreviations: NFLD = Newfoundland and Labrador 





















Depressive symptoms1 (%)       
Presence 33.84 15.67*** 16.25 30.03 14.74*** 15.19 
Absence 66.16 84.33 83.75 69.97 85.26 84.81 
Sociodemographic Factors    
   
Sex (%)       
Female 48.48 51.75 51.64 43.12 48.30 48.15 
Male 51.52 48.25 48.36 56.88 51.70 51.70 
Education (%)       
Less than high school 13.13 1.83*** 2.19 14.69 1.89*** 2.26 
High school graduate 15.66 6.53 6.82 16.56 6.50 6.79 
Some post-secondary 8.08 5.43 5.51 7.51 5.38 5.44 
Post-secondary 
degree/diploma 
63.13 86.21 85.47 61.25 86.24 85.50 
Annual household income (%)       
< $20,000 12.12 3.16*** 3.45 10.99 2.74*** 2.98 
≥	$20,000 and < $50,000 30.81 9.44 10.13 31.66 8.74 9.41 
≥	$50,000 and < $100,000 28.79 28.13 28.15 28.53 27.54 27.57 
≥	$100,000 and < $150,000 16.16 28.05 27.67 15.15 29.06 28.65 
≥	$150,000 12.12 31.21 30.60 13.66 31.91 31.38 
Province (%)       
Ontario 18.69 21.12 21.04 11.59 12.89 12.85 
Alberta  8.08 8.53 8.51 13.44 13.12 13.13 
British Columbia 19.19 21.94 21.85 24.57 31.46 31.26 
Manitoba 11.62 10.58 10.61 8.77 8.50 8.51 
NFLD  7.58 8.29 8.27 2.27 2.43 2.42 
Nova Scotia 15.15 10.56 10.71 5.90 3.71 3.78 
Quebec 19.70 18.99 19.01 33.46 27.88 28.05 
Urban/rural residence (%)       
Urban 85.86 89.29 89.18 87.61 90.35 90.27 
Rural 14.14 10.71 10.82 12.39 9.65 9.73 
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Table 4a. Distribution of depressive symptoms and covariates by low executive function status 
in adults 45–54 years of age, Canadian Longitudinal Study on Aging, continued 
2Chronic conditions: presence of at least 1 of 11 self-reported medical conditions 
Abbreviations: SSA = social support availability 





















Health Factors       
Self-rated general health (%)       
Poor 4.04 1.15*** 1.24 3.12 0.96*** 1.02 
Fair 15.66 6.56 6.85 12.94 6.41 6.60 
Good 40.91 28.26 28.67 43.64 29.03 29.46 
Very good 30.30 43.09 42.68 30.28 42.34 41.99 
Excellent 9.09 20.94 20.56 10.02 21.26 20.93 
Medication for depression (%)       
Yes 14.14 8.91* 9.08 13.21 8.31* 8.46 
No 85.86 91.09 90.92 86.79 91.69 91.54 
Chronic conditions2 (%)       
Yes 63.13 48.85*** 49.31 60.65 48.10** 48.47 
No 36.87 51.15 50.69 39.35 51.90 51.53 
Social Factors       
Marital status (%)       
Single, never married  20.20 10.91*** 11.21 16.36 9.22*** 9.43 
Married/common-law 64.14 76.97 76.56 70.75 81.79 81.47 
Widowed 2.02 0.97 1.00 1.94 0.63 0.67 
Divorced/separated 13.64 11.16 11.24 10.95 8.36 8.43 
Low SSA (%)       
Yes 12.12 4.80*** 5.03 9.42 4.25** 4.41 
No 87.88 95.20 94.97 90.58 95.75 95.59 
Health Behaviours       
Smoking status (%)       
Current 19.70 10.93*** 11.21 16.22 10.32 10.49 
Former 45.96 52.38 52.18 47.62 51.65 51.53 
Never 34.34 36.69 36.62 36.15 38.03 37.98 
Alcohol use (%)       
Current 79.80 89.02*** 88.73 77.55 88.58*** 88.25 
Former 17.17 9.14 9.40 19.11 9.70 9.97 
Never 3.03 1.83 1.87 3.34 1.72 1.77 
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Table 4b. Distribution of depressive symptoms and covariates by low executive function status 
in adults 55–64 years of age, Canadian Longitudinal Study on Aging 
1Presence of depressive symptoms: CES-D10 score ≥10;  
Absence of depressive symptoms: CES-D10 score <10 
Abbreviations: NFLD = Newfoundland and Labrador 





















Depressive symptoms1 (%)       
Presence 31.34 14.70*** 15.57 29.15 14.06*** 14.73 
Absence 68.66 85.30 84.43 70.85 85.94 85.27 
Sociodemographic Factors    
   
Sex (%)       
Female 49.75 51.49 51.40 46.37 49.95 49.80 
Male 50.25 48.51 48.60 53.63 50.05 50.20 
Education (%)       
Less than high school 10.45 2.80*** 3.20 11.31 3.00*** 3.37 
High school graduate 15.17 8.51 8.86 14.84 8.77 9.04 
Some post-secondary 11.19 7.77 7.95 12.81 7.53 7.76 
Post-secondary 
degree/diploma 
63.18 80.91 79.99 61.03 80.70 79.84 
Annual household income (%)       
< $20,000 16.92 4.08*** 4.75 14.54 3.79*** 4.27 
≥	$20,000 and < $50,000 34.58 16.83 17.75 32.59 16.05 16.77 
≥	$50,000 and < $100,000 29.85 35.74 35.43 33.39 36.07 35.96 
≥	$100,000 and < $150,000 10.95 22.63 22.02 10.63 22.67 22.14 
≥	$150,000 7.71 20.72 20.05 8.86 21.41 20.86 
Province (%)       
Ontario 23.38 22.06*** 22.12 16.19 13.54** 13.65 
Alberta  5.97 9.19 9.02 8.04 11.16 11.02 
British Columbia 16.92 21.80 21.54 28.59 32.81 32.62 
Manitoba 12.69 10.80 10.89 11.10 8.44 8.56 
NFLD  12.44 7.49 7.74 4.21 2.18 2.27 
Nova Scotia 12.19 10.12 10.22 5.30 3.58 3.66 
Quebec 16.42 18.56 18.45 26.57 28.29 28.21 
Urban/rural residence (%)       
Urban 90.05 89.83 89.84 88.13 89.89 89.81 
Rural 9.95 10.17 10.16 11.87 10.11 10.19 
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Table 4b. Distribution of depressive symptoms and covariates by low executive function status 
in adults 55–64 years of age, Canadian Longitudinal Study on Aging, continued 
2Chronic conditions: presence of at least 1 of 11 self-reported medical conditions 
Abbreviations: SSA = social support availability 




















Health Factors       
Self-rated general health (%)       
Poor 5.47 1.27*** 1.48 5.21 1.15*** 1.33 
Fair 17.41 6.63 7.19 16.14 6.78 7.19 
Good 36.32 28.41 28.82 36.22 28.10 28.46 
Very good 28.11 42.45 41.71 28.75 41.86 41.28 
Excellent 12.69 21.24 20.80 13.68 22.11 21.74 
Medication for depression (%)       
Yes 16.17 9.45*** 9.80 14.95 9.25** 9.50 
No 83.83 90.55 90.20 85.05 90.75 90.50 
Chronic conditions2 (%)       
Yes 76.37 64.19*** 64.83 74.84 63.58*** 64.08 
No 23.63 35.81 35.17 25.16 36.42 35.92 
Social Factors       
Marital status (%)       
Single, never married  12.94 9.31*** 9.50 7.24 5.35*** 5.53 
Married/common-law 59.20 73.82 73.06 64.85 73.87 72.86 
Widowed 6.47 4.02 4.14 13.27 8.15 8.72 
Divorced/separated 21.39 12.85 13.30 14.63 12.66 12.88 
Low SSA (%)       
Yes 15.17 5.84*** 6.33 13.89 5.02*** 5.41 
No 84.83 94.16 93.67 86.11 94.98 94.59 
Health Behaviours       
Smoking status (%)       
Current 17.66 9.42*** 9.85 17.36 9.23*** 9.59 
Former 52.99 60.45 60.06 54.05 60.62 60.33 
Never 29.35 30.13 30.09 28.59 30.15 30.08 
Alcohol use (%)       
Current 75.93 88.60*** 87.93 76.52 88.53*** 88.01 
Former 20.90 9.67 10.25 20.46 9.66 10.14 
Never 3.48 1.73 1.82 3.01 1.80 1.86 
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Table 4c. Distribution of depressive symptoms and covariates by low executive function status 
in adults 65–74 years of age, Canadian Longitudinal Study on Aging 
1Presence of depressive symptoms: CES-D10 score ≥10;  
Absence of depressive symptoms: CES-D10 score <10 
Abbreviations: NFLD = Newfoundland and Labrador 





















Depressive symptoms1 (%)       
Presence 21.19 12.57*** 13.63 20.72 12.43*** 13.36 
Absence 78.81 87.43 86.37 79.28 87.57 86.64 
Sociodemographic Factors    
   
Sex (%)       
Female 53.48 48.74* 49.32 59.58 52.59** 53.38 
Male 46.52 51.26 50.68 40.42 47.41 46.62 
Education (%)       
Less than high school 17.19 5.26*** 6.73 21.98 5.74*** 7.56 
High school graduate 12.74 9.69 10.07 12.92 9.91 10.24 
Some post-secondary 8.00 8.04 8.03 7.55 8.14 8.07 
Post-secondary 
degree/diploma 
62.07 77.01 75.16 57.55 76.21 74.12 
Annual household income (%)       
< $20,000 13.78 5.16*** 6.22 14.20 4.76*** 5.82 
≥	$20,000 and < $50,000 43.56 28.65 30.49 46.21 28.73 30.69 
≥	$50,000 and < $100,000 31.56 42.35 41.01 28.88 42.84 41.27 
≥	$100,000 and < $150,000 7.70 15.41 14.46 7.16 15.34 14.42 
≥	$150,000 3.41 8.44 7.81 3.53 8.32 7.79 
Province (%)       
Ontario 20.15 21.90*** 21.69 16.09 15.84*** 15.87 
Alberta  7.85 8.58 8.49 7.92 8.12 8.10 
British Columbia 14.07 22.24 21.23 20.66 31.71 30.47 
Manitoba 9.48 10.52 10.40 8.16 8.38 8.36 
NFLD  14.07 6.93 7.81 4.94 2.19 2.50 
Nova Scotia 12.44 11.51 11.62 4.34 3.55 3.64 
Quebec 21.93 18.31 18.76 37.90 30.20 31.07 
Urban/rural residence (%)       
Urban 89.48 90.98 90.79 87.42 90.58* 90.22 
Rural 10.52 9.02 9.21 12.58 9.42 9.78 
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Table 4c. Distribution of depressive symptoms and covariates by low executive function status 
in adults 65–74 years of age, Canadian Longitudinal Study on Aging, continued 
2Chronic conditions: presence of at least 1 of 11 self-reported medical conditions 
Abbreviations: SSA = social support availability 





















Health Factors       
Self-rated general health (%)       
Poor 2.37 1.27*** 1.41 2.52 1.18*** 1.33 
Fair 13.93 5.35 6.41 15.14 5.31 6.42 
Good 34.37 28.15 28.92 36.03 28.88 29.68 
Very good 34.81 42.74 41.76 32.57 41.23 40.26 
Excellent 14.52 22.49 21.50 13.74 23.40 22.32 
Medication for depression (%)       
Yes 9.63 7.16* 7.47 9.95 6.59** 6.97 
No 90.37 92.84 92.53 90.05 93.41 93.03 
Chronic conditions2 (%)       
Yes 81.33 76.49** 77.09 80.77 75.88* 76.43 
No 18.67 23.51 22.91 19.23 24.12 23.57 
Social Factors       
Marital status (%)       
Single, never married  7.26 6.20*** 6.33 7.24 5.32*** 5.53 
Married/common-law 60.89 68.68 67.72 64.85 73.87 72.86 
Widowed 15.26 10.23 10.85 13.27 8.15 8.72 
Divorced/separated 16.59 14.89 15.10 14.63 12.66 12.88 
Low SSA (%)       
Yes 9.78 5.64*** 6.15 8.94 5.29*** 5.70 
No 90.22 94.36 93.85 91.06 94.71 94.30 
Health Behaviours       
Smoking status (%)       
Current 10.81 5.70*** 6.33 10.40 5.09*** 5.69 
Former 61.93 65.21 64.81 61.43 64.42 64.09 
Never 27.26 29.09 28.86 28.17 30.48 30.22 
Alcohol use (%)       
Current 77.19 88.37*** 86.99 75.50 88.56*** 87.09 
Former 19.41 9.92 11.09 20.93 9.87 11.11 
Never 3.41 1.71 1.92 3.57 1.57 1.79 
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Table 4d. Distribution of depressive symptoms and covariates by low executive function status 
in adults 75 years and over, Canadian Longitudinal Study on Aging 
1Presence of depressive symptoms: CES-D10 score ≥10;  
Absence of depressive symptoms: CES-D10 score <10 
Abbreviations: NFLD = Newfoundland and Labrador 



















Not Low  
(n=210,859) Total 
Depressive symptoms1 (%)       
Presence 20.96 13.04*** 15.26 20.95 13.43*** 15.40 
Absence 79.04 86.96 84.74 79.05 86.57 84.60 
Sociodemographic Factors    
   
Sex (%)       
Female 49.22 48.17 48.47 53.24 53.49 53.43 
Male 50.78 51.83 51.53 46.76 46.51 46.57 
Education (%)       
Less than high school 20.18 8.63*** 11.87 24.43 10.73*** 14.32 
High school graduate 15.01 10.57 11.82 15.04 10.88 11.97 
Some post-secondary 8.77 9.16 9.05 7.22 8.68 8.30 
Post-secondary 
degree/diploma 
56.04 71.63 67.26 53.13 69.71 65.41 
Annual household income (%)       
< $20,000 11.21 6.12*** 7.55 12.57 6.48*** 8.07 
≥	$20,000 and < $50,000 46.30 34.17 37.96 49.04 36.64 39.89 
≥	$50,000 and < $100,000 32.36 41.10 38.65 29.51 39.49 36.88 
≥	$100,000 and < $150,000 6.34 13.12 11.12 5.76 12.49 10.73 
≥	$150,000 3.80 4.94 4.62 3.12 4.89 4.43 
Province (%)       
Ontario 21.05 22.09*** 21.80 12.38 11.64*** 11.84 
Alberta  8.19 7.87 7.96 7.51 6.92 7.08 
British Columbia 18.52 25.29 23.39 25.29 32.34 30.49 
Manitoba 12.28 10.15 10.75 11.68 8.94 9.66 
NFLD  9.55 6.73 7.52 2.68 1.66 1.92 
Nova Scotia 11.70 9.66 10.23 4.00 3.14 3.37 
Quebec 18.71 18.21 18.35 36.46 35.35 35.65 
Urban/rural residence (%)       
Urban 92.69 94.37 93.90 92.09 93.57 93.18 
Rural 7.31 5.63 6.10 7.91 6.43 6.82 
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Table 4d. Distribution of depressive symptoms and covariates by low executive function status 
in adults 75 years and over, Canadian Longitudinal Study on Aging, continued 
2Chronic conditions: presence of at least 1 of 11 self-reported medical conditions 
Abbreviations: SSA = social support availability 




















Health Factors       
Self-rated general health (%)       
Poor 2.24 1.03*** 1.37 2.71 0.93*** 1.40 
Fair 12.87 7.30 8.86 13.47 6.66 8.44 
Good 38.21 29.51 31.95 41.47 32.01 34.49 
Very good 34.50 42.51 40.26 32.17 41.71 39.21 
Excellent 12.18 19.66 17.56 10.18 18.69 16.46 
Medication for depression (%)       
Yes 4.68 4.03 4.21 4.86 4.30 4.45 
No 95.32 95.97 95.79 95.14 95.70 95.55 
Chronic conditions2 (%)       
Yes 88.21 85.67* 86.38 88.87 86.72 87.28 
No 11.79 14.33 13.62 11.13 13.28 12.72 
Social Factors       
Marital status (%)       
Single, never married  4.58 5.02*** 4.90 3.82 4.81*** 4.55 
Married/common-law 51.07 58.56 56.46 55.73 62.06 60.41 
Widowed 33.53 24.37 26.94 29.53 21.86 23.87 
Divorced/separated 10.82 12.05 11.71 10.91 11.26 11.17 
Low SSA (%)       
Yes 11.60 8.82* 9.60 10.42 7.74* 8.44 
No 88.10 91.18 90.40 89.58 92.26 91.56 
Health Behaviours       
Smoking status (%)       
Current 4.78 3.16* 3.61 4.36 3.16 3.48 
Former 62.87 67.03 65.86 62.11 66.17 65.11 
Never 32.36 29.81 30.53 33.53 30.67 31.42 
Alcohol use (%)       
Current 77.97 84.26*** 82.49 79.41 85.05** 83.57 
Former 18.03 13.16 14.52 17.31 12.76 13.95 
Never 4.00 2.59 2.98 3.27 2.19 2.48 
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5.2.3 Multivariable regression analyses for the association between depressive symptoms 
and low executive function across age groups younger than 75 years 
 
As a result of significant first-order interactions between the depressive symptoms and 
some covariates, the 75 years and over age group had to be further stratified by SSA. To reduce 
the number of significant interactions, some levels of multilevel variables (i.e., province, income, 
self-rated general health) were combined in these models. For comparison across age groups, 
attempts to stratify the other age groups by SSA were made. However, this was not possible due 
to further issues with significant interactions and limited sample sizes within some cells that 
precluded conducting further stratification.  
5.2.3.1 Depressive symptoms and low executive function across age groups younger than 75 
years 
 
For those 45–54 years old, depressive symptoms were significantly associated with low 
executive function in the crude model (Table 5a, OR=2.75, 95% CI=1.99–3.80). The association 
remained significant after the inclusion of each new chunk of covariates, where, in the final 
model, depressive symptoms were associated with greater odds of low executive function 
(OR=1.57, 95% CI=1.08–2.29). This pattern of results was also observed among those 55–64 
years (Table 5b, OR=1.39, 95% CI=1.04–1.85). For those 65–74 years, there was a positive 
association that became nonsignificant following the inclusion of health covariates (Table 5c).   
5.2.3.2 Covariates and low executive function across age groups younger than 75 years 
 
 Sex was significantly associated with low executive function in those 55–64 years 
(OR=1.39, 85% CI=1.04–1.85). Although sex was not significant in the 45–54 and 65–74 age 
groups, all models displayed a similar pattern: compared to males, females had lower odds of 
low executive function (Tables 5a–5c). Results from other sociodemographic and health 
covariates were largely similar to what has been already presented.  
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 Although the social covariates were not significant across models, the direction of the 
association differed across age groups for both marital status and SSA. For example, in those 45–
54 years, compared to being single, being widowed was negatively associated with low 
executive function. In those 55–64 years and 65–74 years, being widowed was positively 
associated with low executive function. The covariates classified as health behaviours were not 
significantly associated with low executive function. However, current drinkers, compared to 
never drinkers, had lower odds of low executive function in the 45–54, 55–64, and 65–74-year 

















Table 5a. Multivariable analysis of the association between depressive symptoms and low 
executive function in 45–54-year olds, Canadian Longitudinal Study on Aging, n=6,202 
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Province (vs. Ontario)     
 



















































Table 5a. Multivariable analysis of the association between depressive symptoms and low 
executive function in 45–54-year olds, Canadian Longitudinal Study on Aging, n=6,202, 
continued 

















Self-rated general health  
(vs. poor/fair)     
 





















Medication for depression 
(yes vs. no) 






Marital status (vs. single)     
 
Married/common-law    1.14 (0.69-1.89) 
1.10 
(0.67-1.81) 
Widowed     0.89 (0.28-2.84) 
0.89 
(0.28-2.85) 
Divorced/separated    0.72 (0.41-1.26) 
0.72 
(0.41-1.27) 
Low social support availability 
(yes vs. no)4 




Smoking status (vs. never)      
Current     0.76 (0.46-1.23) 
Former     0.80 (0.55-1.15) 
Alcohol use (vs. never)      
Current     0.80 (0.34-1.84) 
Former     1.10 (0.34-1.84) 
1Low executive function was defined as a score ≥	1.5 SD below the mean of the cognitively healthy 
sample. 
2Presence of depressive symptoms was defined as a score ≥ 10 on the CES-D10. 
3Chronic conditions were defined as the presence of at least 1 of 11 self-reported medical conditions. 
4Low social support availability was defined as an average score of ≤ 3 on the MOS-SSS.  
Abbreviations: CI = confidence interval; OR = odds ratio 
Statistically significant values are bolded (p<0.05) 
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Table 5b. Multivariable analysis of the association between depressive symptoms and low 
executive function in 55–64-year olds, Canadian Longitudinal Study on Aging, n=7,747 






































 (vs. less than high school)      
























Annual household income  
(vs. < $20,000)      





















Province (vs. Ontario)     
 
















































Table 5b. Multivariable analysis of the association between depressive symptoms and low 
executive function in 55–64-year olds, Canadian Longitudinal Study on Aging, n=7,747, 
continued 

















Self-rated general health  
(vs. poor/fair)     
 





















Medication for depression  







Marital status (vs. single)      
Married/common-law    1.18 (0.80-1.74) 
1.16 
(0.79-1.72) 
Widowed     1.32 (0.76-2.30) 
1.36 
(0.78-2.38) 
Divorced/separated    1.15 (0.77-1.72) 
1.18 
(0.79-1.76) 
Low social support availability 





Smoking status (vs. never)      
Current     1.19 (0.83-1.71) 
Former     0.85 (0.65-1.11) 
Alcohol use (vs. never)      
Current     0.61 (0.33-1.13) 
Former     1.04 (0.55-1.98) 
1Low executive function was defined as a score ≥	1.5 SD below the mean of the cognitively healthy 
sample. 
2Presence of depressive symptoms was defined as a score ≥ 10 on the CES-D10. 
3Chronic conditions were defined as the presence of at least 1 of 11 self-reported medical conditions. 
4Low social support availability was defined as an average score of ≤ 3 on the MOS-SSS.  
Abbreviations: CI = confidence interval; OR = odds ratio 
Statistically significant values are bolded (p<0.05) 
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Table 5c. Multivariable analysis of the association between depressive symptoms and low 
executive function in 65–74-year olds, Canadian Longitudinal Study on Aging, n=5,464 






































(vs. less than high school)      
























Annual household income  
(vs. < $20,000)      





















Province (vs. Ontario)     
 
















































Table 5c. Multivariable analysis of the association between depressive symptoms and low 
executive function in 65–74-year olds, Canadian Longitudinal Study on Aging, n=5,464, 
continued 

















Self-rated general health  
(vs. poor/fair)     
 





















Medication for depression 
(yes vs. no) 






Marital status (vs. single)     
 
Married/common-law    1.27 (0.87-1.84) 
1.31 
(0.90-1.92) 
Widowed     1.17 (0.77-1.76) 
1.20 
(0.79-1.83) 
Divorced/separated    0.88 (0.59-1.30) 
0.90 
(0.61-1.34) 
Low social support availability 





Smoking status (vs. never)      
Current     1.22 (0.86-1.73) 
Former     0.90 (0.73-1.11) 
Alcohol use (vs. never)      
Current     0.57 (0.34-0.95) 
Former     1.01 (0.58-1.74) 
1Low executive function was defined as a score ≥	1.5 SD below the mean of the cognitively healthy 
sample. 
2Presence of depressive symptoms was defined as a score ≥ 10 on the CES-D10. 
3Chronic conditions were defined as the presence of at least 1 of 11 self-reported medical conditions. 
4Low social support availability was defined as an average score of ≤ 3 on the MOS-SSS.  
Abbreviations: CI = confidence interval; OR = odds ratio 
Statistically significant values are bolded (p<0.05) 
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5.2.4 Multivariable regression analyses for the association between depressive symptoms 
and low executive function in the 75 years and over age group 
 
As previously mentioned, the 75 years and over age group was further stratified by SSA 
due to significant interactions with SSA. The association between depressive symptoms and low 
executive function in those 75 years and over with higher SSA was significant in the crude 
model, and remained significant after the inclusion of all covariates (Table 5d, OR=1.50, 95% 
CI=1.17–1.93). In those 75 years and over with low SSA, there was a negative association 
between depressive symptoms and low executive function, although this did not reach 
significance (Table 5e). This pattern of results was also observed in the models that were 
stratified by SSA with all age groups combined (Table 3a and Table 3b). 
In terms of covariates, for those 75 years and over, the association of sociodemographic 
and health covariates with low executive function, stratified by SSA (Tables 5d and 5e), were 
generally consistent with the results observed in the models stratified by SSA across all age 
groups combined (Tables 3a and 3b). Health behaviours were also consistent with the results 
from the models stratified by SSA across all age groups, with the exception of alcohol use. 
Alcohol use in the low SSA stratum showed notable differences from previously observed 
results. Both current and former drinkers with low SSA, compared to never drinkers, had greater 
odds of low executive function. Although these associations did not reach statistical significance, 
greater odds for low executive function in current alcohol drinkers were not observed in any 





Table 5d. Multivariable analysis of the association between depressive symptoms and low 
executive function in the 75 years and over age group with higher social support availability, 
Canadian Longitudinal Study on Aging, n=3,305 






































 (vs. less than high school)      
























Annual household income  
(vs. < $20,000)      





















Province (vs. Ontario)      















































Table 5d. Multivariable analysis of the association between depressive symptoms and low 
executive function in the 75 years and over age group with higher social support availability, 
Canadian Longitudinal Study on Aging, n=3,305, continued 

















Self-rated general health  
(vs. poor/fair)     
 





















Medication for depression  







Marital status (vs. single)      
Married/common-law     1.16 (0.74-1.83) 
1.15 
(0.73-1.80) 
Widowed     1.57 (1.00-2.47) 
1.56 
(1.00-2.45) 
Divorced/separated    0.94 (0.57-1.55) 
0.94 
(0.57-1.55) 
Smoking status (vs. never)      
Current     1.04 (0.63-1.71) 
Former     0.80 (0.66-0.97) 
Alcohol use (vs. never)      
Current     0.76 (0.47-1.24) 
Former     0.83 (0.49-1.41) 
1Low executive function was defined as a score ≥	1.5 SD below the mean of the cognitively healthy 
sample. 
2Presence of depressive symptoms was defined as a score ≥ 10 on the CES-D10. 
3Chronic conditions were defined as presence of at least 1 of 11 self-reported medical conditions. 
Abbreviations: CI = confidence interval; OR = odds ratio 





Table 5e. Multivariable analysis of the association between depressive symptoms and low 
executive function in the 75 years and over age group with low social support availability, 
Canadian Longitudinal Study on Aging, n=351 






































 (vs. less than high school)      
























Annual household income  
(vs. <$20,000)      





















Province (vs. Ontario)      















































Table 5e. Multivariable analysis of the association between depressive symptoms and low 
executive function in the 75 years and over age group with low social support availability, 
Canadian Longitudinal Study on Aging, n=351, continued 

















Self-rated general health  
(vs. poor/fair)     
 





















Medication for depression  







Marital status (vs. single)     
 
Married/common-law     1.09 (0.38-3.08) 
1.12 
(0.39-3.20) 
Widowed     1.52 (0.60-3.85) 
1.47 
(0.18-1.33) 
Divorced/separated    0.52 (0.19-1.40) 
0.49 
(0.18-1.33) 
Smoking status (vs. never)      
Current     1.84 (0.58-5.90) 
Former     0.77 (0.43-1.38) 
Alcohol use (vs. never)      
Current     1.44 (0.39-5.34) 
Former     2.35 (0.60-9.21) 
1Low executive function was defined as a score ≥	1.5 SD below the mean of the cognitively healthy 
sample. 
2Presence of depressive symptoms was defined as a score ≥ 10 on the CES-D10. 
3Chronic conditions were defined as the presence of at least 1 of 11 self-reported medical conditions.  
Abbreviations: CI = confidence interval; OR = odds ratio 






5.3 Research question 3: Does the association between the presence of depressive 
symptoms and low executive function differ between males and females? 
 
Descriptive results for sex-stratified analyses are presented in Tables 6a and 6b. Results 
for the sex-stratified multivariable analyses are presented in Tables 7a and 7b (males), and 
Tables 8a and 8b (females).  
5.3.1 Descriptive analyses for the association between depressive symptoms and low 
executive function in males and females 
 
Consistent with unstratified and age-stratified analyses, descriptive analyses of the 
unweighted and weighted data in males (Table 6a) and females (Table 6b) showed a significant 
difference between those reporting the presence of depressive symptoms versus absence. 
Overall, in both males and females, there were significant differences in frequency of low 
executive function in those with depressive symptoms versus not. However, females had a higher 
prevalence of reporting the prevalence of depressive symptoms (18.35%) than males (12.08%).  
5.3.2 Descriptive analyses for the association between covariates and low executive 
function in males and females 
 
Overall, the results of the bivariate analyses for males (Table 6a) and females (Table 6b) 
display the same pattern as the unstratified descriptive analyses: all sociodemographic covariates 
were significantly associated with low executive function, with the exception of urban/rural 
residence, and all health covariates were significantly associated with low executive function, 
except for medication for depression.  
 Among social factors, males were more likely to report being married or in a common-
law relationship than females. Widowed females accounted for 30.12% of the sample with low 
executive function, although they only contributed to 12.56% of the full analytic sample. Among 
widowed males, a higher proportion had low executive function (11.15%) than not (3.60%), but 
only accounted for 4.35% of the analytic sample. For SSA, 9.55% of females with low SSA 
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reported low executive function, but they only accounted for 6.02% of the full analytic sample. 
In males, the prevalence of low SSA was 6.89%, with 13.96% of those reporting low SSA 
having low executive function as well.   
Health behaviours followed a similar pattern of results as previously seen in the 
unstratified analyses. However, health behaviours in males had a stronger significant association 
with low executive function compared to health behaviours in females. For example, in females, 
smoking status was not significant in weighted analyses, whereas in males, both smoking status 

















Table 6a. Distribution of depressive symptoms and covariates by low executive function status 
in males, Canadian Longitudinal Study on Aging 
1Presence of depressive symptoms: CES-D10 score ≥10;  
Absence of depressive symptoms: CES-D10 score <10 
Abbreviations: NFLD = Newfoundland and Labrador 

















Not Low  
(n=1,346,345) Total 
Depressive symptoms1 (%)       
Presence 20.46 11.15*** 12.08 21.06 11.50*** 12.15 
Absence 79.54 88.85 87.92 78.94 88.50 87.85 
Sociodemographic Factors    
   
Age, groups (%)       
45–54 years 8.96 28.19*** 26.27 21.49 47.06*** 45.33 
55–64 years 17.73 34.67 32.98 20.96 30.93 30.26 
65–74 years 27.57 23.89 24.25 21.83 14.72 15.20 
75 years and over 45.74 13.26 16.50 35.71 7.28 9.21 
Education (%)       
Less than high school 15.19 3.39*** 4.56 16.78 2.98*** 3.92 
High school graduate 13.52 7.44 8.05 14.38 6.73 7.25 
Some post-secondary 9.39 6.96 7.20 8.61 6.28 6.44 
Post-secondary 
degree/diploma 
61.90 82.21 80.19 60.23 84.01 82.39 
Annual household income (%)       
< $20,000 8.25 3.12*** 3.63 8.96 2.81*** 3.23 
≥	$20,000 and < $50,000 39.07 15.03 17.43 39.86 12.69 14.53 
≥	$50,000 and < $100,000 35.91 35.61 35.64 32.57 31.9 31.98 
≥	$100,000 and < $150,000 10.01 24.12 22.71 10.01 26.11 25.02 
≥	$150,000 6.76 22.12 20.58 8.60 26.45 25.24 
Province (%)       
Ontario 21.07 22.04*** 21.94 13.30 13.52*** 13.50 
Alberta  7.11 8.71 8.55 9.44 12.39 12.19 
British Columbia 17.21 22.68 22.13 23.85 31.78 31.24 
Manitoba 12.55 10.26 10.49 10.91 8.67 8.83 
NFLD 10.27 7.54 7.81 3.10 2.08 2.15 
Nova Scotia 12.03 10.81 10.93 4.44 3.24 3.32 
Quebec 19.75 17.96 18.14 34.96 28.31 28.76 
Urban/rural residence (%)       
Urban 90.52 90.85 90.82 89.41 91.31 91.19 
Rural 9.48 9.15 9.18 1059 8.69 8.81 
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Table 6a. Distribution of depressive symptoms and covariates by low executive function status 
in males, Canadian Longitudinal Study on Aging, continued 
2Chronic conditions: presence of at least 1 of 11 self-reported medical conditions 
Abbreviations: SSA = social support availability 



















Health Factors       
Self-rated general health (%)       
Poor 2.90 1.20*** 1.37 3.16 1.10*** 1.24 
Fair 14.40 6.70 7.47 13.27 6.66 7.11 
Good 36.08 29.75 30.38 38.78 30.46 31.03 
Very good 33.80 41.66 40.88 32.62 41.08 40.51 
Excellent 12.82 20.68 19.90 12.17 20.70 20.12 
Medication for depression (%)       
Yes 5.71 5.24 5.29 6.62 5.48 5.56 
No 94.29 94.76 94.71 93.38 92.52 94.44 
Chronic conditions2 (%)       
Yes 81.39 65.85*** 65.60 77.29 57.47*** 58.82 
No 18.61 36.15 34.40 22.71 42.53 41.18 
Social Factors       
Marital status (%)       
Single, never married  8.34 7.67*** 7.73 8.72 7.73*** 7.80 
Married/common-law 69.27 80.24 79.15 74.57 83.71 83.09 
Widowed 11.15 3.60 4.35 7.36 1.85 2.23 
Divorced/separated 11.24 8.49 8.77 9.38 6.70 6.88 
Low SSA (%)       
Yes 13.96 6.11*** 6.89 11.85 5.27*** 5.71 
No 86.04 93.89 93.11 88.15 94.73 94.29 
Health Behaviours       
Smoking status (%)       
Current 10.71 8.03*** 8.29 11.81 8.59*** 8.81 
Former 66.11 63.29 63.57 63.50 59.52 59.79 
Never 23.18 28.68 28.13 24.69 31.89 31.40 
Alcohol use (%)       
Current 79.81 89.26*** 88.32 79.95 89.44*** 88.80 
Former 17.65 9.23 10.07 17.26 9.09 9.64 
Never 2.55 1.51 1.61 2.79 1.47 1.56 
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Table 6b. Distribution of depressive symptoms and covariates by low executive function status 
in females, Canadian Longitudinal Study on Aging 
1Presence of depressive symptoms: CES-D10 score ≥10;  
Absence of depressive symptoms: CES-D10 score <10 
Abbreviations: NFLD = Newfoundland and Labrador 



















Depressive symptoms1 (%)       
Presence 27.37 17.35*** 18.35 36.92 16.64*** 17.39 
Absence 72.63 82.65 81.65 73.08 83.36 82.16 
Sociodemographic Factors    
   
Age, groups (%)       
45–54 years 8.26 29.62*** 27.49 15.19 44.16*** 42.06 
55–64 years 17.21 36.05 37.17 16.90 31.02 29.99 
65–74 years 31.07 22.25 23.13 30.00 16.41 17.40 
75 years and over 43.46 12.08 15.21 37.91 8.42 10.56 
Education (%)       
Less than high school 18.76 4.26*** 5.71 22.12 4.07*** 5.38 
High school graduate 15.32 9.48 10.06 15.05 9.43 9.83 
Some post-secondary 8.43 7.70 7.78 8.23 7.19 7.27 
Post-secondary 
degree/diploma 
57.49 78.56 76.46 54.60 79.31 77.52 
Annual household income (%)       
< $20,000 17.73 5.50*** 6.72 16.92 4.54*** 5.44 
≥	$20,000 and < $50,000 45.09 24.24 26.32 44.05 19.93 21.69 
≥	$50,000 and < $100,000 26.94 35.87 34.98 27.41 35.08 35.52 
≥	$100,000 and < $150,000 6.80 18.59 17.41 7.59 21.17 20.18 
≥	$150,000 3.44 15.80 14.56 4.03 19.27 18.16 
Province (%)       
Ontario 20.91 21.48*** 21.42 14.50 13.38*** 13.47 
Alberta  8.26 8.67 8.63 8.19 10.10 9.96 
British Columbia 16.78 22.09 21.56 25.25 32.19 31.69 
Manitoba 10.41 10.91 10.86 9.39 8.33 8.40 
NFLD 12.13 7.45 7.92 3.84 2.43 2.53 
Nova Scotia 12.56 10.21 10.44 4.91 3.96 4.03 
Quebec 18.93 19.19 19.16 33.92 29.61 29.92 
Urban/rural residence (%)       
Urban 90.88 90.18 90.25 89.21 89.67 89.64 
Rural 9.12 9.82 9.82 10.79 10.33 10.36 
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Table 6b. Distribution of depressive symptoms and covariates by low executive function status 
in females, Canadian Longitudinal Study on Aging, continued 
2Chronic conditions: presence of at least 1 of 11 self-reported medical conditions 
Abbreviations: SSA = social support availability 
















Not Low  
(n=1,340,299) Total 
Health Factors       
Self-rated general health (%)       
Poor 3.10 1.21*** 1.40 3.25 1.00*** 1.17 
Fair 14.03 6.10 6.89 15.28 6.09 6.75 
Good 37.87 27.17 28.24 40.09 27.44 28.36 
Very good 32.44 43.74 42.61 30.05 42.86 41.93 
Excellent 12.56 21.78 20.86 11.33 22.61 21.79 
Medication for depression (%)       
Yes 12.13 10.86 10.99 12.40 10.58 10.71 
No 87.87 89.14 89.01 87.60 89.42 89.29 
Chronic conditions2 (%)       
Yes 82.53 66.75*** 68.32 80.52 63.04*** 64.31 
No 17.47 33.25 31.68 19.48 36.96 35.69 
Social Factors       
Marital status (%)       
Single, never married  8.00 9.34*** 9.21 7.66 8.04*** 8.01 
Married/common-law 43.98 63.16 61.24 51.94 72.73 71.22 
Widowed 30.12 10.62 12.56 23.44 6.45 7.69 
Divorced/separated 17.90 16.88 16.98 16.96 12.78 13.08 
Low SSA (%)       
Yes 9.55 5.63*** 6.02 9.25 4.59*** 4.93 
No 90.45 94.37 93.98 90.75 95.41 95.07 
Health Behaviours       
Smoking status (%)       
Current 9.47 8.38* 8.49 9.37 8.62 8.68 
Former 52.84 56.87 56.47 52.43 55.58 55.35 
Never 37.69 34.75 35.04 38.20 35.80 35.97 
Alcohol use (%)       
Current 75.22 87.01*** 85.83 75.24 87.12*** 86.26 
Former 20.05 10.78 11.71 20.97 10.82 11.56 
Never 4.73 2.21 2.46 3.80 2.06 2.18 
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5.3.3 Multivariable regression analyses for the association between depressive symptoms 
and low executive function in males and females 
 
As a result of significant first-order interactions, models for males had to be further 
stratified by alcohol use and models for females had to be further stratified by SSA. Attempts 
were made to stratify the opposite sex by the significant interaction term (i.e., females by alcohol 
use and males by SSA). This was not possible due to issues with further significant interactions 
and limited sample sizes within some cells that precluded conducting further stratification. To 
address other significant first-order interactions, some levels of multilevel variables were 
combined (i.e., province, income, self-rated general health).  
5.3.3.1 Regression analyses for the associations in males by alcohol use 
 
Multivariable analyses for the models for males by alcohol use are presented in Table 7a 
and 7b. In these models, alcohol use was stratified into two levels: current drinkers versus 
former/never drinkers. Depressive symptoms were significantly associated with low executive 
function in males who were current or former/never drinkers (Tables 7a and 7b). Overall, the 
strength of the association between depressive symptoms and low executive function was 
stronger in male former/never drinkers (OR=1.70, 95% CI=1.07–2.70), although male current 
drinkers also had increased odds of low executive function (OR=1.49, 95% CI=1.14–1.93).   
The associations between sociodemographic and health covariates with low executive 
function followed the same general pattern observed in previous analyses. For social covariates, 
only certain levels of marital status were significantly associated with low executive function 
among males. In male former/never drinkers, those who reported being married or in a common-
law relationship, widowed, or divorced/separated had greater odds of low executive function 
compared to single males. Low SSA was associated with greater odds of low executive function 
in all models for male former/never drinkers.  
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Table 7a. Multivariable analysis of the association between depressive symptoms and low 
executive function in male former/never drinkers, Canadian Longitudinal Study on Aging, 
n=1,334 





























Age, groups (vs. 45–54 years)      






















 (vs. less than high school)      
























Annual household income  
(vs. < $20,000)      





















Province (vs. Ontario)     
 










































Table 7a. Multivariable analysis of the association between depressive symptoms and low 
executive function in male former/never drinkers, Canadian Longitudinal Study on Aging, 
n=1,334, continued 

















Self-rated general health  
(vs. poor/fair)     
 





















Medication for depression 







Marital status (vs. single)     
 
Married/living with a 





Widowed     2.74 (1.13-6.34) 
2.70 
(1.11-6.55) 
Divorced/separated    1.81 (0.85-3.84) 
1.78 
(0.83-3.77) 
Low social support availability 





Smoking status (vs. never)      
Current     1.06 (0.56-2.00) 
Former     1.17 (0.75-1.81) 
1Low executive function was defined as a score ≥	1.5 SD below the mean of the cognitively healthy 
sample. 
2Presence of depressive symptoms was defined as a score ≥ 10 on the CES-D10. 
3Chronic conditions were defined as the presence of at least 1 of 11 self-reported medical conditions. 
4Low social support availability was defined as an average score of ≤ 3 on the MOS-SSS.  
Abbreviations: CI = confidence interval; OR = odds ratio 





Table 7b. Multivariable analysis of the association between depressive symptoms and low 
executive function in male current drinkers, Canadian Longitudinal Study on Aging, n=10,083 





























Age, groups (vs. 45–54 years)      
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Annual household income  
(vs. < $20,000)      





















Province (vs. Ontario)     
 












































Table 7b. Multivariable analysis of the association between depressive symptoms and low 
executive function in male current drinkers, Canadian Longitudinal Study on Aging, n=10,083, 
continued 

















Self-rated general health  
(vs. poor/fair)     
 





















Medication for depression 







Marital status (vs. single)     
 
Married/living with a 





Widowed     1.04 (0.67-1.62) 
1.07 
(0.68-1.66) 
Divorced/separated    0.64 (0.42-0.97) 
0.64 
(0.43-0.97) 
Low social support availability 
(yes vs. no) 




Smoking status (vs. never)      
Current     1.21 (0.86-1.69) 
Former     0.85 (0.69-1.05) 
1Low executive function was defined as a score ≥	1.5 SD below the mean of the cognitively healthy 
sample. 
2Presence of depressive symptoms was defined as a score ≥ 10 on the CES-D10. 
3Chronic conditions were defined as the presence of at least 1 of 11 self-reported medical conditions. 
4Low social support availability was defined as an average score of ≤ 3 on the MOS-SSS.  
Abbreviations: CI = confidence interval; OR = odds ratio 





5.3.3.2 Regression analyses for the associations in females by social support availability 
 
Models for females stratified by SSA are presented in Tables 8a and 8b.  Depressive 
symptoms were significantly associated with greater odds of low executive function in females 
who reported higher SSA (OR=1.33, 95% CI=1.09–1.62). In females with low SSA, depressive 
symptoms were associated with lower odds of low executive function, although this association 
was not significant (Table 8b). 
Sociodemographic and health variables displayed the same associations that have been 
previously observed models only stratified by SSA. For females who reported low SSA, the 
associations between marital status and low executive function were similar to those observed in 
the models for males and females combined and stratified by only SSA: those with low SSA 
have greater odds of low executive function when reporting to be married or in a common-law 
relationship, widowed, or divorced/separated. When considering health behaviours, among 
females with higher SSA, former smoking associated with lower odds of low executive function 


















Table 8a. Multivariable analysis of the association between depressive symptoms and low 
executive function in females with higher social support availability, Canadian Longitudinal 
Study on Aging, n=10,950 





























Age, groups (vs. 45–54 years)      




























 (vs. less than high school)      
























Annual household income  
(vs. < $20,000)      





















Province (vs. Ontario)     
 















Labrador & Nova 
Scotia 
























Table 8a. Multivariable analysis of the association between depressive symptoms and low 
executive function in females with higher social support availability, Canadian Longitudinal 
Study on Aging, n=10,950, continued 

















Self-rated general health  
(vs. poor/fair)     
 























Medication for depression 







Marital status (vs. single)     
 
Married/living with a 





Widowed     1.29 (0.94-1.77) 
1.31 
(0.96-1.80) 
Divorced/separated    0.93 (0.67-1.29) 
0.95 
(0.68-1.32) 
Smoking status (vs. never)      
Current     0.94 (0.70-1.27) 
Former     0.77 (0.65-0.91) 
Alcohol use (vs. never)      
Current     0.92 (0.62-1.36) 
Former     1.23 (0.81-1.88) 
1Low executive function was defined as a score ≥	1.5 SD below the mean of the cognitively healthy 
sample. 
2Presence of depressive symptoms was defined as a score ≥ 10 on the CES-D10. 
3Chronic conditions were defined as the presence of at least 1 of 11 self-reported medical conditions.  
Abbreviations: CI = confidence interval; OR = odds ratio 






Table 8b. Multivariable analysis of the association between depressive symptoms and low 
executive function in females with low social support availability, Canadian Longitudinal Study 
on Aging, n=702 





























Age, groups (vs. 45–54 years)      






















 (vs. less than high school)      
























Annual household income  
(vs. <$20,000)      





















Province (vs. Ontario)     
 















Labrador & Nova 
Scotia 


























Table 8b. Multivariable analysis of the association between depressive symptoms and low 
executive function in females with low social support availability, Canadian Longitudinal Study 
on Aging, n=702, continued 

















Self-rated general health  
(vs. poor/fair)     
 





















Medication for depression  
(yes vs. no) 






Marital status (vs. single)     
 
Married/living with a 





Widowed     1.80 (0.80-4.04) 
1.76 
(0.77-4.03) 
Divorced/separated    1.13 (0.56-2.26) 
1.19 
(0.59-2.40) 
Smoking status (vs. never)      
Current     1.23 (0.59-2.57) 
Former     0.93 (0.53-1.63) 
Alcohol use (vs. never)      
Current     0.28 (0.10-0.80) 
Former     0.59 (0.19-1.88) 
1Low executive function was defined as a score ≥	1.5 SD below the mean of the cognitively healthy 
sample. 
2Presence of depressive symptoms was defined as a score ≥ 10 on the CES-D10. 
3Chronic conditions were defined as the presence of at least 1 of 11 self-reported medical conditions.  
Abbreviations: CI = confidence interval; OR = odds ratio 







6.1 Study Findings  
 
This study investigated the association between depressive symptoms and executive 
function, a key domain of cognitive function. A number of sociodemographic, health, and social 
factors, as well as health behaviours, were included in the investigation to assess whether they 
affect the association. This study used both descriptive analyses and multivariable logistic 
regression.  
In summary, more than one-sixth of the analytic sample reported the presence of 
depressive symptoms. Across age groups, the prevalence of depressive symptoms was highest 
among those 45–54 years and lowest among those 64–75 years. Between sexes, the prevalence of 
depressive symptoms was higher among females compared to males. Across age groups, the 
prevalence of low executive function was highest among those 75 years and over and lowest 
among those 45–54 years, which is expected as cognitive function has been found to decline in 
older age. The prevalence of low executive function did not differ by sex. In bivariate analyses, 
depressive symptoms were significantly associated with low executive function in the overall 
association, and when stratified by age group and sex. A consistent pattern was observed, where 
the prevalence of depressive symptoms was higher among those who had low executive function 
compared to those who did not have low executive function.  
 Overall, this study found that the presence of depressive symptoms was associated with 
low executive function, after adjusting for confounders. Age, sex, and SSA showed effect 
modification of the association between depressive symptoms and low executive function. When 
stratified by age, those who reported depressive symptoms had greater odds of low executive 
function compared to those who did not report depressive symptoms in the 45–54 year, 55–64 
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year, 65–74 year age groups and in those 75 years and over with higher SSA. The strength of the 
association between depressive symptoms and low executive function increased in the oldest age 
group (i.e., 75 years and over), which is supported by past literature that found that depressive 
symptoms are associated with poorer cognitive outcomes in older adults compared to younger 
age groups.  
When stratified by sex, those who reported depressive symptoms had significantly greater 
odds of low executive function compared to those who did not report depressive symptoms in 
males and in females with higher SSA. The strength of the association between depressive 
symptoms and low executive function differed when comparing males and females. Findings are 
consistent with past literature that depressive symptoms may influence later-life health outcomes 
for males and females differently.  
When stratified by SSA, consistent patterns were observed across all research questions: 
in the higher SSA stratum, those who reported depressive symptoms had significantly greater 
odds of low executive function compared to those who did not report depressive symptoms, 
whereas the association was not significant in the low SSA stratum. As expected, reporting 
depressive symptoms was associated with poorer cognitive outcomes.  
6.1.1 Discussion of the results stratified by social support availability 
 
Following the inclusion of all covariates, depressive symptoms were positively associated 
with low executive function in those with higher SSA. The positive association observed 
between depressive symptoms and low executive function in this study is consistent with past 
literature that also showed positive cross-sectional associations of depressive symptoms with 
cognitive function, and more specifically, executive function (Klojčnik et al., 2017). Some 
longitudinal studies also support a positive association between depressive symptoms with 
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executive function and global cognitive function (Dotson et al., 2008; Freiheit et al., 2012; 
Pantzar et al., 2017; Royall et al., 2012). Given that most of the studies on depression and 
executive function are limited to smaller clinical populations or older adults (Cui et al., 2007; de 
Paula et al., 2016; Klojčnik et al., 2017; Tam & Lam, 2012), findings from this study may be 
more generalizable to the middle-aged and older Canadian population.  
However, the significant and positive association between depressive symptoms and low 
executive function in the higher SSA stratum, and the negative, although not significant, 
association in the low SSA stratum appear to be surprising, given evidence that social support 
has been shown to be a protective factor for depression and cognition separately, and it might be 
expected that higher levels of social support might mitigate the detrimental effects of depressive 
symptoms on cognition (Dickinson, Potter, Hybels, Mcquoid, & Steffens, 2011; Ellwardt, 
Aartsen, Deeg, & Steverink, 2013; Harasemiw, Newall, Shooshtari, Mackenzie, & Menec, 2018; 
Kim, Kwak, Kim, Youm, & Chey, 2019; Rutter, 2019; Seeman, Lusignolo, Albert, & Berkman, 
2001). As this was not observed in this study, the modifying effect of SSA on the association 
between depressive symptoms and executive function may be explained by the reciprocity theory 
or differences in the operationalization of variables between this study and others.  
The reciprocity theory states that receiving support that cannot be returned can be 
distressing for the recipient (Uehara, 1995). The recipient of the support may start to question 
their usefulness and social functioning. As well, undesired feelings of dependence may arise 
(Uehara, 1995). While most studies that reference the reciprocity theory refer to populations of 
individuals with disabilities, other studies have reported the burden of social support among 
healthy adults and those with depression (Gleason, Iida, Shrout, & Bolger, 2008; Sims et al., 
2014). Therefore, it may not be that higher SSA has direct negative effects on cognitive function, 
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but rather higher SSA may be perceived differently by individuals with depressive symptoms. 
For example, it has been shown that some individuals, particularly those living with depression, 
chronic conditions, illnesses or disabilities, perceive higher social support as a stressor 
(Reinhardt, Boerner, & Horowitz, 2006; Sims et al., 2014). In addition, depressive symptoms 
have been shown to increase risk of executive dysfunction (Klojčnik et al., 2017), so it is 
possible that the association is driven by the presence of depressive symptoms, rather than SSA. 
In addition, perceived social support may not be aligned with the needs of the individual 
and may manifest in poorer cognitive function (Sims et al., 2014). As seen in this thesis, 
depressive symptoms in those with higher SSA were associated with greater odds of low 
executive function. This may be a result of misalignment, where the perceived SSA was not 
helpful for those with depressive symptoms, resulting in greater odds of low executive function. 
However, the effects of SSA subtypes were not assessed in this study. Although subtypes of SSA 
have not been explicitly differentiated in the past, some studies suggest that emotional and 
tangible social support affect depressive symptoms differently (Sims et al., 2014). Therefore, in 
addition to overall SSA, subtypes of SSA may modify the association between depressive 
symptoms and executive function differently. Previous unpublished work with CLSA 
Comprehensive data has shown that subtypes of SSA modified the association between 
depressive symptoms and executive function differently (Iacono, 2018). As such, future work 
with the CLSA may be able to further address the role of SSA on the relationship between 
depressive symptoms and executive function by assessing SSA subtypes. 
Other possible explanations for the results stratified by SSA in this study may be 
attributed to the variables studied. Past research has focused on the association between social 
support and cognitive function, rather than on social support as a modifier for the association 
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between depressive symptoms and cognitive function. For example, while there is a longitudinal 
study that found that higher levels of overall social support and its subtypes (e.g., affection and 
positive social interactions) were associated with increased risk of incident cognitive impairment, 
this study did not account for the presence of depressive symptoms (Pillemer, Ayers, & Holtzer, 
2018). In addition, the baseline risk for low executive function has been shown to be higher in 
those with low SSA, before consideration of depressive symptoms (Ellwardt et al., 2013; 
Pillemer & Holtzer, 2016). Therefore, this may be why nonsignificant results were found for the 
association between depressive symptoms and low executive function in the low SSA stratum: it 
may be difficult to detect increases with depressive symptoms beyond the elevated baseline risk 
of low executive function in those with low SSA.  
This study also focused on a larger age range (45–85 years) that included participants 
who reported cognitive conditions, whereas other studies focused on younger adults  (e.g., 
university students) or those 65 years and over with no history of cognitive conditions (Seeman 
et al., 2001). The sample size of this study was also relatively large. Therefore, there may have 
been sufficient power to detect a range of significant results that may not have previously been 
detectable. Furthermore, both marital status and SSA were included as covariates. Given that 
social support is not consistently defined across literature, it may not have been identified as a 
separate form of support that differs from marital status. However, this study did not find that 
marital status affected the association between depressive symptoms and low executive function. 
As this is a cross-sectional study, the temporality between depressive symptoms and level of 
SSA cannot be determined. While some studies have shown that higher SSA increases negative 
affect (i.e., depressed mood), it possible that depressive symptoms cause lower SSA, which has 
been suggested by the literature (Gleason et al., 2008; Riddle, McQuoid, Potter, Steffens, & 
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Taylor, 2015). More severe depressive symptoms may also require higher levels of social 
support. Therefore, while there appears to be a positive association between higher SSA and 
depressive symptoms with low executive function, depressive symptoms, rather than social 
support, may drive the relationship with executive function. Future work should examine 
depressive symptoms as a continuous measure to determine whether severity of depressive 
symptoms is an important determinant in this relationship.  
6.1.2 Discussion of the results stratified by age group 
 
In analyses stratified by age, depressive symptoms were positively associated with low 
executive function across all age groups, with the exception of those 75 years and over with low 
SSA. This is generally consistent with previous studies, which found significant and positive 
dose-response associations between depressive symptoms with cognitive function and executive 
function by age (Barnes et al., 2012; Byers et al., 2012; Chui et al., 2015). There are a few 
studies that have compared depressive symptoms with cognitive function in both middle and 
later life, and observed stronger associations between depressive symptoms and dementia in later 
life (Barnes et al., 2012). In this present study, the 65–74-year age group showed a strong 
association between depressive symptoms and low executive function in the crude model, but not 
in the final model. While it was expected that there would be significant and positive 
associations in the older age groups, a possible explanation for the nonsignificant result may be 
attributed to older adults commonly mistaking their depressive symptoms as part of the normal 
aging process. As such, while those in the 65–74 age group may be feeling clinically relevant 
depressive symptoms, they may be more likely than younger individuals to dismiss their 
depressive symptoms. Older adults have been shown to mistake depressive symptoms as part of 
the normal aging process, or attribute them to changes in societal roles, such as transitioning into 
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retirement. Under-reporting depressive symptoms may also be apparent in this study, as those 
65–74 years had the lowest prevalence of depressive symptoms although the prevalence of 
depressive symptoms is known to increase with age (Blazer, 2003; Minicuci et al., 2002).  
In addition to age, SSA was an effect modifier for the association in the 75 years and over 
age group. This is consistent with some studies that found that depressive symptoms were 
negatively associated with social isolation, and that the strength of the association increased with 
age (Blazer et al., 1991). In addition, compared to other age groups, those 75 years and over with 
depressive symptoms were more likely to report being widowed, and both older age and 
widowhood have been shown to have a negative influence on perceived social support and 
cognitive function (Alexopoulos, 2005). It is also possible that the severity of depressive 
symptoms in the older age groups is greater than in younger age groups, and therefore drives the 
association towards greater risk of low executive function in the older age groups.  
6.1.3 Discussion of the results stratified by sex 
 
In sex-stratified descriptive analyses, females reported a higher prevalence of depressive 
symptoms than males, although the prevalence of low executive function was approximately 
equal between males and females. In bivariate analyses, depressive symptoms were significantly 
associated with executive function in both males and females.  
 In multivariable analyses of males, alcohol use was identified as an effect modifier. For 
both male current drinkers, and male former or never drinkers, reporting depressive symptoms 
was associated with greater odds of low executive function compared to not reporting. This is 
expected as the risk for low executive function has been shown to be higher in those with 
depressive symptoms compared to those without depressive symptoms (Dotson et al., 2008; 
Klojčnik et al., 2017; Pantzar et al., 2017; Reppermund et al., 2011; Royall et al., 2012). 
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Therefore, alcohol use in combination with depressive symptoms may result in additional risk for 
low executive function.  
In this study, compared to males who were current drinkers, males who were former or 
never drinkers showed a stronger positive association between depressive symptoms and greater 
odds for low executive function. A possible explanation for the stronger association observed in 
male former or never drinkers can be described by referencing the J-shaped curve, where those 
who engage in minimal to no drinking are at greater risk for declines in cognitive function than 
current drinkers who consume moderate amounts of alcohol (Alzheimer’s Society of Canada, 
2019; Andreasson, 1998; Tyas, 2001). As such, there may greater risk of low executive function 
in those who report depressive symptoms and former or never drinking, compared to those who 
report depressive symptoms and current drinking. The J-shape curve can also be applied to the 
association between alcohol use and mortality. In Canada, alcohol consumption is a normative 
behaviour. As such, former drinkers may disproportionately include those who stopped drinking 
because of alcoholism, as well as those with health issues with contraindications that include 
alcohol. For example, individuals taking many of the common antidepressants should not 
consume alcohol (Ruitenberg et al., 2002). Also, those taking antidepressants may have more 
severe depressive symptoms. Therefore, those who are former drinkers may be at increased risk 
of mortality and cognitive decline due to other health and medical conditions that caused them to 
stop drinking, including severe depressive symptoms. In turn, this may be why the association is 
stronger in former or never drinkers than current drinkers, although there is still greater odds of 
low executive function observed in both groups.  
 In analyses of females by SSA, females with higher SSA who reported depressive 
symptoms had greater odds of low executive function compared to those who did not report 
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depressive symptoms. In contrast, females with low SSA who reported depressive symptoms had 
lower odds of low executive function, compared to those who did not report depressive 
symptoms. Past studies have found that greater levels of social strain and negative interactions 
were associated with higher global cognitive function (Hughes, Andel, Small, Borenstein, & 
Mortimer, 2008). Therefore, it is possible that the negative relationships females experience, and 
the potential of associated depressive symptoms that arise from these negative relationships, can 
result in more efficient and widespread cognitive functioning through cognitive stimulation 
(Hughes et al., 2008), possibly explaining why females with low SSA who reported depressive 
symptoms had lower odds of low executive function.  
 Females are also more likely to report receiving social support from their children and 
family, whereas males report receiving the majority of their social support from their spouses. 
Over time, females also do not see an increase in support, whereas males observe increases in 
support from their spouses with age (Gurung, Taylor, & Seeman, 2003). Therefore, it is possible 
that with increasing age and depressive symptoms, women are more likely to increase their 
independence due to emotional and social distancing from their spouse. As a result, women with 
depressive symptoms may be less likely to be dependent on social supports and feel more 
motivated to accomplish tasks on their own. In turn, this results in cognitive stimulation and 
possibly explains why those with depressive symptoms but with low SSA have lower odds of 
low executive function. In contrast, females with higher SSA may grow to be dependent on their 
social supports and therefore the effects of depressive symptoms on cognitive function are 
greater. This is similar to the reciprocity theory, as previously described (Uehara, 1995). 
 In conclusion, depressive symptoms were associated with low executive function, and 
results supported age group and sex as effect modifiers. While significant associations were 
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observed among descriptive and multivariable results, it is likely that the strength of the 
associations (i.e., the odds ratios) based off of the analytic sample are an underestimate of the 
Canadian population at large. This is because of possible selection bias. It has been shown that 
individuals who have depression, or are experiencing depressive symptoms, as well as 
individuals with cognitive impairments or chronic conditions, are less likely to volunteer and 
participate in epidemiological studies (Li & Ferraro, 2005; Montgomery et al., 2010; R. O. 
Roberts et al., 2008). As such, the participants in the CLSA, and therefore the analytic sample, 
are likely to be healthier, with higher cognitive functioning and less depressive symptoms than 
the age- and sex-matched Canadian population at large.  
6.2 Strengths 
 
One of the most prominent strengths is the CLSA’s large population-based sample. 
Alongside targeted recruitment of low education areas to reduce possible selection bias for more 
highly educated participants, the CLSA used sampling strata based on age, sex, and province 
during recruitment to yield a more nationally representative sample. In addition, the inclusion of 
a wide age range, capturing adults between 45 to 85 years, allowed for the association between 
depressive symptoms and executive function to be explored across different age groups. Such an 
investigation has not been previously explored in a Canadian sample and will be valuable in 
extending previous findings to middle-aged and older community-dwelling adults. Overall, the 
large and population-based nature of the sample allows results to be more generalizable to the 
community-dwelling aging population in Canada. 
Another strength of this study is the extensive amount of information about demographic, 
health, social, and psychological factors included in the CLSA. Unlike previously published 
cross-sectional and longitudinal studies, this allowed for the association between depressive 
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symptoms and executive function to be explored while controlling for many covariates in the 
regression models. In turn, the ability to include many covariates simultaneously in logistic 
regression models may provide future studies with insights on the types of variables that 
influence the association between depressive symptoms and executive function. For example, 
these covariates included both subjective and objective measures of health; self-rated general 
health has not been previously investigated, although the perspectives of aging adults play an 
important role in health outcomes. Moreover, both structural and functional social factors, such 
as marital status and SSA, have not been considered simultaneously in a single study. As such, 
this study is able to include variables that are more reflective of both objective measures of 
health and subjective perceptions and experiences of aging adults.  
In addition to the consideration of many covariates in a single study, this study was able to 
use a neuropsychological battery to measure executive function. Previous studies have only 
considered measures of global cognitive function or used a single test to represent executive 
function. By using several tests to measure executive function in this study, a more 
representative and accurate assessment of a key cognitive domain was conducted.  
6.3 Limitations 
 
 Although there are many strengths associated with this study, there were also some 
limitations. One limitation is that the heterogeneous sample may increase the risk of confounding 
by variables not accounted for in this study. Moreover, participants in the Comprehensive cohort 
had to live within 25–50 km of a DCS, thereby excluding individuals who lived further away. 
Also, recruitment excluded those living in New Brunswick, Prince Edward Island, 
Saskatchewan, any of the territories, indigenous reserves, long-term care facilities, and military 
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bases. Therefore, findings from the CLSA are not completely generalizable to the Canadian 
aging population.  
 There was also the possibility of participation bias, as the overall response rate was 10%, 
with 97% identifying as Caucasian. As such, the sample may not be fully representative of all 
middle-aged and older adults in Canada. In Canada, 21% of Canadians identify as a visible 
minority, and among those 65 years and over, 12% identify as a visible minority (Statistics 
Canada, 2017, 2018). With regards to the exposure, the CES-D10 captures self-reported 
depressive symptoms experienced in the past week. As such, it does not reflect symptoms 
experienced over longer durations and CES-D10 results are not the same as receiving a clinical 
diagnosis of depression. Therefore, scores from the CES-D10 should be communicated with 
caution and may not be generalizable to individuals with clinical depression. 
 At the time of analysis, only baseline cross-sectional data on the exposure, outcome, and 
covariates were available. As such, the temporality of the association cannot be determined and 
there is the possibility for reverse causation in the association between depressive symptoms and 
executive function. There may also be a cyclical relationship between depressive symptoms and 
executive function, where over time, the impact of one condition may influence the occurrence 








6.4 Implications and Future Directions 
 
 Results from this study support an association between depressive symptoms and low 
executive function. Findings suggest that depressive symptoms are prevalent among middle-aged 
and older adults and present as a potentially amenable factor involved in pathways implicated in 
poorer cognitive outcomes. These findings support previous research indicating that awareness 
of, and access to mental health resources are important. In particular, mental health resources and 
interventions for depressive symptoms may help buffer the effects of the cognitive decline, and 
the domain-specific cognitive decline that occur with age.  
 This investigation addressed existing gaps in literature by extending evidence of an 
association between depressive symptoms and low executive function to middle-aged and older 
community-dwelling adults. In addition, the association was examined across age groups and 
between sexes, with the strongest associations observed in older age groups and in females. As 
such, it is possible that intervention programs that target females and males differently in older 
age may have the strongest impact on reducing cognitive decline. Some examples of ways these 
study findings can be used include targeting psychological barriers, such as stigma against 
mental health, or providing different avenues of support for individuals experiencing depressive 
symptoms as ways to reduce cognitive decline. In addition, by using a neuropsychological 
battery, a more comprehensive assessment of the association between depressive symptoms and 
domain-specific cognitive function was completed while adjusting for a variety of previously 
identified and new covariates. 
 Future research should use longitudinal CLSA data, when it becomes available, to 
determine whether depressive symptoms are associated with cognitive decline across age groups 
and between sexes. Longitudinal analysis will help address the issue of reverse causality, and 
 124 
help to determine the exact nature of the association (i.e., are depressive symptoms a risk factor 
or preclinical symptom of cognitive decline?). Research directed at elucidating the temporal 
association will inform the search for possible treatment opportunities that may vary depending 
on the age and sex of the individual or population in need.  
 In addition, as social support presented as a significant effect modifier in many of the 
models, further, in-depth analyses of how different subtypes of SSA affect the association 
between depressive symptoms and executive function, as well as determining the temporal 
association between social support and depressive symptoms, would help inform new and 
existing social support interventions. Since the exact nature of the beneficial impact of social 
support in relation to depressive symptoms and cognitive function has yet to be established, 
investigating how social support is perceived at different points across the lifespan may provide 
further explanation for the differences in the direction of the association between depressive 
symptoms and low executive function in the higher SSA stratum versus low SSA stratum. It is 
also likely that SSA affects males and females differently, and therefore will moderate the 
association of depressive symptoms with low executive function differently between sexes. 
6.5 Conclusions 
 
 Overall, as the population continues to age, having better awareness about the effects of 
depressive symptoms on cognitive outcomes may contribute to better health outcomes for 
middle-aged and older adults. Research into factors associated with age-related cognitive decline 
is essential for social and health services that aim to help adults maintain their functional 
independence and health into older age. By investigating the association between depressive 
symptoms and executive function, findings from this study extended evidence to areas not 
previously researched. The results indicate that depressive symptoms are likely detrimental to 
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executive function, but the nature of the association differs with age and sex. As well, social 
support was shown to be another important factor closely linked with depressive symptoms and 
cognitive function. Findings from this study will serve as a foundation for further investigation 
using longitudinal data from the CLSA, once these data become available. Future work should 
include allocating resources to examine the longitudinal association between depressive 
symptoms and executive function, and examining whether this longitudinal association differs by 
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Appendix A: Literature Search Strategies 
 
Table A1. Literature search strategy for PubMed 
 Search Terms 
Database Depressive Symptoms Cognitive Function Age Time 











Elderly[tiab] OR Older 
Adult*[tiab] OR Middle 
Age* OR Middle Aged 
Aging[MeSH] OR 
“Ageing” OR Follow-up 
Stud* OR Prospective 
Stud* OR Prospective 
Cohort Stud* OR 
Longitudinal Cohort 
Stud* OR Longitudinal 
Stud* OR Cognitive 
Aging[MeSH] 
 
Overall strategy: #1 AND #2 AND #3 AND #4 
 
#1 Depression[MeSH] OR Depression[tiab] OR Depressive Symptom*[tiab] 
#2 Executive Function[MeSH] OR Executive Function[tiab] OR Neuropsychological Tests[MeSH] 
#3 Aged[MeSH] OR Elderly[tiab] OR Older Adult*[tiab] OR Middle Age* OR Middle Aged 
#4 Aging[MeSH] OR “Ageing” OR Follow-up Stud* OR Prospective Stud* OR Prospective Cohort Stud* OR Longitudinal Cohort 
Stud* OR Longitudinal Stud* OR Cognitive Aging[MeSH] 
 
Search performed on September 15, 2018 and retrieved 399 records. 
 







Table A2. Literature search strategy for PsycINFO 
 Search Terms 
Database Depressive symptoms Cognitive Function Age Time 







Tests” OR Cognitive 
Function” OR 
“Cognitive Impairment” 
Elderly OR “Older 
Adult*” OR Senior* OR 
“aged (65 yrs & older)” 
OR “very old (85 yrs & 
older)” OR “Middle 
Age (40-64 yrs)” 
Aging OR “Follow-Up 
Stud*” OR “Prospective 
Stud*” OR “Prospective 
Cohort Stud*” OR 
“Longitudinal Stud*” 
OR “Longitudinal 
Cohort Stud*” OR 




Overall strategy: #1 AND #2 AND #3 AND #4 AND Peer-Reviewed Journals Only 
 
#1 (Keywords: Depression OR Keywords: Depressive Symptom*) 
#2 (Keywords: Executive Function OR Keywords: Neuropsychological Tests OR Keywords: Cognitive Function OR Keywords: 
Cognitive Impairment) 
#3 (Keywords: Elderly OR Keywords: Older Adult OR Keywords: Senior* OR Keywords: Aged (65 yrs & older) OR Keywords: 
Very Old (85 yrs & older) OR Keywords: Middle Age (40-64 yrs) OR Abstract: Elderly OR Abstract: Older Adult OR Abstract: 
Senior* OR Any Field: Aged (65 yrs & older) OR Any Field: Very Old (85 yrs & older) OR Any Field: Middle Age (40-64 yrs)) 
#4 (Keywords: Follow-Up Stud* OR Keywords: Prospective Stud* OR Keywords: Prospective Cohort Stud* OR Keywords: 
Longitudinal Stud* OR Keywords: Longitudinal Cohort Stud* OR Keywords: Cognitive Aging OR Keywords: Ageing OR Abstract: 
Follow-Up stud* OR Abstract: Prospective Stud* OR Abstract: Prospective Cohort Stud* OR Abstract: Longitudinal Stud* OR 
Abstract: Longitudinal Cohort Stud* OR Abstract: Cognitive Aging OR Abstract: Ageing) 
 
Search performed on September 16th, 2018 and retrieved 608 records. 
 









































Figure A1. Flowchart of systematic literature search strategy 
 
 
Articles excluded if:  
1) Exposure is not depression, depressive symptoms, cognitive function or executive function 
2) Outcome is not depression, depressive symptoms, cognitive function or executive function 
3) Sample only included participants under the age of 45 years
Articles identified using 
PubMed (n = 435) 
Articles identified using 
PsycINFO (n = 641) 
Articles after duplicates 
removed (n = 954) 
61 duplicates removed 
Articles screened by title 
(n = 954) 
Articles screened by title 
and abstract (n = 314) 
Full-text articles assessed 
for eligibility (n = 114) 
Articles included in final 
review (n = 40) 
640 articles excluded 
200 articles excluded 
74 articles excluded 
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Outcome Analysis Results 
Almeida et al., 
2016 
 
Depression as a risk 
factor for cognitive 
impairment in late 
life: The Health in 
Men cohort study 
The original 
Health in Men 
Study (HIMS) is 
an ongoing 
cohort study that 
began in 1996 
and recruited 
men between the 





derived men with 
a history of, or 
current 
depression at the 




the third wave of 
HIMS (2004-
2008).   
Exposure: History of, 
or current depression 
determined by medical 
records, a “yes” 
response to the 
question “Have you 
ever been treated for 
an emotional or 
nervous illness such as 
depression?”, and 

















assessed using the 
2008 modified 
Telephone Interview 
for Cognitive Status 
(TICS). 
 
Men were classified 
as i) normal 
cognitive function 
(TICS >31), ii) mild 
cognitive 
impairment (MCI; 





proportions (%) of 
categorical data 




were determined.  
 
%& tests were used 
to determine the 
probability that the 
distribution of men 
in groups of 
current, past, and 
no history of 
depression was due 
to change. Risk 










increased the risk 
of future cognitive 
impairment (2.07, 
95% CI: 1.24-
3.45). There was 
no dose effect 


















disease, and mild 
cognitive 
impairment. 


















over the age of 





scores ≥ 90 in 
1992-1993, and 
normal cognition 




annually for 6 
years.   
Exposures: Depressive 
symptoms were 
determined using the 





moderate or high 
depressive symptom 
(CES-D-10 score ≥8 
in 1998-1999), low 
(3≤ CES-D-10 score 
≤7), and none (0≤ 
CES-D-10 score ≤2). 
Vascular events, (e.g., 
stroke and transient 
ischemic attack 
(TIA)), were identified 




during follow-up.  
 
Covariates: 
Antidepressant use and 




mellitus status, and 
cerebral MRI. 
Diagnosis of mild 
cognitive 
impairment (MCI) at 
follow-up. This was 
determined using the 
3MS, Digit Symbol 
Test, Benton Visual 
Retention Test, 
Telephone Interview 
for Cognitive Status, 
Telephone Interview 




activities of daily 
living (ADL) and 
instrumental ADL 
impairment, and 
medication use. All 
MCI decisions were 










was used to 
determine ordinal 












used to determine 





increased odds of 
developing MCI 








greater odds of 
MCI.  
 




symptoms in older 
adults with normal 
cognition. The 
odds of developing 
MCI doubles in 
those with 
moderate or high 
depressive 
symptoms (CES-



















literature review.   
Depression or 
depressive were used 





Covariates were not 






were used as search 
terms.  
N/A Dementia and 
depression are 
common in the 




been reported to be 
both a risk factor 
and causative agent 
of Alzheimer’s 
disease and other 
dementias.  





















years of age, and 
recruited from 
primary care 




determined using the 
Structured Clinical 
Interview for DSM-IV 
(SCID). Patients were 
categorized as: i) 
current major 
depressive disorder 
(MDD); ii) current 
minor depression 
(MinD) based on 
DSM-IV criteria; and 
iii) non-depressed.  
 
The 24-item Hamilton 
Depression Rating 















Making Test Part B, 
and Trails A. These 







were used to 
determine time-
dependent effect of 







determine if use of 
antidepressants 
affected risk of 
outcomes after a 3-
year period.  
 
Attrition was 
analyzed using a 
The hazard ratio 
(HR) for cognitive 
disorders per unit 
increase in HDRS-
P was 1.11 (95% 
CI: 1.02-1.21). The 
HR per unit 
increase in HDRS 




in the findings 















gender, and education.  
 
and sequencing, and 
information 
processing/ 
psychomotor speed  
 
DSM-IV criteria 
were used to inform 
diagnoses.  
 
%& test for 
categorical 
variables and a 
nonparametric 
Wilcoxon test for 
continuous 
variables. All tests 
were two-tailed 










NOS after a 3-year 
follow-up period.  
Brodaty et al., 2012 
 
Neuropsychiatric 
symptoms in older 

















for 2 years.  
Exposure: Presence or 
absence of 
neuropsychological 
symptoms (NPS) at 
baseline.  
 
Informants were used 
to determine frequency 
(scale 0-4) and 
severity (scale 0-3) of 







motor behaviour, sleep 
disturbance, and 





defined by a 
diagnosis of mild 
cognitive 
impairment or 
performing 1.5 SD 
below the mean for 







visuospatial abilities.   
 
At follow-up, the 
main outcome was 
cognitive status, 
categorized as: no 
Group differences 
were determined 
using t-tests for 
continuous 
variables and %& 













At baseline, NPS 
were more frequent 











(OR = 2.41, 95% 





found to predict 
dementia (OR = 
2.67, 95% CI: 1.1-
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Covariates: Age, 





or dementia, and 
cognitive decline. 
12.5, p = 0.038), 
but did not predict 
MCI (OR = 0.87; 
95% CI: 0.5-1.5, p 
= 0.63).  
 





cognition in a 
community-based 






who are aged 70-
97 and enrolled 






over the course 




and 2002.   
Exposure: Depression 
symptoms were 
measured using the 
Goldberg Depression 
Scale at baseline and 
follow-up. Scores 
ranged from 0-9, based 
on number of “yes” 
responses. A higher 
score suggests a 




gender, years of 
highest educational 
attainment, potential 
presence of preclinical 
dementia (indicated by 
a score <24 of 30 on 
any of the 
assessments). 
Additional covariates 







using on a range of 
cognitive tests: i) 
processing speed, 
measured with the 
Symbol-Letters 
Modalities Test and 
the Wecsher’s Digit-
Symbol Substitution; 
ii) verbal fluency, 
measured using the 
animal fluency task; 
iii) face and word 
recognition, 
measured using the 
Rivermead 
Behavioural 
Memory Test; iv) 
episodic memory, 
measured with four 
memory tasks 
testing word, face, 
name, and address 
recall and figure 





scores to a 
common metric 
(mean = 100, SD = 
10) at baseline. 
Participants were 
categorized as i) 
having 2≤ 
depression 
























mean simple RT, 





in certain cognitive 










count, activities of 
daily living score, and 
locus of control. 
simple and choice 
reaction time (RT), 





Byers & Yaffe, 
2012 (Review) 
 









literature review.   
Depression or 
depressive symptoms 
in early life, midlife, 
and older age.  
 
Covariates were not 







associated with a 
2-fold increase in 




results but there 
appears to be an 
association. 
However, the 




life and dementia 
is unclear.   












high physical and 
cognitive 
functioning 








symptoms measured at 
baseline using the 
Hopkins Symptom 
Check List (SCL) 
depression subscale. 
The scale has 11 
questions with a 1-4 
set response (1 = not at 
all, 2 = a little, 3 = 
Cognitive function 
was determined 
using: i) an 18-item 
version of the 
Boston Naming 
Test, ii) 
construction, iii) a 
spatial version of the 
Delayed Spatial 
Recognition Span 
Test, iv) a subtest of 
A linear regression 









intervals and effect 
For every quartile 






at follow-up, on 
average, declined. 




years of age at 
baseline and 
followed for a 









1995 to reassess 
cognitive 
performance. 
quite a bit, and 4 = 





criteria for major 
depressive disorders. 








based on status of 
diabetes mellitus, 
previous heart attacks, 
strokes, and other 
chronic diseases, 
cancer, hypertension, 








and v) a delayed 
incidental recall 
after 10 minutes of 
the 18-item Boston 












assessed using the 
nine-item version of 
the SPMSQ. 
Inclusion criteria 
was a score 6 ≤ at 
baseline. Scores < 7 







Model was fitted to 
1,000 bootstrap 
samples and a 
[2.5%, 97.5%] 
distribution of 
primary effect.  
 
Logistic regression 








was performed to 






and to assess if 




different results.  
cognitive 
impairment, their 
mean decline in 
summary cognitive 
score was higher 





increase in baseline 
depressive 
symptoms, there 
was 20% increased 






odds increased per 





associated with a 
larger decline in 
cognitive function 
over a 7-year 
follow-up period. 
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Cui et al., 2007 
 
Does depression 






















New York. All 
participants were 
65 years of age 
and older and 
completed year 1 




function, measured by 
the initiation-
perseveration subscale 
of the Mattis Dementia 
Rating Scale and the 










fibrillation, and left 
ventricular 
hypertrophy. The 
cumulative severity of 
these cerebrovascular 
risk factors represents 




covariates were age, 
gender, education, 
MMSE score, and 
Cumulative Illness 
Rating Scale score. 
 
Depression 
diagnosis at 1-year 
lagged and at each 
subsequent follow-
up point. Diagnosis 
based on consensus 
conference, SCID 
criteria, and patient 
interview and 




categorized as: 1) 
current or partially 
remitted major 
depression; 2) 
current or partially 
remitted minor 
depression (based on 
DSM-IV criteria); 









Baseline data was 
analyzed using %& 
test for categorical 
variables and the 
nonparametric 














Trials A and B, but 
not initiation-
perseveration. 
Older persons with 
depression are at 









impairment in the 
general population: 
Results of the 
Heinz Nixdorf 
Recall Study 
This study used 
cross-sectional 
data from follow-
up time one (i.e., 

















between the ages 
of 50-80 years of 
age were 
included.   
Exposure: A German 
version of the Centre 
for Epidemiological 
Studies 15-item short 
form Depression Scale 
(CES-D). A higher 
score suggested 
greater levels of 





epsilon 4 (APOE-e4) 
status, body mass 
index (BMI; kg/m2), 





of coronary heart 
disease, history of 
stroke, smoking status, 




on the following 





labyrinth test for 
testing processing 
speed; iii) semantic 
category animals test 
and word recall test 
for verbal fluency; 







Diagnosis of MCI 
followed 
International 
Working Group on 
MCI criteria and 
required cognitive 
impairment 
insufficient to fulfill 




were adjusted by 
stratifying age and 
education. Mann-
Whitney U test 

















were used to 
determine 
prevalence rate 








scores were more 













increased PRR for 
overall MCI, non-







MCI differs based 
on the subtype of 
MCI and time of 
onset of depressive 
symptoms. 
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symptoms and the 
incidence of 
dementia and mild 
cognitive 
impairment 
This study used 
data from the 
Baltimore 
Longitudinal 
Study on Aging, 
which consists of 
community-
dwelling adults 
over the age of 
50 years without 
























measured using the 
20-item Center for 
Epidemiological 
Studies Depression 
Scape (CES-D). An 
elevated CES-D score 
was considered ≥16.  
 








mass index, and 
systolic blood 
pressure.  
Incident MCI or 
dementia. A 
diagnosis of MCI 
was determined by 
cognitive 
impairment in a 




but not meeting the 
criteria for 
significant 




R criteria.  
t-tests and 
ANOVAs and %& 








survival curves and 









were used to 
determine whether 








disease as an 
outcome. For all 











Overall, only the 






also show that 
severity of 
depressive 





depression may be 













cognitive decline in 
older adults 
Using data from 
the Baltimore 
Longitudinal 




over the age of 









every two years. 
In 2000, 
participants over 








up period.  
Exposure: Depressive 
symptoms were 
determined using the 
20-item Center for 
Epidemiological 
Studies Depression 
Scale (CES-D). A cut-
off of 16 points was 
used to determine two 
depression categories 




education, and scores 
on the Primary Mental 
Abilities vocabulary 
test. 














Learning Test, the 
Benton Visual 
Retention Test, a 
subtest of the 
Wechsler Adult 
Intelligence Scale-
Revised for digit 
span, the Trail 
Making Test parts A 
and B, the FAS and 
semantic fluency 
test, the Boston 
Naming Test, the 
verbal fluency test, 
the Card Rotations 
Test and the Mini-
Mental State Exam 
and BIMCS. 
Linear mixed 
models were used 
to determine fixed 
and random 
effects. Mixed-
effect models were 
used to account for 
longitudinal 
analyses. Baseline 
age, time interval 
(i.e., years since 
baseline testing), 
and interval were 




fixed effects of all 
independent 
variables and their 
interactions, and 



















individuals with a 







transient, showed a 
greater effect on 
cognitive 
functioning. This is 
emphasized in the 





younger, are more 
vulnerable if they 
have depressive 
symptoms.   
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Freiheit et al., 2012 
 








Data from an 
urban tertiary 
care hospital in 
Alberta were 
obtained for 350 
participants 60 
years and older 











occurred at 6, 12, 
and 30 months. 
Exposure: Depressive 
symptoms, measured 
using the Geriatric 
Depression Scale. 










anxiety, and various 
health characteristics.  
Blood samples, or 
buccal samples when 
neccssary, were also 
collected at time of 
vascularization.  
 
Performance in three 





assessed using the 
Brief Visuospatial 
Memory Test-
Revised and the 
Consortium to 
Establish a Registry 
for Alzheimer’s 
Disease Test of 
Verbal Learning and 
Memory.  
 
Verbal fluency was 
measured using the 
Controlled Oral 
Word Association 
Test. Attention and 
executive function 
were assessed using 
the Trail Making 




assessed using raw 
scores obtained from 
the Mini-Mental 
State Examination.  
Linear mixed 






modelled as a 
categorical 




models were also 
used to compare 


















































cognitive decline in 
late life 
Data for 1,256 
community-
dwelling adults, 










which is a 12-
year prospective 
cohort study with 
assessments 













measured using the 




Items were coded in a 
yes/no format, for a 
maximum score of 20. 
Researchers used 
percentile-based cut-
off points derived 
from the cohort norms. 
The cut-off point was 
at the 90th percentile 
(i.e., score of 5). 
Participants who 




Covariates: Age, sex, 
education, and 
recruitment status 
(present or absence of 
depression at baseline, 
time since baseline, 
presence or absence of 
incident dementia).  
Performance on a 
neuropsychological 
battery from the 
Consortium to 








CERAD word list, 
18-item story for 
immediate and 
delayed retell, P and 
S letter fluency, 
animals and fruits 
category fluency, 
15-item CERAD 
version of the 
Boston Naming 
Test, the 4-item 
CERAD 
Constructional 
Praxis Task, the 
Clock Drawing Test 
and Trails Making 
Test A and B.  
Dementia diagnosis 









was applied to all 
composite 
cognitive scores 





interaction terms.  
 
Post hoc analysis 





(mCESD score ≥5 
at wave 2 = 
transient; mCESD 
score ≥5 at waves 
2 and 3 = 
persistent), and the 






baseline scores in 
all cognitive 
domains and in the 
MMSE, even after 
adjustment, in the 
dementia-free 
group. Depressive 















the rate of decline. 
Therefore, 
depression is not a 
part of incipient 
dementia.    
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genotype, and the 
incidence of mild 
cognitive 
impairment 











started in 1986 
with subsequent 
follow-up every 














was measured using 
the 15-item Geriatric 
Depression Scale 
(GDS). A score ≥6 
was classified as 
depressed.  
Participants who 









History of depression 
(i.e., depressive 
episodes prior to 
enrollment in study) 
was also obtained 
using medical record-
linkage systems from 
the Rochester 
Epidemiology Project.  
 
APOE genotype was 
gathered from blood 
samples.  
 








according to the 













any indication of 
MCI since follow-up 
occurred every 12-
18 months. Criteria 
for diagnosis of 
dementia followed 




Age was also used 
as the time scale 
for a more 
stringent survival 
analysis. Stratified 
analysis for gender 
(men vs. women) 
and by level of 
depression severity 
(GDS scores of 6, 





developed to assess 
multiplicative and 
additive interaction 






preceding baseline.  
 
All tests were two-
tailed and set to * 
= 0.05.  
Depression 
increased the risk 
of MCI and 
dementia. This 
association was 
stronger in men 
(HR = 4.5, 95% 
CI: 1.8-11.3) than 
women (HR = 1.5, 
95% CI: 0.7-3.6).  
Severity of 
symptoms is not 
associated with 
risk of MCI. 
Participants with 




the study, had a 
greater risk of MCI 
than those who 
were positive for 








of each factor on 
risk of MCI. 
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between the ages 
of 65-79 years 












baseline and at 
least one follow-
up assessment 




symptoms (DS) were 
measured using the 
15-item Geriatric 
Depression Scale 
(GDS). Elevated DS 
were considered a 




factor (CVRF) score 











prior hormone therapy 




prior CVD, and 
physical activity), and 
lifestyle habits 
(smoking and alcohol 
use). 










test), verbal fluency 








Test), attention and 
working memory 
(Digit Span Forward 
and Backward Test), 
spatial ability (Card 
Rotations Test), fine 
motor speed (Finger 













mean and standard 










terms (DS by prior 
CVD, and DS and 
CVRF score) were 
used to determine 
moderation effects. 
Models were 
adjusted for all 
covariates. p<0.01 
was defined as 
significant. 
Persistently high 
DS in women were 
associated with 
significant declines 
in global cognition, 
verbal knowledge, 










with both DS and 
CVD performed 
worse on figural 




interaction effect.  
 
History of CVD 
and CVRF score 














in elderly women: 
The Women’s 
Health Initiative 
Memory Study  






between the ages 
of 65 to 79 and 
free of MCI at 
enrollment, was 
























measured using the 
Burnam screening 
algorithm. Cut off 
scores of 0.06 and 
0.009 indicate current 
depressive disorders. 
A CES-D score ≥5 
(out of a possible 18) 
also defined current 
depressive symptoms.  
 
History of depressive 
symptoms was 
ascertained using the 
two-item DIS. 
Responding “yes” to 
both questions was 
defined as having a 




mass index (BMI; 
kg/m2), physical 
exercise, hormone 






Incidence of MCI 
and probable 
dementia, measured 
in four phases.  
 
First, all women 
completed the 3MS 
at baseline and all 
annual follow-up 
visits. Women who 
were deemed 
cognitively healthy 
went on to complete 
Phase 2 and 3 within 
three months of 
Phase 1.  
 
Phase 2 involved the 
administration of the 
modified 
Consortium to 




battery. Within a 
month of completing 
Phase 2, Phase 3 was 
administered, where 
a local physician 
their medical history 
























models were fitted 
to MCI, probable 









to those not 
depressed, women 
with depressive 
disorder had a 
greater risk of 
subsequent MCI 
and incidence of 



















attack or stroke), level 
of vascular disease 
risk (number of risk 
factors and comorbid 
vascular conditions), 
cognitive function 
(measure using the 
Modified Mini-Mental 
State Examination 
(3MS) at baseline and 
annual follow-up’s), 
and history of 
antidepressant and 





IV criteria were used 
for classifying 
participants as i) 
probable dementia, 
ii) MCI, or iii) no 
dementia. MCI was 
based on the 
baseline 
performance at the 
time WHIMS was 
initiated. Women 
classified as having 
probable dementia 
continued to Phase 
4, which consisted 
of a noncontract 
computed 
tomography brain 






than dementia.   
All multivariable 





selection was used 
for models for 
probable dementia, 
MCI, and MCI or 
probable dementia.  
 




history of major 
Using data from 
the German 




symptoms at follow-up 
one, measured using 








used to analyze 
mean cognitive test 
performance scores 
of the four 
Groups with 
depressive 















75 years of age 
and older. This 
study uses data 
from 1, 332 
participants who 
completed 
follow-up one to 
follow-up six. 
Follow-up data 




off score ≥6 indicated 
clinically relevant 
scores. This cut-off 
was used to create the 
two study groups: 1) 
with elevated 
depressive symptoms; 
and 2) without 
elevated depressive 
symptoms. Lifetime 
prevalence of major 
depression diagnosed 
according to DSM-IV 
criteria.  
 
Covariates: Age at 
follow-up one, sex, 
and education level.  
(MMSE), the verbal 
fluency test, the 
Consortium to 




delayed recall and 
recognition 
measures, and the 
Structured Interview 





Dementia of other 
Aetiology according 
to DSM-IV and 
ICD-10 criteria 
(SIDAM) cognitive 
section (SISCO) that 
measures 
orientation, memory 
and higher cortical 
functions. 
participant groups 


























all cognitive tests. 
Participants with a 
lifetime history of 
depression but no 
subsequent 
dementia showed 










on all cognitive 
tests compared to 
the control group. 
Participants with a 







on all cognitive 
tests, other than 








dysfunction is a 
consequence of 





LLD but no 
subsequent 






dementia will have 
large cognitive 
deficits. 
Jungwirth et al., 
2011 
 






subjects aged 75 
This study uses 
data the 287 of 
participants who 










diagnosed using a 
questionnaire based on 
DSM-IV criteria. All 
symptoms were 










speed was measured 
using the Trails 
Making Test-A 
(TMT-A). Executive 
function was based 
Univariate 
ANOVA and t-
tests for binary 
variables were 



















were 75-years of 
age and born 
between May 




May 2000 and 
November 2002, 
with two follow-




The Hamilton Rating 
Scale for Depression 
and the 15-item Short 
Geriatric Depression 





education, intake of 
antidepressants, intake 
of benzodiazepines, 
history of depressive 
disorder, and cerebral 
comorbidity 
(summation of 10 






surgery, brain tumour, 
meningioma, lacunae, 
and/or infarcts, and 
occurrence of the 






on set formation and 
set shifting, 
measured using the 
Trail Making Test-B 
(TMT-B) (set 
shifting) and the 
verbal fluency test 
(animal) (set 
formation).  
into a multiple 
regression analysis 
of variance.  
 
Comparisons 





education), or %& 







on verbal fluency 
and had a slower 
performance time 

























were between the 
ages of 69 and 85 
years and 












status, as outlined by 





depression (BDI 10-15 
points), borderline 
clinical depression 
(BDI 16-19 points), 
moderate depression 
(BDI 20-29 points), 
and severe depression 






possible head injuries, 
potential history of 
psychiatric treatment, 
and current medical 
treatment.  
 
Performance on the 
Montréal Cognitive 
Assessment (MoCA) 
Scale, Trail Making 
Test A and B (TMT-
A and TMT-B, 
respectively), the 
Stroop colour and 
word test, the digit 
span task, the verbal 
fluency task and the 
Rey-Osterrich 





of distribution. A 
Pearson partial 
correlation 
coefficient, r, value 













depression in any 









0.05), entry stops. 
Higher BDI scores 
are correlated with 
lower performance 








performance on the 
BDI and explained 
70% of the 
variance (F(2,69) = 
82.14, p < 0.0005, 
R2Adj = 0.70). The 
strongest predictor 
was the ROCT (2= 
-0.67, p <0.0005), 
then the Stroop test 
(2 = -0.23, p = 
0.15).  
 
Findings show that 
older persons with 
depression have 
difficulty with set 
switching function 








functioning in the 
acute and remitted 
states of late-life 
depression 
Using baseline 
data from the 
Pathways study, 
which is part of 



















established using the 
Structured Clinical 
Interview for Axis I 
DSM-IV Disorders 
(SCID-IV). Severity 
was measured using 
the Hamilton Rating 
Scale for Depression 
(HRSD-17). 
Participants were 
categorized as: i) no 
previous or current 
history of MDD (ND); 
ii) having met criteria 
for DSM-IV diagnosis 
at any point in history 
but euthymic, and iii) 
met criteria for DSM-
IV diagnosis of MDD 
and depressed at time 
of baseline cognitive 
assessment, defined by 
HRSD-17≥12 (MDD-




race, and medical 
burden.  
Performance on 22 
validated cognitive 










verbal ability, and 
visuospatial ability.   
  







used to look at 
overall group 
differences. 3& and 





All raw scores 
were converted to 
Z-scores based on 
distribution of ND 
participants. 
ANACOVA was 
used to compare 






value for multiple 
comparisons. 




































adults who were 










over the age of 










years (F1) and 6-
years (F2).  
Exposures: Depressive 
symptoms were 
measured using a 
revised 90-item 
version of the 
Symptom Checklist 
(SCL-90). For the 
purposes of this study, 
only 16-tems assessing 
depression were 
administered at 
baseline, F1 and F2. 
Symptoms were 
ranked on a Likert 
scale (1 = not at all to 
5=extremely), with 
possible scores 
ranging from 16-80.  
 









Covariates: Age, sex, 
education, baseline 












global cognition, and 





was defined as 
significant cognitive 
impairment. CIND 
was then subdivided 




t-tests and linear 
regression analysis 





to z-scores using 







analysis of baseline 
associations were 
conducted. Linear 
mixed models were 





was used to assess 



























presence of one 
APOE-e4 allele 
was associated 
with higher risk of 
CIND, although it 
did not show a 
moderating effect. 












function and the 
impact of vascular 
disease 
This study uses 









18 years of age 
and older.  
Exposure: Depression 
status was determined 




which is based on 
DSM-IV criteria for a 






Risk Score (FRS), and 
the presence of 
vascular disease. 
Executive function, 
measured using the 
Ruff Figural Fluency 
Test (RFFT).  Score 
was based on total 












and older adults. 
Young adults were 
defined as 
participants 
younger than 60 
years of age. Older 
adults were defined 
as participants 60 
years of age and 
older.  
Younger adults 

























was observed for 




younger and older 
adults. 
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Osorio et al., 2009 
 
Executive function 
in patients with late 
onset depression 
Case-control 




were 60 years 
and older. Cases 
were recruited 
from psychiatric 











who did not have 






according to DSM-IV 
criteria and the 
Yesavage Geriatric 
Depression Scale 
(GDS). It is a 150-item 
scale and depression is 
defined as a GDS 
score ≥7.  
 
Covariates: Age, 
gender, marital status, 
education, personal 
psychiatric and family 
history. 
MEC (Spanish 
version of the Mini 
Mental State Exam) 
performance, which 










(EXIT-S) was also 
used. Scores ranged 





ANOVA was used 
to compare group 
differences 




adjusted for GDS 






psychological tests.  
 
Significance was 
set to p<0.05. 
Compared to 





personal history of 
LOD and GSD 
scores < 7 had 
higher scores on 
the EXIT-S.  
 
 






















ICD-10 criteria. The 
A cognitive test 
battery was applied 
to measure different 





ANOVAs and %& 








pattern of deficits 
support depression 
as state-, rather 










every 6 years and 
participants 78 
years and older 
undergo 
assessments 




were 60 years 
and older at 
baseline (T1). 
Both 3-year and 
6-year follow-
ups were used 







Rating Scale was used 
to determine level and 
severity of depressive 




gathered at T1 and T2.   
 







memory, and spatial 
ability. 









performed at T1 
and T2 to examine 
main effects. 




samples t-tests, and 
all effect sizes 
(Cohen’s d) were 
also determined. 
depressed will see 



















and episodic and 
semantic memory 
was observed, 
suggesting them to 
be a normal part of 
cognitive aging. 
 







enrolled in the 
Italian 
Longitudinal 




using the 30-item 
Geriatric Depression 
Scale (GDS-30). GDS 
score <10 indicates an 
Cognitive function 
was measured using 
the Mini-Mental 
State Examination 
(MMSE) for global 










associated with a 
faster rate of 





Study on Aging 







study stratified a 
random sample 
of the ILSA by 
age and gender. 
There are 2,963 
participants 













absence of depression, 
10≤ GDS score ≤19 
indicates mild 
depression, and a 20≤ 




Covariates: Age, sex, 
and education.  
Babcock Story 














National Institute of 
Neurological and 
Communicative 
Disorders and Stroke 
and the Alzheimer’s 








Diseases and related 
health problems 10th 
revision criteria. 
  

















using only random 
intercepts. Time (at 
baseline and 
follow-up) was 
included as an 
interaction term. 












lower scores for 
global cognitive 
function (p <0.01), 
immediate recall (p 
<0.01), and 
delayed recall (p 
<0.01). 
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part of the 
Neurocognitive 
Outcomes of 
Depression in the 
Elderly study. 
Participants met 
criteria for a 
current episode 
of unipolar major 
depression, over 
the age of 60 
years, and did 




Exposure: Number and 
severity of depressive 








based on the 
Consortium to 




battery. Chose 15 
individuals measures 
from the battery to 
use as independent 
variables. 
 
A yearly consensus 
panel reviewed each 
incident case of AD, 
vascular dementia, 
and Lewy body 
dementia Criteria for 
diagnosis was based 
on DSM-IV. 











technique was used 
to derive a 
specified number 
of reduced models 
based on %&tests. 
After, bivariate and 
logistic regression 
models were used.  
 
 










that the largest 
effect size was 
observed on tests 
for memory and 
executive function.   
Reppermund et al., 
2011 
 
The relationship of 
current depressive 





activities of daily 
This study uses 
baseline data of 
800 participants 










were measured using 
the 15-item short form 
of the Geriatric 
Depression Scale 
(GDS). A GDS score 
≥6 indicates clinical 














All raw cognitive 






and %& tests. 
 
ANCOVA was 




symptoms pose an 








living in an elderly 
population: The 
Sydney Memory 










between the ages 






measured using the 9-
item Goldberg Anxiety 
Scale (GAS), the K-10 
questionnaire, and the 
Satisfaction with Life 
Scale (SWLS).  
 
Cardiovascular risk 
factor index (CVR) 
was determined using 
a regression model 





gender, education, use 
of antidepressants, 

















controlling for age, 
sex and education. 
Antidepressant use, 
CVR, K-10, SWLS 
and GAS were also 
used as covariates. 
Level of 
significance was 




















study uses data 





are aged 65 years 
and older and 
Exposure: Depression 
was measured using 
the Boston form (short 
version) of the Center 
for Epidemiological 
Studies Depression 
(CES-D) scale. This 
scale consisted of 10-
items with yes (1 
MCI diagnosis was 
based on Petersen 
criteria and further 
categorized as 
amnestic MCI and 
naMCI. A diagnosis 
of dementia met 
DSM-III-R criteria. 




tests and %& tests. 
 
Logistic regression 
models were used 




associated with a 
higher risk of 
dementia, even 
after adjustment in 
all models. The 
risk was higher for 
AD than VaD.  
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completed at 18- 
to 24-month 
intervals. 
point)/no (0 points) 
answers for a total 
rating out of 10. A 
CES-D score ≥4 was 







APOE genotype, and 





levels, and high waist 
to hip ratio, with low 
ranges from 0 to 18).  
Alzheimer’s disease 
(AD) met the 
National Institute of 
Neurological 







(VaD) used the 
NINDS-Association 
Internationale pour 



















time to event (i.e., 
incidence of 
dementia or MCI). 
Those who did not 
develop MCI or 
dementia were 
censored at the 
time of their last 
visits. 
Overall, depression 
was related to a 
higher odds of 




MCI to dementia. 
The association 
was stronger for 
VaD than AD. 

























Depression in the 
Exposure: Age and 
time of onset of the 
first (initial) 
depressive episode 
was determined using 
a structured interview. 
Clinicians rated 
severity of depression 
according to the 
Montgomery-Asberg 
Depression Rating 














each domain, a 
Cronbach’s 
coefficient alpha 




models were used 
to assess baseline 
Overall, depressed 
participants 




















scored ≤15 on 






confirmed by a 
clinical interview 













heart disease) were 
determined using self-
reported questions 
from the National 






Covariates: Age, sex, 
education, race, study 
time, and baseline 
neuropsychological 





assessed across the 
group variables: 
depression 
diagnosis, age at 
onset, or remission 
status. Mixed 
model longitudinal 
analyses tested for 
interaction terms 
between time and 
vascular risk factor 
morbidity to 
determine 
differences in the 
effects of time 
across groups.  
 

















Exposure: Presence of 
major depression 
(MD), diagnosed by 
the Mini-International 
Neuropsychiatric 
Interview (MINI).  
 
Performance on the 
Verbal Fluency task, 
as a measure for 
executive function. 




applied to examine 
data. 





poorly on the 
verbal fluency task 












were over the age 













perform better on 
the verbal fluency 



















in executive control 
but not memory 





a list of non-
institutionalized 
residents living 













functional status and 
comorbid conditions 
were assessed using 






measured using the 
Executive Interview 
(EXIT25) and Trail 
Making Test A and 
B (TMT-A and 
TMT-B). Higher 









fixed and random 
effects. A 
goodness of fit %& 
test validated the 
structure of the 
models. A root 
Depressive 
symptoms are 
associated with the 
longitudinal 
change in attention 
and executive 
function, but not 
memory. This 
finding may also 






used. The present 
study included 
547 older retirees 
who were 70 
years or older, 
retirees and 
evaluated at three 
separate time 







baseline test scores, 





Higher time elapsed 









means square error 
approximation 
(RMSEA) was 




indicates a better 
fit). A comparative 
fit index (CFI) was 
used to compare 








The influence of 
depression on 











Studies of the 
Elderly (EPESE). 
This present 
study uses data 







which was measured 




scale. The scale was 
administered at 
baseline (Cronbach’s 
* = 0.82). 
Participants could 
score between the 















	* = 0.74) and 
follow-up 
(Cronbach’s * =
0.74).   
 
Participants errors 
were summed to 
Descriptive 
statistics were used 
to define group 
characteristics. 
Paired-sample t-
test were used to 
compare baseline 
and follow-up 
SPMSQ scores.   
 
Linear regression 
analysis was used 
to predict cognitive 
decline from 









was shown. Higher 
CES-D scores were 
associated with 
cognitive errors 3-










Covariates: Age, race, 
gender, family income, 
education, and 
physical functioning. 
Also controlled for 
baseline cognitive 
functioning score in 
the linear regression 
models. 
form a continuous 
range between 0-10 
errors. The higher 











in late midlife: The 
Whitehall II Study 
Data was 
obtained from 







between the ages 
















measured using the 4-
item depression 
subscale on the 30-
item General Health 
Questionnaire (GHQ). 
Non-cases were 
defined as GHQ score 
≤3; depression cases 
were defined as GHQ 
scores ≥4. Distal 
depressive symptoms 
were defined as GHQ 




defined as GHQ 
depression in the last 2 
assessments of the six-
year follow-up. Any 
case of GHQ 
depression classified 
Cognitive function 
was measured the 
last follow-up 
assessment (phase 7) 
using a battery that 
consisted of six 
standard tasks for 










was defined as 
scores in the lowest 
quantile for each 
cognitive test.  
Logistic regression 
was used to 


















symptoms over the 
18-year follow-up 
and cognitive 
deficits at Phase 7, 
Compared to those 
with no depressive 



























and 2002-2004.  
participants as history 
of GHQ depression. 
 
Covariates: Age, sex, 




coronary heart disease, 
stroke, hypertension, 
and antidepressant use. 
and iv) the 
association 









on all tests. 





































were scored and a 










diabetes, stroke, and 
dementia), coronary 
heart disease (history 
of angina or 
myocardial infarction), 
Cognitive function 
was determined by 
the performance on a 









psychomotor speed.  
 





determine if they 













models were used 




MCI or dementia. 
and covariates 








poorly on a 
majority of the 
cognitive tests at 
the 5-year follow-








impairment in the 
oldest old women. 
However, the exact 





year follow-up is 
the year 20 visit 
of the SOF. The 
present study had 







Cognitive Decline in 
the Elderly score.  
 
cognitive status, 
including a positive 
status for mild 
cognitive 
impairment (MCI) 
or dementia. MCI 
diagnosis was based 
on Petersen and 
colleagues criteria 
and dementia 
diagnosis was based 
on DSM-IV criteria.  
 
 








Beta statistic were 
performed. 
Sundermann, Katz 
& Lipton, 2017 
 
Sex differences in 
the relationship 
between depressive 
symptoms and risk 











in 1993 and 
included men 
and women 70 








measured using the 
15-item Geriatric 
Depression scale. 
GDS-15 scores ranged 
from 0 to 15, with 
higher scores 
indicating a greater 




reported history of 
clinical depression, 
self-reported 
antidepressant use, and 
a comorbidity index 
(based on 
A diagnosis of mild 
cognitive 
impairment (MCI) 
or dementia. A 
diagnosis of MCI 




impairment on the 
Free and Cued 
Selective Reminding 
Test-Free Recall 
and/or the Logical 













were used to 
determine hazard 
ratios for incidence 
of MCI. Nested 
Cox models with 
follow-up time as 
the scale were 
computed. Models 
were used to 
determine the main 
effect of depressive 
Overall, the 
depressive 






with a two-fold 
increased risk of 
MCI in men 
(compared to those 
with no/low DS), 


















to the Consortium to 
Establish a Registry 
for Alzheimer’s 
Disease and the EAS 
Health Assessment 
questionnaire). 
A diagnosis of 
dementia was made 
according to the 
DSM-IV criteria.  
symptoms on 





between men and 
women.  
 
All tests were two-






incidence of MCI 
(compared to 
no/low DS 
women). The same 
trend was not 
applicable for mild 
symptoms.  
 














who were ≥60 
years at baseline, 













DSM-IV criteria and 
symptom severity 
according to the 
Montgomery-Asberg 
Depression Rating 




Performance on a 
variety of cognitive 


















set to p <0.05.  
 






Compared to the 
healthy control 
group, participants 

















recruited from a 
population-based 




≥60 years and 
had a Clinical 
Dementia Rating 
(CDR) scale 







and deficits in 
executive function 
and memory 
Wang & Blazer, 
2015 (Review)  
 
Depression and 








literature review.   
Late-life depression 
(LLD), broadly 
defined as unipolar 
depressive symptoms 
without psychotic 







in adults 65 years of 
age and older. 
 
Covariates were not 
considered in this 
literature review. 
Cognitive symptoms 
consistent with mild 
cognitive disorder or 
mild cognitive 
impairment (MCI).  





contribute to the 
development of 
LLD and comorbid 
cognitive 
impairment(s). 
Despite LLD and 
comorbid cognitive 
impairment being 
one of the most 
prevalent 
psychiatric 










older adults in the 








data from the 
2011–2012 and 
2013–2014 





and consisted of 
3180 participants 




assessed using the 9-
item Patient Health 
Questionnaires (PHS-
9). Scores range from 
0 (not at all) to 3 
(every day), adding up 
to range from 0–27.  
 
Depression status was 
validated using cut-
offs of the PHS-9, 
with total scores of 5–
19 indicating clinically 
relevant depression 
(mild to moderate) and 
total scores of ≥15 
indicating clinically 
significant depression 
(moderate to severe). 
 
 Covariates: Age, sex, 






heart disease, and 
stroke), body height, 
and weight  
Cognitive function 
was measured using 
the Delayed Word 
Recall Test, the 
Animal Fluency 














models were used 







cognitive function.  
 
Estimated effect 
sizes (2) and 95% 
confidence 
intervals were 






















diabetes showed a 
synergistic 
relationship with 











and risk of 
cognitive decline 
and dementia 
among very old 
women 
Participants were 
enrolled in the 
ongoing 
prospective 








1988 and were 
65 years of age 
or older upon 
recruitment. The 
present study 






symptoms (DS) were 
measured using the 
15-item Geriatric 
Depression Scale 
(GDS-15). A higher 
score indicated more 
depressive symptoms. 
The GDS was 
administered in Year 2 
of the SOF, which is 
considered baseline in 
the present study. 
Follow-up assessments 
occurred at years 6, 













attack, stroke, and 
diabetes), and current 





using tests that 
reflect performance 
in global cognitive 
function and 
executive function. 




delayed recall and 
verbal fluency were 
included.  
 
A diagnosis of 




using a two-step 
process that 
followed DSM 
criteria for diagnosis 
of dementia and a 
modified Petersen 
and colleagues’ 







and slopes were 
used to estimate 
the association 
between quartile of 
depressive 
symptom burden 






performance on the 
delayed California 
Verbal Learning 
Test, forward Digit 
Span test, the 3MS, 
and the verbal 
fluency tests at 
year-20 assessment 
was significantly 
associated with the 
higher quartile of 
long-term DS 







Span test. A higher 
quartile of long-
term DS burden 
was associated 
with greater odds 
of developing 
dementia or MCI.   
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Exposure variable Confounding variables 
- Depressive symptoms 
 
Outcome variable 
- Executive function  
 
Effect modifiers 




- Annual household income 
- Province 
- Urban/rural residence 
Health:  
- Self-rated general health 
- Chronic conditions 
- Medication for depression 
Social: 
- Marital status 
- Social support availability 
 
Health behaviours: 
- Smoking status 
- Alcohol use 
 
Figure A2. Conceptual diagram of the association between depressive symptoms and executive function with covariates 
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Appendix D: Provincial and Overall Response Rates in the Canadian Longitudinal Study 
on Aging 
 
Table A4. Provincial and overall response rates for the Tracking Cohort1 
 AB BC MB NB NL NS ON PE QC SK Canada 
CCHS 0.12 0.11 0.15 0.12 0.11 0.13 0.11 0.13 0.13 0.14 0.12 
RDD 0.09 0.11 0.10 0.13 0.09 -- 0.10 0.13 0.15 0.09 0.11 
RTS 0.01 0.01 0.01 0.01 0.01 0.02 0.01 -- 0.02 0.01 0.01 
TS 0.07 0.10 0.09 0.10 0.08 0.02 0.09 0.13 0.13 0.07 0.10 
HR1 -- -- 0.08 0.07 0.06 0.12 0.04 0.06 -- 0.09 0.07 
HR2 -- 0.02 0.03 0.02 0.01 0.08 -- 0.02 -- -- 0.03 
HR -- 0.02 0.07 0.05 0.05 0.10 0.04 0.05 -- 0.09 0.06 
Overall 0.08 0.09 0.09 0.08 0.07 0.10 0.08 0.09 0.13 0.08 0.09 
CCHS: Canadian Community Health Survey 
RDD: Random Digit Dialing 
RTS: Random (Telephone) Sampling from listed telephone numbers  
TS: Telephone Sampling 
HRI: Initial Health Registry mail-outs 
HR2: Health Registry mail-outs targeting lower-educated areas 
HR: Health Registry mail-outs (estimates based on number of eligible people who were sent 
letters) 
1(Canadian Longitudinal Study on Aging, 2017a) 
 
Table A5. Provincial and overall response rates for the Comprehensive Cohort1 
 AB BC MB NL NS ON QC Canada 
RDD 0.11 0.10 0.13 0.19 0.16 0.10 0.12 0.11 
RTS 0.01 0.01 0.01 0.01 0.01 0.01 0.03 0.02 
TS 0.11 0.10 0.10 0.15 0.12 0.09 0.10 0.10 
HR1 -- 0.02 0.09 0.06 0.16 0.09 -- 0.09 
HR2 -- -- -- -- 0.08 -- -- 0.08 
HR -- 0.02 0.09 0.06 0.14 0.09 -- 0.09 
Overall 0.11 0.09 0.10 0.12 0.13 0.09 0.10 0.10 
CCHS: Canadian Community Health Survey 
RDD: Random Digit Dialing 
RTS: Random (Telephone) Sampling from listed telephone numbers  
TS: Telephone Sampling 
HRI: Initial Health Registry mail-outs 
HR2: Health Registry mail-outs targeting lower-educated areas 
HR: Health Registry mail-outs (estimates based on number of eligible people who were sent 
letters) 
1(Canadian Longitudinal Study on Aging, 2017a) 
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Appendix F: Center for Epidemiological Studies Depression Scale 
 
Table A6. Center for Epidemiological Studies Depression (CES-D) Scale1  
(A) I was bothered by things that usually don’t bother me?a 
(B) I did not feel like eating; my appetite was poor. 
(C) I felt I could not shake off the blues even with help from my family or friends. 
(D) I felt that I was just as good as other people.  
(E) I had trouble keeping my mind on what I was doing.a 
(F) I felt depressed.a 
(G) I felt that everything I did was an effort.a 
(H) I felt hopeful about the future.a 
(I) I thought my life had been a failure. 
(J) I felt fearful.a 
(K) My sleep was restless.a 
(L) I was happy.a 
(M) I talked less than usual.  
(N) I felt lonely.a 
(O) People were unfriendly. 
(P) I enjoyed life. 
(Q) I had crying spells. 
(R) I felt sad. 
(S) I felt that people dislike me. 
(T) I could not get “going.”a 
1All questions refer to how participants have felt in the past week, that is, from [DATE ONE 
WEEK AGO] to yesterday. Participants were asked “How often were you…” 
aIndicates items on the 10-item version of the Center for Epidemiological Studies Depression 
Scale (CES-D10). There are four possible responses for each item: rarely or never (less than 1 
day), some of the time (1–2 days), occasionally (3–4 days), or all of the time (5–7 days). 



















Appendix G: Model Fit 
 







Depressive symptoms and executive function  
Research Question 1 (Stratified by social support availability) 
Higher social support availability 0.81 0.005 0.80 0.82 
Low social support availability 0.79 0.015 0.74 0.80 
Research Question 2 (Stratified by age group) 
45–54-year age group 0.76 0.019 0.72 0.79 
55–64-year age group 0.75 0.013 0.73 0.78 
65–74-year age group 0.70 0.011 0.69 0.73 
75 years and over (Higher social 
support availability) 
0.70 0.010 0.66 0.73 
75 years and over (Low social support 
availability) 
0.72 0.028 0.67 0.78 
Research Question 3 (Stratified by sex) 
Males (Former/never drinkers) 0.79 0.015 0.76 0.82 
Males (Current drinkers) 0.80 0.007 0.79 0.82 
Females (Higher social support 
availability) 
0.81 0.007 0.80 0.83 
Females (Low social support 
availability) 
0.78 0.023 0.73 0.82 
*Diagnostics reflect results from the final model (Model E) that includes all covariates 




















Appendix H: Supplementary Results Tables for Stratified Analyses 
 
A. Analyses for the association of depressive symptoms and covariates with low executive 
function by social support availability  
 
 In research question 1, the association was stratified by SSA. Descriptive results for each 
stratum of social support (i.e., higher SSA versus low SSA) are presented in Tables A8 and A9. 
These descriptive results correspond to the multivariable results presented in Section 5.1.3, 
Tables 3a and 3b of the main body.  
 Notably, the prevalence of depressive symptoms in those with low SSA (44.46%) is more 
than three times greater than the prevalence of depressive symptoms in those with higher SSA 
(13.23%). Of those who reported depressive symptoms in the low SSA stratum, 43.70% have 
low executive function. Of those who reported depressive symptoms in the higher SSA stratum, 
21.32% have low executive function. Those who report low SSA and depressive symptoms are 













Table A8. Distribution of depressive symptoms and covariates by low executive function status 
in participants with higher social support availability, Canadian Longitudinal Study on Aging 
1Presence of depressive symptoms: CES-D10 score ≥10;  
Absence of depressive symptoms: CES-D10 score <10 
Abbreviations: NFLD = Newfoundland and Labrador 
















Depressive symptoms1 (%)       
Presence 21.32 12.39*** 13.23 21.84 12.32*** 12.95 
Absence 78.68 87.61 86.77 78.16 87.68 87.05 
Sociodemographic Factors    
   
Age, groups (%)       
45–54 years 8.57 29.24*** 27.29 18.45 45.94*** 44.11 
55–64 years 16.79 35.38 33.63 18.14 30.94 30.09 
65–74 years 29.99 23.12 23.76 26.52 15.50 16.23 
75 years and over 44.66 12.27 15.32 36.88 7.62 9.56 
Sex (%)       
Female 51.75 50.64 50.74 52.48 50.07 50.23 
Male 48.25 49.36 49.26 47.52 49.93 49.77 
Education (%)       
Less than high school 16.00 3.61*** 4.78 18.70 3.30*** 4.33 
High school graduate 15.02 8.49 9.11 15.31 8.09 8.57 
Some post-secondary 8.62 7.18 7.32 8.19 6.59 6.70 
Post-secondary 
degree/diploma 
60.36 80.72 78.80 57.80 82.02 80.41 
Annual household income (%)       
< $20,000 11.03 3.39*** 4.11 10.98 2.87*** 3.41 
≥	$20,000 and < $50,000 41.70 18.67 20.84 42.04 15.44 17.21 
≥	$50,000 and < $100,000 32.55 36.12 35.79 30.62 33.69 33.49 
≥	$100,000 and < $150,000 9.11 22.02 20.81 9.46 24.25 23.26 
≥	$150,000 5.61 19.79 18.46 6.90 23.75 22.63 
Province (%)       
Ontario 20.63 21.80*** 21.69 13.79 13.48*** 13.50 
Alberta  7.98 8.62 8.56 9.28 11.27 11.13 
British Columbia 16.64 22.33 21.79 24.63 31.98 31.49 
Manitoba 10.88 10.52 10.55 9.53 8.44 8.51 
NFLD 12.06 7.60 8.02 3.72 2.29 2.38 
Nova Scotia 12.65 `0.72 10.90 4.69 3.65 3.72 
Quebec 19.15 18.41 18.48 34.36 28.89 29.26 
Urban/rural residence (%)       
Urban 90.35 90.30 90.30 89.04 90.33 90.25 
Rural 9.65 9.70 9.70 10.96 9.67 9.75 
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Table A8. Distribution of depressive symptoms and covariates by low executive function status 
in participants with higher social support availability, Canadian Longitudinal Study on Aging, 
continued 
2Chronic conditions: presence of at least 1 of 11 self-reported medical conditions 
























Health Factors       
Self-rated general health (%)       
Poor 2.61 1.04*** 1.19 2.93 0.88*** 1.02 
Fair 12.90 5.82 6.48 12.92 5.85 6.32 
Good 36.63 27.82 48.65 39.59 28.39 29.13 
Very good 34.61 43.50 42.66 32.35 42.64 41.95 
Excellent 13.24 21.83 21.02 12.22 22.24 21.57 
Medication for depression (%)       
Yes 8.67 7.73 7.82  9.34 7.74 7.85 
No 91.33 92.27 92.18 90.66 92.26 92.15 
Chronic conditions2 (%)       
Yes 81.29 64.90*** 66.45 78.02 59.88*** 61.08 
No 18.71 35.10 33.55 21.98 40.12 38.92 
Social Factors       
Marital status (%)       
Single, never married  6.99 7.30*** 7.27 7.17 6.78*** 6.80 
Married/common-law 60.91 74.37 73.10 66.79 80.44 79.54 
Widowed 19.89 6.76 8.00 15.02 3.91 4.65 
Divorced/separated 12.21 11.57 11.63 11.02 8.87 9.01 
Health Behaviours       
Smoking status (%)       
Current 8.62 7.62 7.72 9.33 8.05 8.14 
Former 60.71 60.45 60.47 58.83 57.92 57.98 
Never 30.67 31.93 31.81 31.84 34.03 33.88 
Alcohol use (%)       
Current 79.03 88.64*** 87.74 79.18 88.72*** 88.08 
Former 17.53 9.55 10.30 17.59 9.60 10.13 
Never 3.45 1.81 1.96 3.23 1.69 1.79 
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Table A9. Distribution of depressive symptoms and covariates by low executive function status 
in participants with low social support availability, Canadian Longitudinal Study on Aging 
1Presence of depressive symptoms: CES-D10 score ≥10;  
Absence of depressive symptoms: CES-D10 score <10 
Abbreviations: NFLD = Newfoundland and Labrador 














Not Low  
(n=132,390) Total 
Depressive symptoms1 (%)       
Presence 43.70 44.63 44.46 43.29 47.75 47.13 
Absence 56.30 55.37 55.54 56.71 52.35 52.87 
Sociodemographic Factors    
   
Age, groups (%)       
45–54 years 8.89 23.63*** 20.95 16.35 39.38*** 36.19 
55–64 years 22.59 35.19 32.91 24.94 31.57 30.65 
65–74 years 24.44 22.15 22.57 22.17 16.72 17.48 
75 years and over 44.07 19.03 23.57 36.55 12.32 15.69 
Sex (%)       
Female 41.11 48.48* 47.15 45.56 46.45 46.33 
Male 58.89 51.52 52.85 54.44 53.55 53.67 
Education (%)       
Less than high school 24.44 7.30*** 10.41 26.70 7.82*** 10.44 
High school graduate 10.00 8.12 8.46 9.75 7.78 8.05 
Some post-secondary 11.11 9.76 10.01 10.33 9.49 9.61 
Post-secondary 
degree/diploma 
54.44 74.82 71.12 53.22 74.92 71.90 
Annual household income (%)       
< $20,000 28.15 19.28*** 20.89 30.99 19.26*** 20.88 
≥	$20,000 and < $50,000 45.19 35.93 37.61 41.94 32.93 34.18 
≥	$50,000 and < $100,000 22.59 29.61 28.34 23.73 29.91 29.05 
≥	$100,000 and < $150,000 2.96 10.17 8.87 2.72 12.12 10.82 
≥	$150,000 1.11 5.00 4.30 0.63 5.78 5.07 
Province (%)       
Ontario 23.70 21.00 21.49 15.08 12.84*** 13.15 
Alberta  5.56 9.76 9.00 4.67 10.88 10.02 
British Columbia 19.63 23.22 22.57 24.08 32.12 31.01 
Manitoba 15.93 11.73 12.49 15.19 9.61 10.39 
NFLD 4.81 5.82 5.64 1.42 1.68 1.64 
Nova Scotia 9.63 7.05 7.52 4.59 2.69 2.96 
Quebec 20.74 21.41 21.29 34.97 30.17 30.84 
Urban/rural residence (%)       
Urban 93.33 6.67 93.89 91.54 8.46 93.33 
Rural 94.01 5.99 6.11 93.62 6.38 6.67 
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Table A9. Distribution of depressive symptoms and covariates by low executive function status 
in participants with low social support availability, Canadian Longitudinal Study on Aging, 
continued 
2Chronic conditions: presence of at least 1 of 11 self-reported medical conditions 


















Not Low  
(n=132,390) Total 
Health Factors       
Self-rated general health (%)       
Poor 5.93 3.77*** 4.16 5.61 4.29* 4.47 
Fair 24.07 15.75 17.26 26.18 16.40 17.76 
Good 39.63 38.56 38.75 38.31 39.87 39.66 
Very good 21.85 30.11 28.61 22.23 29.09 28.14 
Excellent 8.52 11.81 11.22 7.67 10.35 9.98 
Medication for depression (%)       
Yes 11.11 13.62 13.16 11.91 13.39 13.18 
No 88.89 86.38 86.84 88.09 86.61 86.82 
Chronic conditions2 (%)       
Yes 87.04 71.86*** 74.61 86.99 67.48*** 70.19 
No 12.96 28.14 25.39 13.01 32.52 29.81 
Social Factors       
Marital status (%)       
Single, never married  25.99 27.97*** 25.99 16.65 29.30*** 27.54 
Married/common-law 26.66 27.40 26.66 29.22 35.60 34.71 
Widowed 15.78 13.29 15.78 21.33 8.70 10.46 
Divorced/separated 31.56 31.34 31.56 32.80 26.40 27.29 
Health Behaviours       
Smoking status (%)       
Current 21.11 17.56 18.20 20.94 19.36 19.58 
Former 49.63 53.65 52.92 48.78 50.48 50.25 
Never 29.26 28.79 28.88 30.28 30.16 30.18 
Alcohol use (%)       
Current 65.93 79.74*** 77.23 63.32 79.95*** 77.64 
Former 28.89 17.47 19.54 32.70 16.87 19.07 
Never 5.19 2.79 3.22 3.98 3.18 3.29 
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B. Analyses for the association of depressive symptoms and covariates with low executive 
function in those 75 years and over by social support availability  
 
In research question 2, the association between depressive symptoms and low executive 
function in those 75 years and over was stratified by SSA. Descriptive results for each stratum of 
social support (i.e., higher SSA versus low SSA) are presented in Tables A10 and A11 of 
Appendix H. These descriptive results correspond to the multivariable results presented in 



































Table A10. Distribution of depressive symptoms and covariates by low executive function status 
in adults 75 years and over with higher social support availability, Canadian Longitudinal Study 
on Aging 
1Presence of depressive symptoms: CES-D10 score ≥10;  
Absence of depressive symptoms: CES-D10 score <10 
Abbreviations: NFLD = Newfoundland and Labrador 


















Not Low  
(n=194,546) Total 
Depressive symptoms1 (%)       
Presence 19.40 11.18*** 13.43 19.40 11.52*** 13.54 
Absence 80.60 88.82 86.57 80.60 88.48 86.46 
Sociodemographic Factors    
   
Sex (%)       
Female 50.17 47.87 48.50 53.71 53.08 53.24 
Male 49.83 52.13 51.50 46.29 46.92 46.76 
Education (%)       
Less than high school 19.74 8.09*** 11.29 24.63 10.18*** 13.88 
High school graduate 14.99 10.84 11.98 14.74 11.00 11.96 
Some post-secondary 8.16 9.22 8.93 6.58 8.73 8.18 
Post-secondary 
degree/diploma 
57.11 71.85 67.81 54.05 70.09 65.98 
Annual household income (%)       
< $20,000 9,70 5.42*** 6.60 11.05 5.87*** 7.19 
≥	$20,000 and < $50,000 45.76 33.69 37.00 49.35 35.85 39.31 
≥	$50,000 and < $100,000 33.41 42.24 39.82 29.92 40.40 37.71 
≥	$100,000 and < $150,000 7.06 13.51 11.74 6.35 12.78 11.13 
≥	$150,000 4.08 5.13 4.84 3.32 5.11 4.65 
Province (%)       
Ontario 21.28 22.31*** 22.03 12.59 11.69 11.91 
Alberta  8.27 7.51 7.72 7.69 6.76 7.00 
British Columbia 17.53 25.69 23.45 24.46 32.84 30.69 
Manitoba 12.02 9.80 10.41 11.35 8.59 9.30 
NFLD  10.03 6.84 7.72 2.79 1.67 1.96 
Nova Scotia 12.13 9.80 10.44 4.10 3.15 3.39 
Quebec 18.74 18.06 18.25 37.03 35.30 35.75 
Urban/rural residence (%)       
Urban 92.50 94.29 93.80 91.92 93.34 92.97 
Rural 7.50 5.71 6.20 8.08 6.66 7.03 
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Table A10. Distribution of depressive symptoms and covariates by low executive function status 
in adults 75 years and over with higher social support availability, Canadian Longitudinal Study 
on Aging, continued 
2Chronic conditions: presence of at least 1 of 11 self-reported medical conditions 





















Not Low  
(n=194,546) Total 
Health Factors       
Self-rated general health (%)       
Poor 2.21 0.92*** 1.27 2.70 0.82*** 1.30 
Fair 12.02 6.88 8.29 12.89 6.25 7.95 
Good 37.82 28.61 31.13 41.35 31.33 33.81 
Very good 35.83 43.83 41.63 33.12 42.86 40.36 
Excellent 12.13 19.77 17.67 9.94 18.86 16.58 
Medication for depression (%)       
Yes 4.63 3.92 4.11 4.98 4.23 4.42 
No 95.37 96.08 95.89 95.02 95.77 95.58 
Chronic conditions2 (%)       
Yes 87.76 85.36 86.02 88.70 86.24 86.87 
No 12.24 14.64 13.98 11.30 13.76 13.13 
Social Factors       
Marital status (%)       
Single, never married  3.75 4.25*** 4.11 3.10 4.17** 3.90 
Married/common-law 55.02 61.97 60.06 59.54 64.94 63.56 
Widowed 32.08 23.48 25.84 28.19 21.18 22.98 
Divorced/separated 9.15 10.30 9.98 9.17 9.71 9.57 
Health Behaviours       
Smoking status (%)       
Current 3.97 2.96 3.24 3.83 3.01 3.22 
Former 63.84 67.39 66.41 63.22 66.34 65.54 
Never 32.19 29.65 30.35 32.95 30.65 31.23 
Alcohol use (%)       
Current 79.38 84.86*** 83.36 80.79 85.55* 84.33 
Former 16.65 12.76 13.83 15.91 12.37 13.28 
Never 3.97 2.38 2.81 3.30 2.08 2.39 
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Table A11. Distribution of depressive symptoms and covariates by low executive function status 
in adults 75 years and over with low social support availability, Canadian Longitudinal Study on 
Aging 
1Presence of depressive symptoms: CES-D10 score ≥10;  
Absence of depressive symptoms: CES-D10 score <10 
Abbreviations: NFLD = Newfoundland and Labrador 

















Not Low  
(n=16,313) Total 
Depressive symptoms1 (%)       
Presence 32.77 32.33 32.48 34.29 36.26 35.62 
Absence 67.23 67.67 67.52 65.71 63.74 64.38 
Sociodemographic Factors    
   
Sex (%)       
Female 42.04 51.29 48.15 49.13 58.41 55.41 
Male 57.98 48.71 51.85 50.87 41.59 44.59 
Education (%)       
Less than high school 23.52 14.22** 17.38 22.70 17.31* 19.05 
High school graduate 15.13 7.76 10.26 17.67 9.49 12.14 
Some post-secondary 13.45 8.62 10.26 12.73 8.09 9.59 
Post-secondary 
degree/diploma 
47.90 69.40 62.11 46.90 65.11 59.22 
Annual household income (%)       
< $20,000 22.69 13.36** 16.52 25.62 13.80** 17.62 
≥	$20,000 and < $50,000 50.42 45.26 47.01 46.38 46.13 46.21 
≥	$50,000 and < $100,000 24.37 29.31 27.64 26.00 28.70 27.83 
≥	$100,000 and < $150,000 0.84 9.05 6.27 0.68 9.04 6.34 
≥	$150,000 1.68 3.02 2.56 1.33 2.33 2.00 
Province (%)       
Ontario 19.33 19.83 19.66 10.64 11.07 10.93 
Alberta  7.56 11.64 10.26 5.97 8.87 7.93 
British Columbia 26.05 21.12 22.79 32.43 26.46 28.39 
Manitoba 14.29 13.79 13.96 14.46 13.12 13.56 
NFLD  5.88 5.60 5.70 1.72 1.49 1.56 
Nova Scotia 8.40 8.19 8.26 3.19 3.03 3.09 
Quebec 18.49 19.83 19.37 31.59 35.96 34.55 
Urban/rural residence (%)       
Urban 94.12 95.26 94.87 93.51 96.40 95.47 
Rural 5.88 4.74 5.13 6.49 3.60 4.53 
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Table A11. Distribution of depressive symptoms and covariates by low executive function status 
in adults 75 years and over with low social support availability, Canadian Longitudinal Study on 
Aging, continued 
2Chronic conditions: presence of at least 1 of 11 self-reported medical conditions 




















Health Factors       
Self-rated general health (%)       
Poor 2.52 2.16 2.28 2.82 2.29 2.46 
Fair 19.33 11.64 14.25 18.44 11.55 13.78 
Good 41.18 38.79 39.60 42.51 41.53 41.85 
Very good 24.37 28.88 27.35 24.05 28.02 26.74 
Excellent 12.61 18.53 16.52 12.18 16.62 15.18 
Medication for depression (%)       
Yes 5.04 5.17 5.13 3.88 5.22 4.78 
No 94.96 94.83 94.87 96.12 94.78 95.22 
Chronic conditions2 (%)       
Yes 91.60 88.79 89.74 90.27 92.37 91.69 
No 8.40 11.21 10.26 9.73 7.63 8.31 
Social Factors       
Marital status (%)       
Single, never married  10.92 12.93 12.25 10.00 12.46** 11.66 
Married/common-law 21.01 23.28 22.51 23.04 27.76 26.23 
Widowed 44.54 33.62 37.32 41.08 29.97 33.56 
Divorced/separated 23.53 30.17 27.92 25.88 29.81 28.54 
Health Behaviours       
Smoking status (%)       
Current 10.92 5.17 7.12 8.90 4.97 6.24 
Former 55.46 63.36 60.68 52.55 64.09 60.36 
Never 33.61 31.47 32.19 38.56 30.94 33.41 
Alcohol use (%)       
Current 67.23 78.02* 74.36 67.64 78.98* 75.31 
Former 28.57 17.24 21.08 29.36 17.44 21.30 
Never 4.20 4.74 4.56 3.00 3.58 3.40 
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C. Analyses for the association of depressive symptoms and covariates with low executive 
function by sex and alcohol use 
 
In research question 3, alcohol use was a significant first-order interaction among males. 
Therefore, models for males were stratified by alcohol use (i.e., current drinkers versus 
former/never drinkers).  
Descriptive results for each stratum of alcohol use (i.e., current drinkers versus 
former/never drinkers) for males are presented in Tables A12 and A13 of Appendix H. The 

















Table A12. Distribution of depressive symptoms and covariates by low executive function status 
in male former/never drinkers, Canadian Longitudinal Study on Aging 
1Presence of depressive symptoms: CES-D10 score ≥10;  
Absence of depressive symptoms: CES-D10 score <10 
Abbreviations: NFLD = Newfoundland and Labrador 



















Depressive symptoms1 (%)       
Presence 28.26 15.49*** 17.69 30.27 15.58*** 17.37 
Absence 71.74 84.51 82.31 69.73 84.42 82.63 
Sociodemographic Factors    
   
Age, groups (%)       
45–54 years 9.13 26.99*** 23.91 25.66 47.35*** 44.72 
55–64 years 21.30 34.87 32.53 24.27 31.61 30.72 
65–74 years 26.96 21.83 22.71 21.15 13.22 14.19 
75 years and over 42.61 16.30 20.84 28.92 7.82 10.38 
Education (%)       
Less than high school 15.22 4.80*** 6.60 17.65 3.58*** 5.29 
High school graduate 17.39 9.42 10.79 18.59 8.67 9.87 
Some post-secondary 10.43 7.70 8.17 7.73 6.83 6.94 
Post-secondary 
degree/diploma 
56.96 78.08 74.44 56.04 80.92 77.90 
Annual household income (%)       
< $20,000 11.74 6.70*** 7.57 15.62 5.76*** 6.96 
≥	$20,000 and < $50,000 50.43 23.82 28.41 51.88 19.98 23.86 
≥	$50,000 and < $100,000 25.65 35.51 33.81 19.49 34.21 32.42 
≥	$100,000 and < $150,000 8.26 19.66 17.69 8.79 22.30 20.65 
≥	$150,000 3.91 14.31 12.52 4.22 17.76 16.11 
Province (%)       
Ontario 22.17 20.65* 20.91 14.34 12.72*** 12.91 
Alberta  6.96 8.97 8.62 9.83 12.99 12.60 
British Columbia 21.74 31.25 29.61 29.88 44.74 42.94 
Manitoba 10.00 10.60 10.49 9.87 8.54 8.70 
NFLD 10.87 5.98 6.82 2.90 1.72 1.87 
Nova Scotia 13.04 11.41 11.69 4.78 3.42 3.58 
Quebec 15.22 11.14 11.84 28.41 15.87 17.39 
Urban/rural residence (%)       
Urban 90.87 92.75 7.57 92.58 94.84 94.57 
Rural 9.13 7.25 92.43 7.42 5.16 5.43 
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Table A12. Distribution of depressive symptoms and covariates by low executive function status 
in male former/never drinkers, Canadian Longitudinal Study on Aging, continued 
2Chronic conditions: presence of at least 1 of 11 self-reported medical conditions 
Abbreviations: SSA = social support availability 


















Not Low  
(n=142,129) Total 
Health Factors       
Self-rated general health (%)       
Poor 3.91 2.99*** 3.15 4.48 3.07** 3.24 
Fair 21.30 9.78 11.77 21.18 10.12 11.46 
Good 32.17 31.34 31.48 34.27 30.39 30.87 
Very good 30.87 38.22 36.96 29.71 38.87 37.76 
Excellent 11.74 17.66 16.64 10.35 17.54 16.67 
Medication for depression (%)       
Yes 9.57 9.33 9.37 11.55 9.73 9.95 
No 90.43 90.67 90.63 88.45 90.27 90.05 
Chronic conditions2 (%)       
Yes 84.78 67.93*** 70.84 81.22 61.57*** 63.96 
No 15.22 32.07 29.16 18.78 38.43 36.04 
Social Factors       
Marital status (%)       
Single, never married  8.70 10.69*** 10.34 7.72 10.51*** 10.17 
Married/common-law 63.91 76.45 74.29 72.82 81.55 80.49 
Widowed 11.30 3.26 4.65 6.35 1.43 2.03 
Divorced/separated 16.09 9.60 10.72 13.11 6.51 7.31 
Low SSA (%)       
Yes 20.43 10.05*** 11.84 19.67 8.50*** 9.86 
No 79.57 89.95 88.16 80.33 91.50 90.14 
Health Behaviours       
Smoking status (%)       
Current 11.74 9.33** 9.75 11.53 9.81** 10.02 
Former 61.74 52.81 54.35 62.10 47.12 48.94 
Never 26.52 37.86 35.91 26.37 43.07 41.04 
 217 
Table A13. Distribution of depressive symptoms and covariates by low executive function status 
in male current drinkers, Canadian Longitudinal Study on Aging 
1Presence of depressive symptoms: CES-D10 score ≥10;  
Absence of depressive symptoms: CES-D10 score <10 
Abbreviations: NFLD = Newfoundland and Labrador 



















Depressive symptoms1 (%)       
Presence 18.48 10.63*** 11.34 18.75 11.02*** 11.49 
Absence 81.52 89.37 88.66 81.25 88.98 88.51 
Sociodemographic Factors    
   
Age, groups (%)       
45–54 years 8.91 28.33*** 26.58 20.45 47.03*** 45.40 
55–64 years 16.83 34.64 33.04 20.13 30.85 30.20 
65–74 years 27.72 24.13 24.46 22.01 14.90 15.33 
75 years and over 46.53 12.90 15.93 37.42 7.22 9.07 
Education (%)       
Less than high school 15.18 3.22*** 4.29 16.56 2.91*** 3.75 
High school graduate 12.54 7.21 7.69 13.33 6.50 6.92 
Some post-secondary 9.13 6.87 7.07 8.83 6.21 6.37 
Post-secondary 
degree/diploma 
63.15 82.71 80.95 61.29 84.37 82.96 
Annual household income (%)       
< $20,000 7.37 2.69*** 3.11 7.29 2.46*** 2.76 
≥	$20,000 and < $50,000 36.19 13.97 15.98 36.85 11.83 13.36 
≥	$50,000 and < $100,000 38.50 35.62 35.88 35.85 31.66 31.92 
≥	$100,000 and < $150,000 10.75 24.66 23.38 10.31 26.56 25.57 
≥	$150,000 7.48 23.05 21.65 9.70 27.48 26.39 
Province (%)       
Ontario 20.79 22.20*** 22.08 13.04 13.61*** 13.58 
Alberta  7.15 8.68 8.54 9.35 12.32 12.14 
British Columbia 16.06 21.65 21.14 22.33 30.25 29.77 
Manitoba 13.20 10.22 10.49 11.18 8.69 8.84 
NFLD 10.12 7.73 7.94 3.15 2.12 2.19 
Nova Scotia 11.77 10.74 10.83 4.35 3.22 3.29 
Quebec 20.90 18.78 18.97 36.61 29.78 30.19 
Urban/rural residence (%)       
Urban 90.43 90.63 90.61 88.61 90.90 90.76 
Rural 9.57 9.37 9.39 11.39 9.10 9.24 
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Table A13. Distribution of depressive symptoms and covariates by low executive function status 
in male current drinkers, Canadian Longitudinal Study on Aging, continued 
2Chronic conditions: presence of at least 1 of 11 self-reported medical conditions 
Abbreviations: SSA = social support availability 




















Health Factors       
Self-rated general health (%)       
Poor 2.64 0.98*** 1.13 2.83 0.86*** 0.98 
Fair 12.65 6.33 6.90 11.28 6.25 6.56 
Good 37.07 29.56 30.24 39.91 30.47 31.05 
Very good 34.54 42.08 41.40 33.35 41.34 40.85 
Excellent 13.09 21.05 20.33 12.63 21.07 20.55 
Medication for depression (%)       
Yes 4.73 4.75 4.75 5.39 4.98 95.00 
No 95.27 95.25 95.27 94.61 95.02 5.00 
Chronic conditions2 (%)       
Yes 80.53 63.35*** 64.90 76.31 56.99*** 58.17 
No 19.47 36.65 35.10 23.69 43.01 41.83 
Social Factors       
Marital status (%)       
Single, never married  8.25 7.30*** 7.39 8.97 7.41*** 7.50 
Married/common-law 70.63 80.70 79.79 74.98 83.97 83.42 
Widowed 11.11 3.64 4.31 7.61 1.90 2.25 
Divorced/separated 10.01 8.36 8.51 8.45 6.73 6.83 
Low SSA (%)       
Yes 12.32 5.64*** 6.24 9.89 4.88*** 5.19 
No 87.68 94.36 93.76 90.11 95.12 94.81 
Health Behaviours       
Smoking status (%)       
Current 22.33 27.58*** 27.11 11.88 8.45** 8.66 
Former 67.22 64.55 64.79 63.86 60.98 61.16 
Never 10.45 7.87 8.10 24.27 30.57 30.18 
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Table A14. Distribution of depressive symptoms and covariates by low executive function status 
in female former/never drinkers, Canadian Longitudinal Study on Aging 
1Presence of depressive symptoms: CES-D10 score ≥10;  
Absence of depressive symptoms: CES-D10 score <10 
Abbreviations: NFLD = Newfoundland and Labrador 

















Not Low  
(n=172,637) Total 
Depressive symptoms1 (%)       
Presence 34.03 23.55*** 25.38 31.37 22.16** 23.37 
Absence 65.97 76.45 74.62 68.63 77.84 76.63 
Sociodemographic Factors    
   
Age, groups (%)       
45–54 years 6.60 26.49*** 23.02 12.57 42.10*** 38.23 
55–64 years 17.01 33.16 30.35 16.22 29.25 27.54 
65–74 years 31.94 23.18 24.71 33.85 16.83 19.06 
75 years and over 44.44 17.17 21.93 37.36 11.83 15.17 
Education (%)       
Less than high school 25.00 6.75*** 9.93 27.97 6.71*** 9.49 
High school graduate 15.28 11.59 12.24 13.33 11.11 11.40 
Some post-secondary 8.68 8.73 8.72 7.83 8.20 8.15 
Post-secondary 
degree/diploma 
51.04 72.93 69.11 50.87 73.98 70.95 
Annual household income (%)       
< $20,000 22.22 12.03*** 13.81 21.60 10.42*** 11.89 
≥	$20,000 and < $50,000 52.78 31.33 35.07 50.29 26.25 29.40 
≥	$50,000 and < $100,000 20.83 32.94 30.83 22.75 32.78 31.46 
≥	$100,000 and < $150,000 3.47 14.01 12.17 3.25 17.69 15.80 
≥	$150,000 0.69 9.68 8.12 2.11 12.87 11.46 
Province (%)       
Ontario 23.61 19.00 19.81 15.80 11.79 12.31 
Alberta  7.29 7.26 7.26 6.71 7.97 7.81 
British Columbia 23.26 30.96 30.96 36.73 45.66 44.49 
Manitoba 11.81 13.21 13.21 10.44 9.85 9.93 
NFLD 9.38 6.31 6.31 2.85 1.98 2.10 
Nova Scotia 11.11 9.98 9.98 4.36 3.74 3.82 
Quebec 13.54 13.28 13.28 23.11 19.01 19.55 
Urban/rural residence (%)       
Urban 92.71 92.59 92.61 93.30 92.35 92.47 
Rural 7.29 7.41 7.39 6.70 7.65 7.53 
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Table A14. Distribution of depressive symptoms and covariates by low executive function status 
in female former/never drinkers, Canadian Longitudinal Study on Aging, continued 
2Chronic conditions: presence of at least 1 of 11 self-reported medical conditions 
Abbreviations: SSA = social support availability 



















Not Low  
(n=172,637) Total 
Health Factors       
Self-rated general health (%)       
Poor 5.90 2.93*** 3.45 5.99 2.36*** 2.84 
Fair 19.44 10.71 12.24 22.37 10.62 12.16 
Good 37.85 33.60 34.34 37.39 32.09 32.79 
Very good 29.51 36.02 34.89 29.37 36.25 35.35 
Excellent 7.29 16.73 15.08 4.88 18.67 16.86 
Medication for depression (%)       
Yes 15.28 13.06 13.45 16.57 11.86 12.48 
No 84.72 86.94 86.55 83.43 88.14 87.52 
Chronic conditions2 (%)       
Yes 88.89 70.65*** 73.83 86.81 65.85*** 68.59 
No 11.11 29.35 26.17 13.19 34.15 31.41 
Social Factors       
Marital status (%)       
Single, never married  11.46 10.49*** 10.66 11.79 8.47*** 8.91 
Married/common-law 36.81 58.18 54.45 43.57 69.00 65.66 
Widowed 32.29 13.28 16.60 24.98 8.11 10.32 
Divorced/separated 19.44 18.05 18.29 19.66 14.42 15.11 
Low SSA (%)       
Yes 15.63 9.98** 10.96 15.22 8.38** 9.27 
No 84.38 90.02 89.04 84.78 91.62 90.73 
Health Behaviours       
Smoking status (%)       
Current 7.64 8.36 8.24 7.57 8.68 8.54 
Former 43.75 42.85 43.00 42.40 41.40 41.53 
Never 48.61 48.79 48.76 50.03 49.92 49.93 
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Table A15. Distribution of depressive symptoms and covariates by low executive function status 
in female current drinkers, Canadian Longitudinal Study on Aging 
1Presence of depressive symptoms: CES-D10 score ≥10;  
Absence of depressive symptoms: CES-D10 score <10 
Abbreviations: NFLD = Newfoundland and Labrador 



















Depressive symptoms1 (%)       
Presence 25.17 16.42*** 17.19 25.46 15.83*** 16.44 
Absence 74.83 83.58 82.81 74.54 84.17 83.56 
Sociodemographic Factors    
   
Age, groups (%)       
45–54 years 8.81 30.09*** 28.23 16.06 44.47*** 42.67 
55–64 years 17.28 36.49 34.81 17.12 32.28 30.38 
65–74 years 30.78 22.11 22.87 28.74 16.34 17.13 
75 years and over 43.14 11.32 14.10 38.09 7.91 9.83 
Education (%)       
Less than high school 16.70 3.89*** 5.01 20.19 3.68*** 4.73 
High school graduate 15.33 9.16 9.70 15.62 9.18 9.59 
Some post-secondary 8.35 7.55 7.62 8.37 7.04 7.12 
Post-secondary 
degree/diploma 
59.61 79.40 77.67 55.83 80.10 78.56 
Annual household income (%)       
< $20,000 16.25 4.53*** 5.55 15.37 3.67*** 4.42 
≥	$20,000 and < $50,000 42.56 23.18 24.88 42.00 19.00 20.46 
≥	$50,000 and < $100,000 28.95 36.31 35.67 28.94 35.42 35.01 
≥	$100,000 and < $150,000 7.89 19.27 18.28 9.01 21.69 20.88 
≥	$150,000 4.35 16.71 15.63 4.67 20.22 19.23 
Province (%)       
Ontario 20.02 21.85*** 21.69 14.07 13.62*** 13.65 
Alberta  8.58 8.89 8.86 8.68 10.41 10.30 
British Columbia 14.65 20.76 20.23 21.47 30.20 29.65 
Manitoba 9.95 10.56 10.51 9.04 8.10 8.16 
NFLD 13.04 7.63 8.10 4.16 2.50 2.60 
Nova Scotia 13.04 10.24 10.49 5.09 4.00 4.07 
Quebec 20.71 20.07 20.13 37.48 31.18 31.58 
Urban/rural residence (%)       
Urban 90.27 89.82 89.86 87.86 89.28 89.19 
Rural 9.73 10.18 10.14 12.14 10.72 10.81 
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Table A15. Distribution of depressive symptoms and covariates by low executive function status 
in female current drinkers, Canadian Longitudinal Study on Aging, continued 
2Chronic conditions: presence of at least 1 of 11 self-reported medical conditions 
Abbreviations: SSA = social support availability 



























Health Factors       
Self-rated general health (%)       
Poor 2.17 0.95*** 1.06 2.35 0.80*** 0.90 
Fair 12.24 5.41 6.01 12.95 5.42 5.89 
Good 37.87 26.21 27.23 40.98 26.75 27.65 
Very good 33.41 44.89 43.89 30.27 43.84 42.98 
Excellent 14.30 22.54 21.82 13.45 23.20 22.58 
Medication for depression (%)       
Yes 11.10 10.53 10.58 11.03 10.39 10.43 
No 88.90 89.47 89.42 88.97 89.61 89.57 
Chronic conditions2 (%)       
Yes 80.43 66.17*** 67.41 78.46 62.63*** 63.63 
No 19.57 33.83 32.59 21.54 37.37 36.37 
Social Factors       
Marital status (%)       
Single, never married  6.86 9.17*** 8.97 6.30 7.98*** 7.87 
Married/common-law 46.34 63.90 62.36 54.69 73.28 72.10 
Widowed 29.41 10.22 11.90 22.93 6.21 7.27 
Divorced/separated 17.39 16.71 16.77 16.08 12.53 12.76 
Low SSA (%)       
Yes 7.55 4.99** 5.21 7.28 4.03*** 4.23 
No 92.45 95.01 94.79 92.72 95.97 95.77 
Health Behaviours       
Smoking status (%)       
Current 10.07 8.38 8.53 9.97 8.61 8.70 
Former 55.84 58.97 58.69 55.73 57.68 57.56 
Never 34.10 32.65 32.78 34.31 33.71 33.75 
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D. Analyses for the association of depressive symptoms and covariates with low executive 
function by sex and social support availability 
 
In research question 3, SSA was a significant first-order interaction term among females. 
Therefore, female models were stratified by SSA (i.e., higher SSA versus low SSA) and are 
presented in the main body of text (Section 5.3.3.2).  
For males and females, separately, descriptive results for each stratum of social support 


































Table A16. Distribution of depressive symptoms and covariates by low executive function status 
in males with higher social support availability, Canadian Longitudinal Study on Aging 
1Presence of depressive symptoms: CES-D10 score ≥10;  
Absence of depressive symptoms: CES-D10 score <10 
Abbreviations: NFLD = Newfoundland and Labrador 

















Not Low  
(n=1,275,452) Total 
Depressive symptoms1 (%)       
Presence 17.04 9.43*** 10.13 18.48 9.85*** 10.40 
Absence 82.96 90.57 89.87 81.52 90.15 89.60 
Sociodemographic Factors    
   
Age, groups (%)       
45–54 years 9.08 28.38*** 26.60 22.23 47.18*** 45.60 
55–64 years 16.63 34.66 33.00 19.70 30.89 30.18 
65–74 years 28.16 24.00 24.38 22.15 14.77 15.24 
75 years and over 46.12 12.95 16.01 35.92 7.16 8.98 
Education (%)       
Less than high school 13.47 3.14*** 4.09 14.93 2.72*** 3.49 
High school graduate 14.08 7.38 8.00 15.21 6.66 7.21 
Some post-secondary 9.18 6.75 6.97 8.39 6.09 6.24 
Post-secondary 
degree/diploma 
63.27 82.74 80.94 61.47 84.53 83.07 
Annual household income (%)       
< $20,000 6.22 2.06*** 2.45 7.23 1.92*** 2.26 
≥	$20,000 and < $50,000 37.76 14.01 16.20 38.97 11.79 13.51 
≥	$50,000 and < $100,000 37.45 35.94 36.08 33.29 32.07 32.14 
≥	$100,000 and < $150,000 11.02 24.85 23.57 10.90 26.73 25.72 
≥	$150,000 7.55 23.14 21.70 9.60 27.50 26.36 
Province (%)       
Ontario 20.31 22.17*** 21.99 12.81 13.62*** 13.57 
Alberta  7.45 8.55 8.45 10.01 12.37 12.22 
British Columbia 17.04 22.61 22.10 24.29 31.37 31.26 
Manitoba 12.45 10.15 10.36 10.62 8.60 8.73 
NFLD 11.22 7.68 8.01 3.35 2.13 2.21 
Nova Scotia 12.14 11.13 11.22 4.33 3.30 3.37 
Quebec 19.39 17.72 17.87 34.60 28.25 28.65 
Urban/rural residence (%)       
Urban 90.20 90.65 90.61 89.23 91.18 91.05 
Rural 9.80 9.35 9.39 10.77 8.82 8.95 
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Table A16. Distribution of depressive symptoms and covariates by low executive function status 
in males with higher social support availability, Canadian Longitudinal Study on Aging, 
continued 
2Chronic conditions: presence of at least 1 of 11 self-reported medical conditions 
























Health Factors       
Self-rated general health (%)       
Poor 2.65 0.98*** 1.14 3.02 0.88*** 1.02 
Fair 12.45 6.23 6.80 11.05 6.24 6.54 
Good 35.51 29.13 29.72 39.09 29.89 30.47 
Very good 35.71 42.39 41.78 33.88 41.74 41.24 
Excellent 13.67 21.26 20.56 12.96 21.26 20.73 
Medication for depression (%)       
Yes 5.61 5.04 5.09 6.65 5.29 5.38 
No 94.39 94.96 94.91 93.35 94.71 94.62 
Chronic conditions2 (%)       
Yes 80.31 63.55*** 65.10 75.80 57.23*** 58.41 
No 19.69 36.45 34.90 24.20 42.77 41.59 
Social Factors       
Marital status (%)       
Single, never married  6.63 6.08*** 6.13 7.32 6.21*** 6.28 
Married/common-law 76.53 83.54 82.90 80.40 86.36 85.98 
Widowed 8.98 3.14 3.68 5.90 1.63 1.90 
Divorced/separated 7.86 7.23 7.29 6.38 5.80 5.84 
Health Behaviours       
Smoking status (%)       
Current 8.67 7.36*** 7.48 10.24 7.94** 8.09 
Former 68.37 63.68 64.11 65.07 59.91 60.24 
Never 22.96 28.96 28.41 24.69 32.15 31.67 
Alcohol use (%)       
Current 81.33 89.71*** 88.94 81.73 89.80*** 89.29 
Former 15.92 8.82 9.47 15.24 8.77 9.18 
Never 2.76 1.47 1.59 3.04 1.43 1.53 
 226 
Table A17. Distribution of depressive symptoms and covariates by low executive function status 
in males with low social support availability, Canadian Longitudinal Study on Aging 
1Presence of depressive symptoms: CES-D10 score ≥10;  
Absence of depressive symptoms: CES-D10 score <10 
Abbreviations: NFLD = Newfoundland and Labrador 



















Depressive symptoms1 (%)       
Presence 41.51 37.58 38.37 40.26 41.25* 41.11 
Absence 58.49 62.42 61.63 59.74 58.75 58.89 
Sociodemographic Factors    
   
Age, groups (%)       
45–54 years 8.18 25.16*** 31.73 16.04 44.88*** 40.82 
55–64 years 24.53 34.71 32.66 30.34 31.73 31.53 
65–74 years 23.90 22.13 22.49 19.47 13.82 14.62 
75 years and over 43.40 17.99 23.13 34.15 9.57 13.03 
Education (%)       
Less than high school 25.79 7.17*** 10.93 30.47 7.78*** 10.97 
High school graduate 10.06 8.44 8.77 8.23 7.95 7.99 
Some post-secondary 10.69 10.19 10.29 10.23 9.65 9.74 
Post-secondary 
degree/diploma 
53.46 74.20 70.01 51.07 74.62 71.30 
Annual household income (%)       
< $20,000 20.75 19.43*** 19.70 22.07 18.84*** 19.29 
≥	$20,000 and < $50,000 47.17 30.73 34.05 47.00 28.91 31.43 
≥	$50,000 and < $100,000 26.42 30.57 29.73 27.54 29.50 29.22 
≥	$100,000 and < $150,000 3.77 12.90 11.05 3.39 15.10 13.47 
≥	$150,000 1.89 6.37 5.46 0.00 7.66 6.59 
Province (%)       
Ontario 25.79 20.06* 21.22 16.90 11.67** 12.41 
Alberta  5.03 11.15 9.91 5.27 12.79 11.73 
British Columbia 18.24 23.73 22.62 20.55 32.67 30.97 
Manitoba 13.21 12.10 12.33 13.12 10.04 10.47 
NFLD 4.40 5.41 5.21 1.27 1.24 1.24 
Nova Scotia 11.32 5.89 6.99 5.21 2.19 2.62 
Quebec 22.01 21.66 21.73 37.67 29.40 30.56 
Urban/rural residence (%)       
Urban 92.45 93.95 93.65 90.70 93.80 93.37 
Rural 7.55 6.05 6.35 9.30 6.20 6.63 
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Table A17. Distribution of depressive symptoms and covariates by low executive function status 
in males with low social support availability, Canadian Longitudinal Study on Aging, continued 
2Chronic conditions: presence of at least 1 of 11 self-reported medical conditions 

























Health Factors       
Self-rated general health (%)       
Poor 4.40 4.46** 4.45 4.23 4.94** 4.84 
Fair 26.42 14.01 16.52 29.76 14.31 16.49 
Good 39.62 39.33 39.39 36.42 40.85 40.22 
Very good 22.01 30.41 28.72 23.26 29.27 28.43 
Excellent 7.55 11.78 10.93 6.33 10.63 10.03 
Medication for depression (%)       
Yes 6.29 8.44 8.01 6.41 8.80 8.47 
No 93.71 91.56 91.99 93.59 91.20 91.53 
Chronic conditions2 (%)       
Yes 88.05 68.31*** 72.30 88.41 61.78*** 65.53 
No 11.95 31.69 27.70 11.59 38.22 34.47 
Social Factors       
Marital status (%)       
Single, never married  18.87 32.01*** 29.35 19.14 35.23*** 32.97 
Married/common-law 24.53 29.46 28.46 30.97 36.06 35.34 
Widowed 24.53 10.67 13.47 18.21 5.80 7.55 
Divorced/separated 32.08 27.87 28.72 31.68 22.90 21.14 
Health Behaviours       
Smoking status (%)       
Current 23.27 18.31 19.31 23.51 20.29 20.75 
Former 52.20 57.32 56.29 51.85 52.50 52.41 
Never 24.53 24.36 24.40 24.64 27.21 26.85 
Alcohol use (%)       
Current 70.44 82.32*** 79.92 66.72 82.95*** 80.67 
Former 28.30 15.61 18.17 32.30 14.87 17.33 
Never 1.26 2.07 1.91 0.97 2.17 2.00 
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Table A18. Distribution of depressive symptoms and covariates by low executive function status 
in females with higher social support availability, Canadian Longitudinal Study on Aging 
1Presence of depressive symptoms: CES-D10 score ≥10;  
Absence of depressive symptoms: CES-D10 score <10 
Abbreviations: NFLD = Newfoundland and Labrador 
















Not Low  
(n=1,278,801) Total 
Depressive symptoms1 (%)       
Presence 25.31 84.73*** 16.24 24.88 14.79*** 15.49 
Absence 74.69 15.27 83.76 75.12 85.21 84.51 
Sociodemographic Factors    
   
Age, groups (%)       
45–54 years 8.09 30.07*** 27.96 15.04 44.70*** 42.64 
55–64 years 16.94 36.07 34.24 16.74 31.00 30.01 
65–74 years 31.68 22.25 23.16 30.48 16.23 17.22 
75 years and over 43.29 11.60 14.64 37.75 8.08 10.14 
Education (%)       
Less than high school 18.36 4.07*** 5.44 22.11 3.89*** 5.15 
High school graduate 15.89 9.58 10.18 15.40 9.51 9.92 
Some post-secondary 8.09 7.61 7.65 8.01 7.09 7.15 
Post-secondary 
degree/diploma 
57.66 78.75 76.72 54.48 79.51 77.77 
Annual household income (%)       
< $20,000 15.51 4.69*** 5.73 14.36 3.81*** 4.54 
≥	$20,000 and < $50,000 45.39 23.21 25.34 44.82 19.09 20.87 
≥	$50,000 and < $100,000 27.97 36.31 35.51 28.21 35.31 34.82 
≥	$100,000 and < $150,000 7.33 19.26 18.12 8.16 21.77 20.83 
≥	$150,000 3.81 16.53 15.31 4.44 20.02 18.94 
Province (%)       
Ontario 20.93 21.45*** 21.40 14.67 13.35*** 13.44 
Alberta  8.47 8.70 8.68 8.63 10.16 10.06 
British Columbia 16.2 22.05 21.50 24.94 32.22 31.72 
Manitoba 9.42 10.88 10.74 8.54 8.29 8.30 
NFLD 12.84 7.53 8.04 4.06 2.44 2.56 
Nova Scotia 13.13 10.32 10.59 5.02 4.00 4.07 
Quebec 18.93 19.07 19.06 34.14 29.54 29.86 
Urban/rural residence (%)       
Urban 90.49 89.95 90.00 88.87 89.49 89.45 
Rural 9.51 10.05 10.00 11.13 10.51 10.55 
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Table A18. Distribution of depressive symptoms and covariates by low executive function status 
in females with higher social support availability, Canadian Longitudinal Study on Aging, 
continued 
2Chronic conditions: presence of at least 1 of 11 self-reported medical conditions 
























Health Factors       
Self-rated general health (%)       
Poor 2.57 1.10*** 1.24 2.84 0.88*** 1.02 
Fair 13.32 5.41 6.17 14.61 5.47 6.11 
Good 37.68 26.54 27.61 40.04 26.89 27.80 
Very good 33.59 44.57 43.52 30.97 43.54 42.66 
Excellent 12.84 22.38 21.46 11.54 23.22 22.41 
Medication for depression (%)       
Yes 11.51 10.36 10.47 11.78 10.19 10.30 
No 88.49 89.64 89.53 88.22 89.81 89.70 
Chronic conditions2 (%)       
Yes 82.21 66.22*** 67.75 80.04 62.51*** 63.73 
No 17.79 33.78 32.25 19.96 37.49 36.27 
Social Factors       
Marital status (%)       
Single, never married  7.33 8.49*** 8.37 7.05 7.35*** 7.33 
Married/common-law 46.34 65.42 63.59 54.47 74.54 73.15 
Widowed 30.07 10.29 12.19 23.28 6.18 7.37 
Divorced/separated 16.27 15.80 15.84 15.21 11.93 12.16 
Health Behaviours       
Smoking status (%)       
Current 8.56 7.88 7.95 8.51 8.16 8.18 
Former 53.57 57.30 56.94 53.17 55.94 55.75 
Never 37.87 34.82 35.11 38.32 35.90 36.07 
Alcohol use (%)       
Current 76.88 87.60*** 86.58 17.86 18.28*** 18.22 
Former 19.03 10.26 11.11 45.12 48.16 47.75 
Never 4.09 2.13 2.32 37.02 33.56 34.03 
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Table A19. Distribution of depressive symptoms and covariates by low executive function status 
in females with low social support availability, Canadian Longitudinal Study on Aging 
1Presence of depressive symptoms: CES-D10 score ≥10;  
Absence of depressive symptoms: CES-D10 score <10 
Abbreviations: NFLD = Newfoundland and Labrador 



















Depressive symptoms1 (%)       
Presence 46.85 52.12 51.28 46.92 55.23 54.06 
Absence 53.15 47.88 48.72 53.08 44.77 45.91 
Sociodemographic Factors    
   
Age, groups (%)       
45–54 years 9.91 22.00*** 20.09 16.72 33.05*** 30.82 
55–64 years 19.82 35.70 33.19 18.48 31.40 29.63 
65–74 years 25.23 22.17 22.65 23.39 20.06 20.79 
75 years and over 45.05 20.14 24.07 39.41 15.49 18.76 
Education (%)       
Less than high school 22.52 7.45*** 9.83 22.18 7.87*** 9.82 
High school graduate 9.91 7.78 8.12 11.57 7.57 8.12 
Some post-secondary 11.71 9.31 9.69 10.45 9.30 9.46 
Post-secondary 
degree/diploma 
55.86 75.47 72.36 55.80 75.26 72.60 
Annual household income (%)       
< $20,000 38.74 19.12*** 22.22 41.95 19.74*** 22.77 
≥	$20,000 and < $50,000 42.34 41.46 41.60 36.53 37.57 37.43 
≥	$50,000 and < $100,000 17.12 28.60 26.78 19.55 30.38 28.90 
≥	$100,000 and < $150,000 1.80 7.28 6.41 1.97 8.69 7.77 
≥	$150,000 0.00 3.55 2.99 0.00 3.62 3.12 
Province (%)       
Ontario 20.72 22.00 21.79 12.90 14.19 14.01 
Alberta  6.31 8.29 7.98 3.96 8.68 8.03 
British Columbia 21.62 22.67 22.51 28.30 31.49 31.06 
Manitoba 19.82 11.34 12.68 17.67 9.13 10.29 
NFLD 5.41 6.26 6.13 1.60 2.18 2.10 
Nova Scotia 7.21 8.29 8.12 3.84 3.27 3.35 
Quebec 18.92 21.15 20.80 31.74 31.06 31.15 
Urban/rural residence (%)       
Urban 94.59 94.08 94.16 92.54 93.40 93.29 
Rural 5.41 5.92 5.84 7.46 6.60 6.71 
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Health Factors       
Self-rated general health (%)       
Poor 8.11 3.05 3.85 7.26 3.53 4.04 
Fair 20.72 17.60 18.09 21.90 18.81 19.23 
Good 3964 37.73 38.03 40.57 38.76 39.00 
Very good 21.62 29.78 28.49 21.01 28.88 27.80 
Excellent 9.91 11.84 11.54 9.26 10.02 9.92 
Medication for depression (%)       
Yes 18.02 19.12 18.95 18.47 18.67 18.64 
No 81.98 80.88 81.05 81.53 81.33 81.36 
Chronic conditions2 (%)       
Yes 85.59 75.63* 77.21 85.29 74.05* 75.58 
No 14.41 24.37 22.79 14.71 25.95 24.42 
Social Factors       
Marital status (%)       
Single, never married  14.41 23.69** 22.22 13.69 22.46** 21.26 
Married/common-law 21.92 25.21 24.64 27.13 35.06 33.98 
Widowed 30.63 16.07 18.38 25.05 12.04 13.82 
Divorced/separated 33.33 35.03 34.76 34.14 30.44 30.94 
Health Behaviours       
Smoking status (%)       
Current 18.02 16.75 16.95 17.86 18.28 18.22 
Former 45.95 49.75 49.15 45.12 48.16 47.75 
Never 36.04 33.50 33.90 37.02 33.56 34.03 
Alcohol use (%)       
Current 59.46 76.99*** 74.22 59.24 76.49** 74.13 
Former 29.73 19.46 21.08 33.18 19.17 21.08 
Never 10.81 3.55 4.70 7.57 4.34 4.79 
